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Many pathways feed into the cellular respiration system.  Hemoglobin supplies the oxygen 
necessary for aerobic respiration.  Glycerol metabolism contributes electrons to the electron 
transport chain.  Rap1B regulates superoxide production and platelet activation.  I have 
determined 14 mutant structures that demonstrate how changes affect the regulation and function 
of the above systems: structural models of Enterococcus casseliflavus glycerol kinase mutants 
with glycerol or ethylene glycol, Pseudomonas aeruginosa glycerol kinase with glycerol or 
ethylene glycol, octameric human hemoglobin mutants, and two Rap1B mutants.  The structures 
demonstrate that small changes in one region of the model can significantly affect the protein 
activity and adopted conformation of other portions of the model.   
In the case of En. casseliflavus GK, the presence of loop interactions creates a domino 
effect that closes the active cleft and orients the substrates properly for glycerol phosphorylation.  
The His232Arg mutants with glycerol or ethylene glycol contain contacts between the activation 
loop and Domain I that stabilize a conformation that causes closure of the glycerol binding cleft.  
The P. aeruginosa GK adopts similar conformations to the E. coli structure in the glycerol-bound 
form.  The activation cleft closes when bound to glycerol rather than ethylene glycol as in the 
En. casseliflavus structures, but requires ATP to stabilize the area close to the active site 
entrance.   
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 v 
The octameric structure of the hemoglobin mutants are affected by the presence of ligand 
in the molecule.  The αAsn78Cys mutant does not show the same type of variability in the 
disulfide bridges, and therefore it does not have as much variability in the tetramers as the 
βGly83Cys mutants.  The structures and crystallographic results suggest that the ligand stabilizes 
the βGly83Cys mutant relative tetramer motion.   
The Rap1B models demonstrate changes in the switch II region determined by the 
phosphorylation of Ser179 rather than the presence of GTP.  The negatively-charged Ser179Asp 
residue changes the interaction between the C-terminal loop and the core of the protein, 
presenting a binding area that is inaccessible in the Ser179Ala mutant.   
 vi 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS .................................................................................................... XXI 
ABBREVIATIONS ............................................................................................................... XXIII 
1.0 RESPIRATION BACKGROUND .............................................................................. 1 
1.1 HEMOGLOBIN AS A KEY MOLECULE IN RESPIRATION .................... 1 
1.1.1 Modulating Oxygen Affinity to Create a Physiologically Relevant Oxygen 
Carrier ........................................................................................................................... 4 
1.1.2 Models of allostery ........................................................................................... 5 
1.1.3 Blood substitutes .............................................................................................. 6 
1.2 GLYCEROL METABOLISM FEEDS INTO RESPIRATION...................... 6 
1.2.1 Glyerol Metabolism Pathway ......................................................................... 7 
1.2.2 Regulation of Glycerol Metabolism ............................................................... 8 
1.2.3 Control of the Glp pathway in Gram negative bacteria .............................. 9 
1.2.4 Control of the Glp pathway in Gram positive bacteria ............................. 10 
1.3 RAP1B REGULATION AND OXIDATIVE BURST RESPONSE .............. 12 
1.3.1 G-protein function ......................................................................................... 12 
1.3.2 Ras superfamily of G proteins ...................................................................... 12 
2.0 CONTROL OF GLYCEROL METABOLISM ...................................................... 14 
2.1 INTRODUCTION ............................................................................................. 14 
 vii 
2.1.1 Mutants that affect GK activity ................................................................... 15 
2.1.2 GK Regulation and Protein-Protein Interactions....................................... 16 
2.2 MATERIALS AND METHODS ...................................................................... 17 
2.2.1 Cloning of Enterococcus casseliflavus glycerol kinase................................ 17 
2.2.2 Cloning of Pseudomonas aeruginosa glycerol kinase.................................. 17 
2.2.3 Protein expression.......................................................................................... 18 
2.2.4 Purification of His-tagged Protein ............................................................... 19 
2.2.5 Non-his-tagged Purification .......................................................................... 21 
2.2.6 GK-GlpO pull-down assay ............................................................................ 22 
2.2.7 En casseliflavus GK-En. faecalis HPr crystallization ................................. 23 
2.2.8 GK Crystallization ......................................................................................... 24 
2.2.9 Cryocooling conditions .................................................................................. 25 
2.2.10 Data collection and Processing .................................................................... 26 
2.2.11 Molecular replacement ................................................................................ 30 
2.2.12 Model refinement ......................................................................................... 31 
2.2.13 Model analysis ............................................................................................... 33 
2.3 RESULTS ........................................................................................................... 35 
2.3.1 Crystal description ........................................................................................ 35 
2.3.2 Crystallization of GK-HPr ............................................................................ 41 
2.3.3 Overall tetrameric structure ......................................................................... 42 
2.3.4 Glycerol and ethylene glycol interactions .................................................... 45 
2.3.5 En. casseliflavus activation loop ................................................................... 52 
2.3.6 The relationship between active cleft volume and activation .................... 55 
 viii 
2.3.7 Interaction between En. casseliflavus GK and En. faecalis HPr and effects 
on crystallization ........................................................................................................ 65 
2.3.8 Interactions between GK and GlpD or GlpO and crystallization trials ... 66 
2.4 DISCUSSION ..................................................................................................... 68 
2.4.1 Activation caused by activation loop stabilization...................................... 69 
2.4.2 Glycerol placement and activation ............................................................... 69 
2.4.3 Controlling activation – drug targets........................................................... 71 
2.4.4 Summary and Future Directions.................................................................. 71 
3.0 OCTAMERIC HEMOGLOBIN ............................................................................... 73 
3.1 INTRODUCTION ............................................................................................. 73 
3.1.1 Hemoglobin structure organization and nomenclature ............................. 73 
3.1.2 Mutants affecting views of allostery and hemoglobin activity .................. 74 
3.1.3 Blood substitutes ............................................................................................ 76 
3.1.4 Octameric hemoglobin .................................................................................. 77 
3.1.5 Mutant rationale ............................................................................................ 78 
3.2 MATERIALS AND METHODS ...................................................................... 79 
3.2.1 Expression and Purification of rHb ............................................................. 79 
3.2.2 Secondary purification of oHb after freezing ............................................. 80 
3.2.3 Crystallization ................................................................................................ 81 
3.2.4 Creation of oHbCN mutants and crystallization ........................................ 82 
3.2.5 Data Collection ............................................................................................... 86 
3.2.6 Data processing .............................................................................................. 87 
3.2.7 Molecular replacement and Model refinement ........................................... 89 
 ix 
3.2.8 Model analysis ................................................................................................ 90 
3.3 RESULTS ........................................................................................................... 92 
3.3.1 Determining acceptable buffer conditions .................................................. 92 
3.3.2 Crystallization and data refinement ............................................................ 93 
3.3.3 Octameric nomenclature ............................................................................... 96 
3.3.4 Stability of the octameric hemoglobin ....................................................... 101 
3.3.5 Comparison of octameric mutants and previously-determined models . 107 
3.3.6 Comparison of Heme Pockets ..................................................................... 120 
3.3.7 Effects of the βPhe41Tyr mutation ............................................................ 128 
3.3.8 Cysteine positioning and activity................................................................ 130 
3.3.9 oHb vs. HbCN .............................................................................................. 131 
3.4 DISCUSSION ................................................................................................... 138 
3.4.1 Effects of the βPhe41Tyr mutation ............................................................ 139 
3.4.2 Effects of cyanide on crystallization........................................................... 140 
3.4.3 Comparison to HbA..................................................................................... 140 
3.4.4 Summary and Future Directions................................................................ 141 
4.0 RAP1B ....................................................................................................................... 143 
4.1 INTRODUCTION ........................................................................................... 143 
4.2 MATERIALS AND METHODS .................................................................... 144 
4.2.1 Crystallization .............................................................................................. 144 
4.2.2 Data Collection and Processing .................................................................. 144 
4.2.3 Model Refinement........................................................................................ 145 
4.3 RESULTS ......................................................................................................... 146 
 x 
4.3.1 Overall Structure and Changes in the C-terminus ................................... 146 
4.3.2 GTP site ........................................................................................................ 148 
4.3.3 Protein changes close to the active site ...................................................... 151 
4.3.4 Changes in the Switch II Region ................................................................ 151 
4.4 DISCUSSION ................................................................................................... 152 
4.4.1 Position of Thr35 as a significant modulator ............................................ 153 
4.4.2 Summary ...................................................................................................... 153 
5.0 CONCLUSION ......................................................................................................... 155 
BIBLIOGRAPHY ..................................................................................................................... 161 
 xi 
 LIST OF TABLES 
 
Table 2.1 Data processing statistics for En. casseliflavus His232Arg and His232Glu models .... 28 
Table 2.2 Data processing statistics for the P. aeruginosa GK with either glycerol or ethylene 
glycol............................................................................................................................................. 29 
Table 2.3 Data processing statistics for representative En. casseliflavus GK-En. faecalis HPr 
cocrystallization trials ................................................................................................................... 30 
Table 2.4 Molecular replacement and refinement statistics for the En. casseliflavus His232ArgR 
and His232Glu models with glycerol or ethylene glycol. ............................................................. 32 
Table 2.5 Molecular replacement and refinement statistics for P. aeruginosa GK with glycerol or 
ethylene glycol .............................................................................................................................. 33 
Table 2.6 Escherichia coli models currently in the PDB.  The PDB ID, select molecular 
statistics, mutations, and other ligands are listed for reference. ................................................... 43 
Table 2.7 Comparison of P. aeruginosa GK tetramer with active and inactive E. coli GK 
tetramers ........................................................................................................................................ 44 
Table 2.8.Rotation necessary to superimpose other monomers onto P. aeruginosa GK with 
glycerol ......................................................................................................................................... 44 
Table 2.9. Rotation necessary to superimpose other monomers onto P. aeruginosa GK with 
ethylene glycol .............................................................................................................................. 44 
 xii 
Table 2.10 En. casseliflavus His232Arg hydrogen bonding distances between glycerol and active 
site residues ................................................................................................................................... 48 
Table 2.11 En. casseliflavus His232Glu hydrogen bonding distances between the glycerol and 
glycerol kinase active site residues ............................................................................................... 49 
Table 2.12 Average hydrogen bonding distances (Å) between glycerol and glycerol kinase active 
site residues in En. casseliflavus mutants. .................................................................................... 49 
Table 2.13 En. casseliflavus His232Arg hydrogen bonding distances between ethylene glycol 
and glycerol kinase active site residues. ....................................................................................... 50 
Table 2.14 En. casseliflavus His232Glu hydrogen bonding distances between ethylene glycol 
and glycerol kinase active site residues ........................................................................................ 51 
Table 2.15 Average hydrogen bonding distances between ethylene glycol and En. casseliflavus 
glycerol kinase active site residues ............................................................................................... 51 
Table 2.16. Hydrogen bonding distances between P. aeruginosa active site residues and glycerol 
(GOL) or ethylene glycol (EDO). ................................................................................................. 52 
Table 2.17. Volume and surface area of channels in deposited PDB, calculated by 
3
V. .............. 57 
Table 2.18. Volume and surface area of channels in GK monomers determined via 
3
V with an 
inner radius of 2Å ......................................................................................................................... 59 
Table 2.19. Volume and surface area of channels in GK monomers, determined via 
3
V with an 
inner radius of 3Å ......................................................................................................................... 62 
Table 2.20 Association and Dissociation of En. casseliflavus GK and En. faecalis HPr using SPR
....................................................................................................................................................... 66 
Table 3.1 Helix designations for α and β chains adapted from references. [3, 4] ........................ 74 
Table 3.2 PEG pH and buffer screen ............................................................................................ 85 
 xiii 
Table 3.3 Data processing statistics for oHb and oHbCN data sets.............................................. 88 
Table 3.4 Data refinement statistics of oHb mutants and oHbCN mutants .................................. 91 
Table 3.5: Disulfide bridge geometry of the three oHb mutants and rHbCN(βGly83Cys) and rHb 
(βGly83Cys-Phe41Tyr) demonstrates changes that affect the relative position and reduction of 
these mutants ............................................................................................................................... 102 
Table 3.6 RMSD between α1β1 and α2β2.  Cα atoms of the α1β1 dimer were superimposed and 
the RMSD calculated (bottom portion).  RMSD of α2β2 Cα atoms were calculated after 
superposition of the α1β1 dimer, shown in the upper portion of the table. βGly83Cys (G83C), 
βGly83Cys-Phe41Tyr (F41Y) and αAsn78Cys (N78C) tetramers are shown. .......................... 104 
Table 3.7 Average RMSD (Å) of the α1β1 Cα atoms. ................................................................. 105 
Table 3.8 Average RMSD (Å) of the α2β2 Cα atoms after superposition of the α1β1 Cα atoms. 105 
Table 3.9 RMSD (Å) of the Cα atoms of the βGly83Cys and βGly83Cys-Phe41Tyr octamers. 105 
Table 3.10 RMSD (Å) of the tetramers of each of the oxidized mutants after superposition of the 
tetramer Cα atoms.  βGly83Cys (G83C), βGly83Cys-Phe41Tyr (F41Y) and αAsn78Cys (N78C).
..................................................................................................................................................... 106 
Table 3.11 Average RMSD (Å) of the Cα atoms after superposition of the mutant tetramers. . 106 
Table 3.12 PDB ID and Characteristics of HbA Models Used for Comparison ........................ 107 
Table 3.13 Comparison of cyanide-bound high salt βGly83Cys with published HbA structures. 
Dimers were superimposed separately to obtain the RMSD (Å).  In places where only one dimer 
is listed, the second dimer is obtainable by symmetry relations and would give the same RMSD 
as the α1β1 dimer. ........................................................................................................................ 109 
Table 3.14 βGly83Cys comparison against various tetrameric HbA models.  The entire tetramer 
was superimposed to obtain the tetramer RMSD.  The α1β1 dimer was superimposed to obtain the 
 xiv 
α1β1 RMSD, after which the RMSD of the nonsuperimposed α2β2 dimer and the angle necessary 
to superimpose the second dimer were determined. ................................................................... 110 
Table 3.15 βGly83Cys-Phe41Tyr comparison against various HbA models.  The entire tetramer 
was superimposed to obtain the tetramer RMSD.  The α1β1 dimer was superimposed to obtain the 
α1β1 RMSD, after which the RMSD of the nonsuperimposed α2β2 dimer and the angle necessary 
to superimpose the second dimer were determined. ................................................................... 111 
Table 3.16 αAsn78Cys comparison with various HbA models.  The entire tetramer was 
superimposed to obtain the tetramer RMSD.  The α1β1 dimer was superimposed to obtain the 
α1β1 RMSD, after which the RMSD of the nonsuperimposed α2β2 dimer and the angle necessary 
to superimpose the second dimer were determined. ................................................................... 113 
Table 3.17 Average Cα RMSD (Å) of the tetramers .................................................................. 114 
Table 3.18 Average angle necessary to superimpose α2β2 dimers after superposition of α1β1 
dimers .......................................................................................................................................... 114 
Table 3.19 Hydrogen bonding contacts (Å) between α1β1 dimers for αAsn78Cys dimers ........ 114 
Table 3.20 Hydrogen bonding contacts (Å) between α1-β2 dimers in αAsn78Cys mutant ........ 115 
Table 3.21 Hydrogen bonding contacts (Å) between the α1 and β1 subunits in the βGly83Cys 
mutant ......................................................................................................................................... 116 
Table 3.22 Hydrogen bonding (Å) distances between the α1 and β2 monomers in βGly83Cys 
mutant ......................................................................................................................................... 117 
Table 3.23 Hydrogen bonding distances (Å) between α1 and β1 monomers in the βGly83Cys-
Phe41Tyr mutant ......................................................................................................................... 118 
Table 3.24 Hydrogen bonding distances (Å) between α1 and β2 monomers in the βGly83Cys-
Phe41Tyr mutant ......................................................................................................................... 119 
 xv 
Table 3.25 Distance from heme iron to various planes in the heme pocket.  All numbers are in 
Ångstroms.  Shown are distances from the iron to the proximal histidine (Prox His), distal 
histidine (Dist His), hydroxyl ligand (OH), the plane described by the 4 pyrrol nitrogens (Pyr N 
plane), and the plane described by the outer carbon atoms of the porphyrin ring (Por C plane).
..................................................................................................................................................... 125 
Table 3.26 Average heme pocket geometry in the oxidized octameric mutants. ....................... 127 
Table 3.27 Hydrogen bonding distances of mutant βPhe41Tyr interactions .............................. 130 
Table 3.28 Heme group geometry of the high salt βGly83Cys CN structure. All numbers are in 
Ångstroms.  Shown are distances from the iron to the proximal histidine (Prox His), distal 
histidine (Dist His), hydroxyl ligand (OH), the plane described by the 4 pyrrol nitrogens (Pyr N 
plane), and the plane described by the outer carbon atoms of the porphyrin ring (Por C plane).
..................................................................................................................................................... 135 
Table 3.29 RMSD of dimers of the high salt octameric βGly83Cys CN and previously published 
structures (by chain) after α1β1 dimer superposition.  Where only one dimer comparison is 
listed, the second dimer is related by the asymmetric unit and would give identical RMSD 
values. ......................................................................................................................................... 135 
Table 3.30 Comparison of high salt βGly83Cys with previously published structures.  See text 
for detailed methods. ................................................................................................................... 137 
Table 4.1 Data Refinement Statistics for Rap Ser179D and Rap Ser179A. ............................... 146 
 xvi 
LIST OF FIGURES 
 
Figure 1.1 Tetrameric HbA contains 2 α subunits (in shades of red) and 2 β subunits (in shades of 
blue). Each monomer contains a heme group (in yellow).  A yellow carbon monoxide molecule 
is shown interacting with each heme group. ................................................................................... 3 
Figure 1.2 The tetrameric nomenclature and positions of GK (left).  The image on the right 
shows Domain I (green), Domain II (blue) and the activation loop where phosphorylation occurs 
in Gram positive bacteria (red). .................................................................................................... 10 
Figure 2.1 15% SDS-PAGE gel of his-tagged En. casseliflavus GK purification. ...................... 20 
Figure 2.2 15% SDS-PAGE gel of his-tagged E. faecalis HPr purification.  Elution 1 shows 
purified HPr, which was used for crystallization and SPR trials. ................................................. 21 
Figure 2.3 15% SDS-PAGE gel of En. casseliflavus GK fractions after the MonoQ column show 
highly purified protein. ................................................................................................................. 22 
Figure 2.4 En. casseliflavus His232Arg mutant with glycerol from a modified Hampton crystal 
screen I 42 with 0.05 M KH2PO4, 17% PEG 8000 and 10% glycerol.  Image taken by Dr. Ruth L. 
Saxl. .............................................................................................................................................. 36 
Figure 2.5 En. casseliflavus His232Arg mutant with ethylene glycol in Hampton crystal screen I 
42, 0.05 M KH2PO4 and 17% PEG 8000.  Image taken by Dr. Ruth L. Saxl............................... 37 
 xvii 
Figure 2.6 En. casseliflavus His232Glu mutant with ethylene glycol in Hampton crystal screen I 
42, 0.05 M KH2PO4 and 20% PEG 8000.  Image taken by Dr. Ruth L. Saxl............................... 38 
Figure 2.7 En. casseliflavus His232Glu with glycerol in Hampton crystal screen II 27, 0.01 M 
ZnSO4, 0.2 M MES pH 6.5 and 25% v/v PEG 550 MME.  Image taken by Dr. Ruth L. Saxl. ... 39 
Figure 2.8 P. aeruginosa GK with glycerol in Hampton cryo II 15, consisting of 0.375 M 
ammonium sulfate, 0.075 M sodium citrate pH 5.6, 0.75 M lithium sulfate and 25% v/v glycerol. 
Image taken by Dr. Ruth L. Saxl. ................................................................................................. 40 
Figure 2.9 P. aeruginosa GK with ethylene glycol crystallized in Wizard I 8, consisting of 2.0 M 
ammonium sulfate, 0.1 M sodium citrate pH 5.5.  Image taken by Dr. Ruth L. Saxl. ................. 41 
Figure 2.10 Crystals of GK:HPr in Emerald cryo I 41, consisting of 25% v/v 1,2-propanediol, 0.1 
M sodium phosphate/citrate pH 4.2, 5% w/v PEG 3000, 10% v/v glycerol................................. 42 
Figure 2.11 En. casseliflavus glycerol-bound active site Hydrophobic residues are shown in 
yellow, while hydrophilic residues are shown in blue.  The phosphate in magenta is at the 
entrance to the active cleft. ........................................................................................................... 47 
Figure 2.12 En. casseliflavus ethylene glycol active site.  Hydrophobic residues are shown in 
yellow, while hydrophilic residues are shown in blue.  The phosphate in magenta is at the 
entrance to the active cleft. ........................................................................................................... 47 
Figure 2.13 Comparison of E. casseliflavus GK loops shows the large changes in the 
hydrophobic residues caused by the His232Arg and His232Glu mutations ................................. 54 
Figure 3.1 Spectra from 400 nm to 600 nm of βGly83Cys after thawing, oxidation, and treatment 
with cyanide. ................................................................................................................................. 84 
Figure 3.2 Polyacrylamide native gels (7.5%) of Superdex 200 fractions of αAsn78Cys.  
Fractions show that one peak consists of stable octameric αAsn78Cys, while the other peak 
 xviii 
consists of tetrameric αAsn78Cys.  βGly83Cys and βGly83Cys-Phe41Tyr mutants show the 
same feature. ................................................................................................................................. 93 
Figure 3.3 βGly83Cys crystals obtained from of 20% w/v PEG 3000, 0.1 M Tris pH 10.0, 0.2 M 
calcium acetate. ............................................................................................................................. 94 
Figure 3.4 βGly83Cys-Phe41Tyr crystals 20% w/v PEG 3000, 0.1 M Tris pH 9.0, 0.2 M calcium 
acetate. .......................................................................................................................................... 94 
Figure 3.5 αAsn78Cys crystals obtained from 0.17 M lithium sulfate, 85 mM Tris-HCl pH 8.5, 
25.5% PEG 4000, and 15% glycerol. ........................................................................................... 95 
Figure 3.6 βGly83Cys CN in Wizard I 33, consisting of 2.0 M ammonium sulfate, 0.1 M CAPS 
pH 10.5, 0.2 M lithium sulfate. ..................................................................................................... 95 
Figure 3.7 βGly83Cys CN in Wiz I 28, consisting of 20% PEG 3000, 0.1 M HEPES pH 7.5, 0.2 
M sodium chloride. ....................................................................................................................... 96 
Figure 3.8 Nomenclature of Octameric Hemoglobin ................................................................... 97 
Figure 3.9 Overall octemeric structure of oHb mutants demonstrates the difference in relative 
tetramer orientation in α and β mutants.α monomers are in shades of red, β monomers are in 
shades of blue. ............................................................................................................................. 100 
Figure 3.10 Superposition of the two βGly83Cys octamers found in the same asymmetric unit 
shows changes between the two tetramers are caused by changes in the disulfide bridge 
geometry. .................................................................................................................................... 101 
Figure 3.11 Differences in the αAsn78Cys (red) and βGly83Cys (green) disulfide bridges cause 
changes in the relative orientations of the tetramers. The inset shows an expanded view of the 
superimposed disulfide bridges. .................................................................................................. 103 
 xix 
Figure 3.12 Electron density of representative heme pockets demonstrating the aquamet form of 
βGly83Cys-Phe41Tyr. ................................................................................................................ 122 
Figure 3.13 Electron density of the heme pocket in βGly83Cys demonstrating the ligand-bound 
and unbound forms of the aquamet model. ................................................................................. 123 
Figure 3.14 Electron density of the αAsn78Cys aquamet model with representative images of the 
α and β heme pockets. ................................................................................................................. 124 
Figure 3.15 Hydrogen Bonding Interactions of the Mutated βTyr41 in βGly83Cys-Phe41Tyr . 129 
Figure 3.16 Proximity of βTyr41 and Interacting Residues to the β Heme ................................ 130 
Figure 3.17 Superposition of one tetramer of the βGly83Cys CN (green) and oβGly83Cys (blue) 
shows the large difference in the position of the second tetramer due to changes in the disulfide 
bridge geometry.  The second tetramer is shifted by 24°. .......................................................... 133 
Figure 3.18 Cyanide-bound βGly83Cys heme compared to hydroxyl-bound βGly83Cys heme.  
The distal His moves away from the heme pocket to accommodate the cyanide. ...................... 134 
Figure 4.1 Superposition of Ser179Ala (magenta) and Ser179D (blue) showing the differences in 
the C-terminal loop position ....................................................................................................... 147 
Figure 4.2 C-terminal region showing the Ser179Asp mutant (blue) with the mutation point 
marked with a ball at the Cα and Ser179Ala mutant (magenta).  The C-terminal loop extends in 
the Ser179 mutant and is stabilized by interactions between the negatively-charged Asp179 and 
the protein core. .......................................................................................................................... 148 
Figure 4.3 GDP binding site in Rap Ser179Ala.  The binding site and interactions are identical in 
the Ser179Ala and Ser179Asp mutants.  Dotted lines show the hydrogen bonding interactions 
between the protein and GDP. .................................................................................................... 149 
 xx 
Figure 4.4 Electron density of the GDP and surrounding residues in Rap1B Ser179A.  The 
Rap1B Ser179D contains the same contacts. .............................................................................. 150 
Figure 4.5 The Cα trace of the Ser179Asp mutant (blue) and Ser179Ala mutant (magenta). ... 152 
 xxi 
ACKNOWLEDGEMENTS 
I would like to thank my research advisor, Dr. Joanne I. Yeh, for her support and guidance 
during my graduate career.  She has given me a series of interesting projects and has provided 
opportunities for me that would otherwise have been unattainable.   
My committee members have been extremely supportive.  I would like to thank Dr. Paula 
Grabowski, Dr. Roger Hendrix and Dr. Anthony Schwacha for their understanding and guidance.  
I would like to thank Dr. Andrew VanDemark for his willingness to step in on a very short 
notice.   
Without the support of other researchers who helped me during graduate school, this 
research would not have been possible.  Members of the Yeh lab assisted in my training both in 
research and in life.  Dr. Ruth L. Saxl, Dr. Shoucheng Du, Dr. JohnJeff Alvarado, Dr. Haibin 
Shi, Dr. Unmesh Chinte, Dr. Laurie Betts and Dr. Ivan Vorontsov were always available and 
willing to answer questions.  Dr. Chien Ho and his laboratory were very generous in providing 
me with octameric hemoglobin protein, and providing me with interesting feedback and 
discussions about the work.  Dr. Daniel Altschuler and his laboratory provided Rap1B and 
interesting interpretations of the Rap1B models.   
Last but not least I would like to express appreciation for my family and friends who 
were supportive of my dreams and encouraged me throughout my schooling.  Special thanks 
 xxii 
goes to Ms. Vanessa Kettering and Mr. John Orndorff, Jr, both of whom tolerated my laboratory 
schedule.   
 xxiii 
ABBREVIATIONS 
Abbreviations that are used are shown with the full name and the abbreviation in 
parentheses for its first instance.  All further instances use the listed abbreviation.  Abbreviations 
that are found within this dissertation are as follows: 2,3-diphosphoglycerol (2,3-DPG); 
adenosine diphosphate (ADP); adenosine triphosphate (ATP); Bis(2-hydroxyethyl)amino-
tris(hydroxymethyl)methane (Bis-Tris); 1,3-Bis[tris(hydroxymethyl)methylamino]propane 
(BTP); 3-(Cyclohexylamino)-1-propanesulfonic acid (CAPS); 2-(cyclohexylamino) 
ethanesulfonic acid (CHES); cyanide (CN); carbon monoxide (CO); carbon dioxide (CO2); 
dihydroxyacetone phosphate (DHAP); Enterococcus casseliflavus (En. casseliflavus); 
Escherichia coli (E. coli); Enterococcus faecalis (En. faecalis); electron transport chain (ETC); 
flavin adenine dinucleotide (FAD); flavin adenine dinucleotide hydroquinone (FADH2); 
glycerol-3-phosphate (G3P); guanosine diphosphate (GDP); glycerol kinase (GK); Enterococcus 
casseliflavus glycerol kinase complexed with Enterococcus faecalis histidine phosphorylating 
protein (GK:HPr); syn-glycerol-3-phosphate dehydrogenase (GlpD); glycerol facilitator (GlpF); 
syn-glycerol-3-phosphate oxidase (GlpO); glycerol-3- phosphate transporter (GlpT); guanosine 
triphosphate (GTP); adult human hemoglobin (HbA); hemoglobin-based oxygen carriers 
(HBOC); 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES); histidine 
phosphorylating protein (HPr); haptoglobin (Hpt); isopropyl β-D-1-thiogalactopyranoside 
(IPTG);  Koshland, Nemethy, Filmer (KNF); monomethyl ether (MME); 2-(N-
 xxiv 
Morpholino)ethanesulfonic acid (MES); Monod, Wyman, Changeux (MWC); nicotinamide 
adenine dinucleotide (NAD
+
); nicotinamide adenine dinucleotide hydroquinone (NADH); 
nicotinamide adenine diphosphate hydroquinone (NADPH); oxygen molecule (O2); octameric 
hemoglobin (oHb); Pseudomonas aeruginosa (P. aeruginosa); protein data bank (PDB); 
polyethylene glycol (PEG); phosphotransferase system (PTS); Root mean square deviation 
(RMSD); Streptococcus pyogenes (S. pyogenes); N-(Tris[hydroxymethyl]methyl)-3-
aminopropanesulfonic acid (TAPS); tris(hydroxymethyl)aminomethane (Tris);  
 
 
 
 1 
1.0  RESPIRATION BACKGROUND 
Respiration is a broad term that applies to several biological processes.  Cellular respiration is the 
catabolic process of breaking items such as glucose or glycerol down so that the cell can use the 
products to form energy.  Respiration can also refer to the act of breathing and supplying oxygen 
to the various parts of the body.  The electron transport chain (ETC) utilizes oxygen, carried by 
hemoglobin, as a final electron acceptor, splitting oxygen into two molecules of water.  Oxygen 
from respiration can be shunted to create superoxide for destroying pathogens, which is 
controlled by Rap1 proteins.  The electrons can be supplied by either nicotinamide adenine 
dinucleotide (NADH) or flavin adenine dinucleotide hydroquinone (FADH2).  Glycerol 
metabolism can also provide electrons for use in the ETC.  This dissertation examines 
hemoglobin, the glycerol metabolism pathway, and superoxide production, all of which are 
involved in respiration.   
1.1 HEMOGLOBIN AS A KEY MOLECULE IN RESPIRATION 
Human hemoglobin has been studied for over a century.  The individual components of the blood 
cells and the ability to form red crystals were first examined, followed by the structure and 
allosteric regulation of oxygen delivery [1].  Adult human hemoglobin consists of two  
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dimers, creating a heterotetramer [2-7].  The  chains consist of 141 residues, whereas the  
chains contain 146 residues.  Although only 43% identical, the two chains fold into a nearly 
identical tertiary structure, and are also nearly identical in tertiary structure to myoglobin, despite 
only 26% and 25.5% amino acid identity between myoglobin and hemoglobin α and β, 
respectively [8].  Myoglobin serves as a monomeric oxygen carrier in muscle tissue [9].  
Hemoglobin was the second crystal structure that was determined, revealing a quaternary 
structure that consisted of a dimer of interacting  dimers (see [3, 4] for interactions).  The 
more stable dimerization interactions stabilize the 11 and 22 dimers, whereas interactions 
between dimers are listed as 12 or 21 interactions (see Figure 1.1). 
Hemoglobin contains a prosthetic group heme (see Figure 1.1).  Heme contains four 
imidazole rings linked together with the nitrogen atoms pointing towards the center of the ring.  
An iron atom is coordinated by the nitrogen atoms.  Portions of the carbon ring contain methyl or 
ethyl groups that further enhance the hydrophobicity of the heme group.  Two carboxylate 
groups are attached to two of the four imidazole groups, oriented on the same side of the 
porphyrin ring.  The carboxylate groups create a hydrophilic area that helps the heme orient in 
the hydrophobic pocket of the α and β monomers of hemoglobin.  Each monomer contains one 
heme group, which stabilizes the hemoglobin tertiary structure [2-4, 6, 7, 10-12].  During oxygen 
transport, one molecule of oxygen binds to each heme group.  Without the heme group, 
hemoglobin would be unable to carry oxygen.  Carbon monoxide, another two-atom molecule 
with similar electron properties to oxygen, can also bind to the heme groups [13, 14].  Carbon 
monoxide binding is much tighter than oxygen binding in either free or bound heme, but the 
presence of protein in bound heme significantly decreases the relative affinity of carbon 
monoxide [15].  The iron present in heme only binds to oxygen or carbon monoxide when in a 
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reduced +2 state.  When oxidized, heme does not bind to either oxygen or carbon monoxide, but 
it does bind to cyanide.   
 
Figure 1.1 Tetrameric HbA contains 2 α subunits (in shades of red) and 2 β subunits (in shades of 
blue). Each monomer contains a heme group (in yellow).  A yellow carbon monoxide molecule is shown 
interacting with each heme group. 
Intimate interactions between the 1-2 monomers strongly affect the uptake and release 
of oxygen.  Initial models of allosteric regulation proposed, in conjunction with Perutz’s 
hemoglobin models, that salt bridges and hydrogen bonds between the 1-2 monomers 
restrained the quaternary structure into the T conformation [2-4].  The T conformation is 
considered to be the Tense state, as the lack of a sixth ligand (normally formed by the oxygen 
molecule) is absent and allows the heme iron to deform the heme porphyrin plane [2].  The R 
state is considered to be the Relaxed state because the iron is in the same plane as the porphyrin 
carbon and nitrogen atoms [2].  Adult human hemoglobin (HbA) adopts the R state when 
liganded with oxygen, carbon monoxide, cyanide or water when oxidized [2-4, 6, 7, 12, 16, 17].  
Additionally, mutations along the interface can drastically affect the cooperativity and oxygen 
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affinity.  Mutations are listed as being the from the α or β monomer with the mutant created 
listed as for other proteins.  For example, the mutation Trp37Ala (a mutation on the β chain at 
residue 37 that replaces Trp with Ala) removes critical interactions in the 12 interface, 
increasing the oxygen affinity and drastically reducing the cooperativity [6].  However, 
mutations that decrease the oxygen affinity correlate to an increased heme oxidation [18].  
1.1.1 Modulating Oxygen Affinity to Create a Physiologically Relevant Oxygen Carrier 
In order to decrease the oxygen affinity of HbA in red blood cells, 2,3-diphosphoglycerol (2,3-
DPG) is created by the body.  2,3-DPG binds in the cavity between the β subunits created in the 
ligand-free T-state of HbA.  The area of this cavity is surrounded by positively-charged amino 
acids βLys82, βHis2, βHis143 and the NH3
+
 terminus of βVal1 [11, 19, 20].  The effects exerted 
by these small molecules finely tune the oxygen affinity of HbA, so that the delivery of oxygen 
is tightly optimized to physiological partial pressures, osmotic, and pH conditions [21, 22].  
Specific changes in the configuration of residues at the porphyrin binding site when effectors are 
bound further augment the oligomeric interactions that lead to cooperativity, resulting in the 
modulation of oxygen (O2), carbon monoxide (CO), and nitric oxide (NO) binding affinities [2, 
10, 23-25]  
During oxygen binding, HbA undergoes significant conformational shifts [3, 4, 6, 7].  
The unliganded form is considered to be in the T state, or tense state, as the heme group is in a 
conformation that pushes the iron atom out of the plane of the porphyrin group [2].  The liganded 
form consists of the heme iron having six interactions, rather than the five seen in the T state [2].  
The interactions including the new interaction with the ligand in the heme pocket, bring the iron 
into the plane of the porphyrin ring, resulting in the R state, or relaxed state [2].  Demonstrated 
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interactions in the x-ray crystal T state are broken during the T to R transition (see [3, 4, 6, 7] for 
details).  The hydrogen bonds are proposed to stabilize the T state conformation.   
1.1.2 Models of allostery 
Two main models of hemoglobin allostery were introduced during the mid 1960’s: the Koshland, 
Nemethy, Filmer model (KNF) known as the sequential model [26], and the Monod, Wyman, 
Changeux model (MWC) known as the concerted model [27].  Both models are based on the 
presence of two affinity states of hemoglobin, a low-affinity T state usually seen in the 
unliganded hemoglobin, and a high-affinity R state usually seen in the liganded hemoglobin.  In 
the sequential model, the binding of one ligand to one monomer creates a structural change that 
is communicated to the surrounding monomers and increases their affinity for binding the next 
successive ligand.  The tetramer can contain a combination of monomers in the T state or the R 
state.  In the concerted model, binding of ligands puts energetic stress on the T state, causing the 
entire tetramer to become R state in the process of binding successive ligands.  The concerted 
model is supported in part by crystallographic data, as no x-ray crystal structure to date 
simultaneously contains the structural T state and R state.  Current models have taken the 
concerted model, and proposed that the structural and energetic transition between the T and R 
states are modulated by the binding of one oxygen molecule to one  dimer, and a second 
oxygen molecule to the other  dimer [28, 29].  Yonetani and coworkers are also supporting a 
model of allostery that suggests a separation between the structural state of T and R and the 
affinity state of T and R [16, 30].   
A series of models have been proposed since the MWC and KNF models, some of which 
were detailed by Eaton, et al. [31].  The symmetry rule model proposed by Ackers and 
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coworkers is a combination of the two models, whereby the ligand state of one monomer affects 
the affinity of the monomer close to it to bind oxygen, and one ligand in each  dimer must be 
bound in order to switch from the T to the R state [32].  All of these models seek to 
accommodate the differences in the MWC 2-state model with the reality of ligand binding to 
hemoglobin.  Many of the models create a situation where the last ligand to bind to hemoglobin 
has unreasonable affinity (sometimes a negative affinity).  Current understanding of the 
biochemical models is necessary in order to create an appropriate blood substitute. 
1.1.3 Blood substitutes 
As the major oxygen carrier in mammalian systems, decreases in blood hemoglobin levels will 
affect the ability to carry out respiration.  Current blood replacements consist of blood 
transfusions, which have storage requirements that limit their use in military and emergency 
situations [33].  Our collaborators at Carnegie Mellon University have created a series of 
octameric hemoglobins to be used to create a cell-free hemoglobin based oxygen carrier (HBOC) 
[34].  Here we discuss the effects these mutations have on the structure and biochemistry of 
hemoglobin.   
 
1.2 GLYCEROL METABOLISM FEEDS INTO RESPIRATION 
Glucose is a common “starter molecule” for respiration.  The 6-carbon glucose gets broken down 
in aerobic respiration to smaller molecules, eventually becoming carbon dioxide and donating 
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electrons to the electron transport chain (ETC) via nicotinamide adenine dinucleotide (NAD
+
) or 
flavin adenine dinucleotide (FAD) in the Kreb’s cycle [35].  Electrons from citric acid, α-
ketogluterate and malate reduce NAD
+
 to nicotinamide adenine dinucleotide hydroquinone 
(NADH).  The electrons from succinate are transferred to FAD to form flavin adenine 
dinucleotide hydroquinone (FADH2).  NADH and FADH2 then donate their electrons to 
Complex I and Complex II of the ETC, respectively.  The electrons travel through the ETC, 
pumping protons to create a proton gradient, and finally end up reducing O2 and splitting it to 
create two water molecules.   
In the absence of glucose, many organisms can use other carbon sources, such as 
glycerol.  Glycerol is a 3-carbon molecule and can enter the aerobic respiration pathway as 
pyruvate.  Glycerol can also be used through the glycerol metabolism pathway.  Bacteria often 
utilize the glycerol metabolism pathway in the absence of phosphotransferase system (PTS) 
sugars such as glucose and fructose [36, 37].  Some bacterial strains do not grow well or do not 
grow at all if glycerol is not present [36, 38-41].   
1.2.1 Glyerol Metabolism Pathway 
The glycerol metabolism pathway starts with glycerol entering the cell via facilitated diffusion 
using the GlpF transporter.  Once glycerol is inside the cell, it is phosphorylated by glycerol 
kinase (GK), creating a negatively charged glycerol-3-phosphate (G3P) that stays in the 
cytoplasm.  G3P can also enter the cell via the GlpT transporter.  G3P is dehydrogenated by 
GlpD or GlpO, depending on the bacteria.  GlpD is a periplasmic membrane protein the uses 
FAD to pull the electrons from G3P and create dihydroxyacetone phosphate (DHAP) [42, 43].  
 8 
GlpO performs a functionally similar process, but is a cytosolic protein [44].  The resulting 
electron transfer can be used to initiate the electron transport chain as in the case of glucose. 
1.2.2 Regulation of Glycerol Metabolism 
Bacteria can use multiple carbon sources during growth, but have preferential pathways.  The 
most commonly-used pathway is the phosphoenolpyruvate pathway, in which glucose is brought 
into the cell, phosphorylated, and broken down into energy and other organic compounds [36]. 
These are listed at the PTS pathway, and are regulated via a series of enzyme phosphorylations, 
resulting in glucose gene expression [45].  However, when glucose is not present, other carbon 
sources, such as glycerol, can be used for energy and creating organic compounds [46].   
The glycerol pathway is important for regulating growth in bacteria.  When glycerol-3-
phosphate (G3P) is present, a repressor is turned off, allowing expression of the glp operon and 
genes that allow bacteria to trap and utilize glycerol.  The glp operon consists of the glpK, glpF, 
glpD, glpR, glpT and glpQ [47-50].  GlpF encodes a glycerol facilitator GlpF that allows 
glycerol to enter the cell via facilitated diffusion [51].  Without the gene product from glpK, 
glycerol kinase, the glycerol would leave the cell.  Glycerol kinase (GK) phosphorylates glycerol 
to G3P, trapping it inside of the cell and lowering the glycerol concentration inside the cell so 
that more glycerol can enter.  G3P created by GK gets shuttled to sn-glycerol-3-phosphate 
dehydrogenase (GlpD), the product of glpD, where it is converted to dihydroxyacetone 
phosphate (DHAP).  DHAP can be used as an energy source or shuttled through pathways to 
create complex organic compounds necessary for cell growth.  In some cases, the glycerol 
pathway is necessary for cell growth, and mutants that do not contain the glp operon are inviable 
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[37, 46, 49].  Although the pathway is found in both Gram positive and Gram negative bacteria, 
they are controlled very differently between the two groups. 
1.2.3 Control of the Glp pathway in Gram negative bacteria 
In Gram negative bacteria, GK activity is downregulated when fructose 1,6-bisphosphate 
(FBP) binds to loops present at the top of Domain I [52, 53] (see Figure 1.2 for domain 
structure).  The interaction stabilizes an inactive tetramer [53].  This is different from the 
interactions with unphosphorylated enzyme IIA for glucose (EIIA
Glc
), which also decreases 
activity of GK [54].  The unphosphorylated EIIA
Glc
 interacts with portions of GK ~30Å away 
from the active site at residues 474-479 [54-56].  Phosphorylated EIIA
Glc
 will not interact with 
GK because phosphorylation site would be buried in a hydrophobic pocket without enough room 
to account for the highly charged moiety [56].   
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Figure 1.2 The tetrameric nomenclature and positions of GK (left).  The image on the right shows 
Domain I (green), Domain II (blue) and the activation loop where phosphorylation occurs in Gram positive 
bacteria (red). 
Glycerol kinase is in a structural family with hexokinase, actin, and hsp70.  These 
structures contain an ATPase fold and a binding pocket for the substrate [54].  The GK models 
consist of two domains, I and II, which can be further split into three subsections.  In GK the 
subsections IA, IB, IIA and IIB are found in the other members of its family.  However, the 
subsections IC and IIC are only found in GK.  These subsections are necessary for interaction 
with HPr and EIIA
Glc
 [54].   
1.2.4 Control of the Glp pathway in Gram positive bacteria 
In the Gram positive bacteria, the activity of GK is modulated by directly 
phosphorylating a histidine on the activation loop.  The presence of G3P and lack of PTS sugars 
initiate a phosphorylation cascade that phosphorylates a histidine phosphorylating protein (HPr) 
and allows it to pick up an extra phosphate to phosphorylate the activation loop of GK in Gram 
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positive bacteria [46].  The activation loop corresponds to the residues that are used for FBP 
binding in Gram negative bacteria.  The discrepancy is caused by the fact that the Gram negative 
and Gram positive bacteria use a different orientation of dimers to regulate GK activity.  In E. 
coli, the OY dimer is the physiologically relevant dimer, and stabilization of the tetramer 
prevents glycerol phosphorylation [57, 58].  Disruption of the OX dimer in E. coli GK by 
addition of large bulky residues in the OX dimer interface reduce or eliminate inhibition by FBP 
but do not inhibit activation [57, 58].  Previous attempts at crystallizing the Gram positive 
Enterococcus faecalis GK had been unsuccessful [59].  The Deutscher lab had created a series of 
mutants with the desire to examine how the particular mutations affected GK activity [59].  The 
Deutscher lab mutated E. casseliflavus GK to modify the phosphorylated histidine, His232.  The 
His232Ala mutant has the same activity level as the basal activity level of the wild type (WT) 
GK.  The His232Glu mutant adds a negative charge to mimic the charge of the phosphorylated 
histidine [59].  However, the activity level decreases -2.5-fold rather than increasing as expected 
[59].  A His232Arg mutant was also created, with a positive charge on the position of the 
regulating histidine, but this mutant has an increased activity.  The 12-fold increase in activity is 
more than the 8-10-fold increase in activity seen in the activated phosphorylated GK [59].  The 
structures and the mutations’ affects on the activity are discussed in this dissertation. 
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1.3 RAP1B REGULATION AND OXIDATIVE BURST RESPONSE 
1.3.1 G-protein function 
G-proteins are a family of small proteins between 16-21 kDa in size that are regulated by the 
presence of guanosine trophosphate (GTP) or guanosine diphosphate (GDP).  When bound to 
GTP, the proteins are activated and bind to a number of cellular response proteins.  G-proteins 
contain two switch regions, switch I and switch II, that change in response to GTP hydrolysis 
and regulate binding with effector proteins [60-62]. 
1.3.2 Ras superfamily of G proteins 
The Ras superfamily contains proteins from the Ras, Rab, Rho, Arf, Rap, Ran, Rheb and Ral 
families, all of which are G proteins.  These proteins have approximately 50% sequence 
homology to each other, and contain a high amount of structural similarity.  Ras activates the 
MAPK pathway (reviewed in [63, 64]).  Many proteins in the Ras superfamily are involved in 
regulation of cellular processes, including intracellular trafficking, actin cytoskeletal remodeling, 
cell polarity and cell cycle progression [65-67].  Ras is involved in the respiration pathway.  The 
Gly12Val Ras mutant has been shown to retain GTP in the active site rather than hydrolyzing it 
[68].  The Gly12Val mutant switches the mitochondrial system from oxidative phosphorylation 
to glycolysis [69].   
In the superoxide response, molecular oxygen is reduced by the nicotinamide adenine 
diphosphate hydroquinone (NADPH) oxidase complex to form superoxide (O2
-•) [70, 71].  
Rap1A, a G-protein very similar to Ras, has been shown to affect the production of superoxide in 
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human B lymphocytes [72, 73].    Both Rap1A and Rap1B have been shown to be 
phosphorylated at this C-terminus at Ser residues by protein kinase A [73-79].  Both Rap1A and 
Rap1B contain hydrophibic post-translational modifications that cause them to be associated 
with the cell membrane [80, 81].  Rap1B in particular is isoprenylated at Cys181 [82].  However, 
phosphorylation of Rap1B Ser179 causes the protein to dissociate from the membrane and 
become cytosolic [83, 84].  The dissociation is proposed to affect activation and recruitment of 
secondary proteins to the membrane [82].  Rap1B activation has also been shown to induce 
platelet activation (reviewed in [85]).  
Many protein data bank (PDB) models have demonstrated the Ras protein core that 
consists of a mixture of alpha and beta structures.  The beta sheets have been shown to interact 
with various regulators [86-89].  The models show two switch regions that are involved in 
protein-protein interactions and regulation.  The G-proteins also contain a GTP nucleotide 
binding site and a divalent cation binding site (usually magnesium).   
Rap1B is extremely similar to Rap1A, with only the C-terminal tail comprising the 
difference.  However, all structures published thus far contain a terminated Rap1 protein, with a 
deletion between residues 166-168 [87-89].  Studies of Ras demonstrate long-distance 
interactions are necessary for dissociation of GDP from the active site [90].  Two mutants have 
been created to elucidate the means by which the phosphorylation affects the structure, and 
therefore the activity of Rap1B.  These are the first structures of the full-length Rap1B protein.   
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2.0  CONTROL OF GLYCEROL METABOLISM 
2.1 INTRODUCTION 
People with cystic fibrosis suffer from a buildup of liquid in their lungs, resulting in a 
propensity for infections.  The excess liquid makes it difficult to clear the lungs of extraneous 
foreign materials, including bacteria.  After contracting pneumonia, infections with bacteria such 
as Pseudomonas aeruginosa (P. aeruginosa) can become problematic.  A challenge of treating 
Pseudomonas infections in lungs is their tendency to form biofilms, bacterial colonies that are 
connected by a film of polysaccharides, rhamnose, etc. [91].  Glycerol can be used to create 
multiple sugars so preventing glycerol kinase activity may also be used to prevent biofilm 
formation [92].  Syn-glycerol-3-phosphate dehydrogenase (GlpD), one of the proteins in the 
glycerol metabolism pathway, has been shown to affect biofilm production and persister cells 
[49].  While activation has been examined in Gram negative E. coli, this mechanism has not been 
previously determined for Gram positive pathogens such as Enterococcus faecalis (En. faecalis). 
Glycerol kinase (GK) from both Gram positive and Gram negative bacteria has a distance of 
approximately 25-30 Å from the activation or repression site to the glycerol binding site (see 
Figure 1.2).  In Gram negative systems, EIIA
Glc
 interacts with GK to prevent activation by 
binding to Domain II near the OY dimer interface (see Figure 1.2) [54].  When EIIA
Glc
 is 
phosphorylated, it dissociates from GK, activating the protein [93].  In Gram positive systems, a 
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histidine on an activation or regulation loop is phosphorylated by a histidine-phosphorylating 
protein (HPr), activating GK [94]. The glycerol binding site and ATP binding site are situated 
between Domain I and Domain II [54].  Glycerol binds further into the activation cleft and must 
bind to GK first, after which ATP can bind close to the activation cleft entrance for phosphoryl 
transfer [54].  The phosphorylated histidine stays phosphorylated throughout the process, and can 
keep GK active until the phosphate dissociates from the histidine [94].  Once GK phosphorylates 
glycerol to glycerol-3-phosphate (G3P), it transfers G3P to either GlpD or GlpO [95, 96].  In 
order to understand this regulation process and the differences in the control mechanisms, 
examination of the Gram positive structures and the interactions between GK, HPr, GlpD and 
GlpO are necessary. 
2.1.1 Mutants that affect GK activity 
The Deutscher lab created a variety of mutations that altered the activity of the Gram positive 
Enterococcus casseliflavus (En. casseliflavus) GK.  Previous mutations in the Bacillus subtillus 
GK altered the activity contradictory to the expectations [97].  The Deutscher lab mutated E. 
casseliflavus GK to modify the phosphorylated histidine, His232.  The His232Ala mutant has the 
same activity level as the basal activity level of the wild type (WT) GK.  The His232Glu mutant 
adds a negative charge to mimic the charge of the phosphorylated histidine [59].  However, the 
activity level decreases -2.5-fold rather than increasing as expected [59].  A His232Arg mutant 
was also created, with a positive charge on the position of the regulating histidine, but this 
mutant has an increased activity.  The 12-fold increase in activity is more than the 8-10-fold 
increase in activity seen in the activated phosphorylated GK [59].  We crystallized and 
determined the structures of the En. casseliflavus His232Arg and His232Glu mutants in the 
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presence of glycerol or ethylene glycol in order to determine how these mutations affect the 
structure and activate En. casseliflavus GK.  In order to complete a secondary comparison, we 
also crystallized and determined the structures of P. aeruginosa GK in the presence of glycerol 
or ethylene glycol.  The glycerol-bound state shows the substrate-protein interactions that are 
necessary for activation, while the ethylene glycol-bound state shows an intermediate binding 
state of GK between the glycerol-bound state and the unbound state.  These are the first 
structures that give insight into GK activation in Gram positive bacteria, and demonstrate the 
processes that occur during glycerol binding.   
2.1.2 GK Regulation and Protein-Protein Interactions 
In order to determine the structural components of the GK-HPr interaction, I attempted to 
cocrystallize the En. casseliflavus GK with the En. faecalis HPr.  The En. faecalis and En. 
casseliflavus HPr are 88% identical, with 97% homology [98].  The resultant structures give 
insight into the regulation of the En. casseliflavus glycerol pathway.   
I also examined the interaction between P. aeruginosa GK and GlpD or GlpO variants 
from different bacterial species.  The Yeh lab was the first laboratory to determine the crystal 
structure of the E. coli GlpD, a monotopic membrane protein [99].  Both GlpD and GlpO pull 
electrons from the substrate G3P and transfer them to either NAD
+
 or FAD.  Electrons are then 
transferred to ubiquinones, which are associated with GlpD.   
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2.2 MATERIALS AND METHODS 
 
2.2.1 Cloning of Enterococcus casseliflavus glycerol kinase 
Dr. Ruth L. Saxl cloned the En. casseliflavus GK from the plasmids generously provided by the 
Deutscher lab.  PCR used 200 ng of DNA template, 1.5 mM MgSO4, 0.2 mM dNTPs, 1X KOD 
buffer, KOD polymerase 1U/µL, 0.3 µM 3’ primer, 0.3 µM 5’ primer.  After a 5 min 95° start, 
20 cycles of 95° 1 min, 1.5 min 43°, 2 min 70°, followed by 20 cycles of 1 min 95°, 0.5 min 69°, 
2 min 70° were followed by 10 min 70° and 4° cool.  The product was blunt ligated into TOPO 
blunt vector using 1 µL TOPO-blunt, 4 µL pCR product, 1X T4 buffer and 1 µL T4 ligase in a 
total of 10 µL.  Vector was used to transform chemically competent DH5 cells.   
2.2.2 Cloning of Pseudomonas aeruginosa glycerol kinase 
The P. aeruginosa GK gene was cloned by Dr. Ruth L. Saxl using genomic P. aeruginosa DNA, 
ATCC 15442, and primers of 5’ CC CAT ATG CAT CAC CAT CAC CAT CAC CAT CAC 
GAA ACC CTG TAT TTT CAG GGC AAC GAC AAG CAC AAC AAG AAA T 3’ that 
includes a 8-His N terminal tag, a TEV site, and an NdeI cleavage site, and a second primer of 5’ 
GA CTC GAG TCA CAG TTC GCC GTC GTC C 3’ that includes the stop codon and XhoI 
cleavage site for insertion into the plasmid.  A second set of primers were needed for the middle 
of the P. aeruginosa GK, as the gene contained an internal XhoI site that would render only a 
partial GK gene if not mutated.  The resulting mutation, a Glu209Glu mutation, was introduced 
 18 
via a primer with the sequence 5’ GGA TGC TCG AAG TGC TCG ACA 3’ and complementary 
primer.  The cloned segment was placed in a TOPO vector, a blunt-end ligation, and TOP10 cells 
were transformed to allow for propagation of the vector.  The vector was sequenced to determine 
that the sequence is correct, and then was purified via a Qiagen Miniprep kit.  The GK insert was 
digested out of the TOPO vector via BamHI and HinDIII endonuclease sites and ligated into 
pQE30-Xa vector between the BamHI and HinDIII restriction sites.  pQE30-Xa containing P. 
aeruginosa GK was sequenced and used to transform XL1Blue cells for expression and 
purification. 
2.2.3 Protein expression 
GK was expressed by Dr. Ruth L. Saxl and me as in Yeh, et al. and Yeh, et al. [100, 101].  
Overnight cultures of BL21DE3 pLysS were grown in Luria broth (LB, 10 g sodium chloride, 10 
g tryptone, 5 g yeast extract per liter) and 50 µg/mL carbenicillin, 50 µg/mL chloramphenicol.  
The overnight culture was centrifuged at 4000 rpm in eppendorf 5910R centrifuge for 10-30 min, 
the LB decanted, and resuspended in enough LB plus carbenicillin and chloramphenicol to 
inoculate LB with a 1:100 ratio.  Bacteria were grown to a density of 0.6-1.0 OD600,after which 
protein expression was induced for 4 hr using a final concentration of 1 mM IPTG.  Cells were 
centrifuged for 20-30 min using a Sorvall RC3C Plus centrifuge at 4000 rpm.  Cells were 
resuspended in 50 mM Tris pH 7.4, and then centrifuged again for 10-30 min at 4000 rpm using 
the ependorf 5810R centrifuge.  Cells were frozen at -20°C or -80ºC until use. 
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2.2.4 Purification of His-tagged Protein 
Cells were thawed on ice, suspended in 20-50 mL of 50 mM Tris pH 7.4-7.5 with 1X His-tagged 
protease inhibitor from Sigma-Aldrich and broken open using three passes through a fluidizer.  
The buffer for the fluidizer was 50 mM Tris pH 7.4.  The suspension of broken cells was 
centrifuged for 30 min at 4000 rpm in ependorf 5810R centrifuge, and then further centrifuged 
for 1 hr at 100,000 G in a Sorval WX Ultra with a Ti70 rotor.  This eliminated the cell debris and 
membrane components.  The supernatant was put onto a cobalt column either by incubating with 
cobalt beads on a nutator to keep the 1:1 ratio of beads:liquid suspended overnight at 4°C or by 
flowing them over the beads using a gravity flow column.  The supernatant was loaded onto a 
either a nickel column or a cobalt column, washed with wash buffer and eluted with elution 
buffer.  Wash buffer for the nickel column consisted of 50 mM Tris pH 7.5, 300 mM sodium 
chloride, and 20 mM imidazole.  Elution buffer for the nickel column consisted of 50 mM Tris 
pH 7.5, 300 mM sodium chloride, and 300 mM imidazole.  Wash buffer for the cobalt column 
contained 50 mM Tris pH 7.5, 150 mM sodium chloride and 10 mM imidazole.  Elution buffer 
for the cobalt column contained 50 mM Tris pH 7.5, 150 mM sodium chloride, 150 mM 
imidazole.  The column was washed with 10 times the column volume in wash buffer.  Protein 
was eluted using four times the column volume of elution buffer.  The protein was diluted at 
least 10X with 50 mM Tris pH 7.5, then buffer exchanged and concentrated to 8-20 mg/mL 
before being flash frozen and stored at -80°C until use.  Purification was preferentially done 
using a cobalt column that requires lower imidazole concentrations to elute the protein because 
the GK is unstable in high concentrations of imidazole and has a tendency to precipitate.  GK 
was concentrated to 8-20 mg/mL and buffer exchanged into 50 mM Tris pH 8.0 using Amicon 
concentrators with 30 kDa cutoff.  HPr was concentrated to 8-20 mg/mL and buffer exchanged 
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into 20 mM Tris pH 8.0 using Amicon concentrators with 3-5 kDa cutoff.  Protein was separated 
into 50-200 µL aliquots, flash frozen in liquid nitrogen and stored at -80°C.  
SDS-PAGE gels were run at each step to follow the protein purification steps.  Previous 
work by Dr. Ruth L. Saxl and Dr. Shoucheng Du had shown that the En. casseliflavus GK 
appears on an SDS-PAGE gel at 55 kDa, and E. faecalis HPr runs on an SDS-PAGE gel around 
9 kDa.  1X loading buffer of 2 mM BME, 2% SDS, 5% glycerol, 50 mM Tris-HCL pH 6.8 and 
bromphenol blue was added to 15 µL of sample.  The sample was incubated at 90°C for 15 min, 
then loaded into wells of a discontinuous SDS-PAGE gel, with a stacking gel of 4% 
polyacrylamide/bis-acrylamide on top of the separating gel.  Gels were run at constant voltage of 
120 V for approximately 1-1.5 hr.  Gels were stained with Coomassie blue stain and destained 
with 10% ethanol, 40% acetic acid.  Gels showing the purified En. casseliflavus GK and En. 
faecalis HPr are in Figure 2.1 and Figure 2.2. 
 
Figure 2.1 15% SDS-PAGE gel of his-tagged En. casseliflavus GK purification. 
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Figure 2.2 15% SDS-PAGE gel of his-tagged E. faecalis HPr purification.  Elution 1 shows purified 
HPr, which was used for crystallization and SPR trials. 
2.2.5 Non-his-tagged Purification 
En. casseliflavus GK was purified as detailed in Yeh et al. and Yeh et al. [100, 101].  Cells were 
treated the same as those containing the plasmid with a His-tagged GK (see Section 2.2.4) 
through centrifugation of the cell debris at 100,000 G and collection of the supernatant.  
Supernatant was loaded onto DEAE columns and eluted using a 0 M to 1 M sodium chloride 
gradient in 20 mM Tris pH 8.0.  Fractions containing GK were pooled, dialyzed into 20 mM Tris 
pH 8.0 to remove the salt and loaded onto a MonoQ column.  Protein was eluted from the 
MonoQ column using a gradient of 0 M to 1 M sodium chloride (see Figure 2.3).  Fractions 
containing purified GK were pooled, concentrated and buffer exchanged into 20 mM Tris pH 8.0 
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in an Amicon spin concentrator with a molecular weight cutoff of 30 kDa.  Protein was flash 
frozen in aliquots of 50-200 µL and stored at -80°C until use.   
 
Figure 2.3 15% SDS-PAGE gel of En. casseliflavus GK fractions after the MonoQ column show 
highly purified protein. 
2.2.6 GK-GlpO pull-down assay 
Experience with attempting GK-HPr cocrystallizations, as well as initial pull-down and SPR 
work by Dr. Shoucheng Du and Dr. Haibin Shi suggested that association of GK and other 
members of the glycerol metabolism pathway was buffer-dependent.  His-tagged P. aeruginosa 
GK was incubated overnight on cobalt resin beads so that the protein could bind to the cobalt 
beads.  1 mL syringes were prepared as mini columns by removing the plunger and putting a 
porous plastic plug into the bottom of the syringe.  The GK-bound beads were aliquoted into 14 
different 1 mL syringes that contained a plastic plug on the opening to prevent the beads from 
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leaking out of the syringe.  The beads were washed with a buffer, each buffer containing slightly 
different conditions.  The Streptococcus pyogenes GlpO was put over the beads, washed and 
eluted as in the purifications.  This procedure allowed a much higher throughput than previous 
procedures, and did not require that the native gels be tailored specifically to the conditions 
tested.  No buffer contained a pH lower than 6.0, as that would prevent the GK from interacting 
with the column.  None of the buffers used had structures close to Tris (i.e. bicine, tricine, BTP, 
etc.). 
2.2.7 En casseliflavus GK-En. faecalis HPr crystallization 
Initial cocrystsallization attempts used En. casseliflavus GK and En. faecalis HPr incubated 
together in molar ratios of 1:1 to 1:5.  (For further reference, this combination is listed as 
GK:HPr.)  After incubation of 5-30 min, 96-well crystal screens were set up using 80 µL of 
mother liquor, 0.4-0.5 µL of protein between 8-15 mg/mL and 0.4-0.5 µL of crystallant.   
Later attempts at cocrystallization used En. casseliflavus GK and En. faecalis HPr that 
were copurified together.  50 µL of HPr were neutated overnight at 4°C with a 50% slurry of 5 
mL cobalt beads and 50 mM Tris-HCl pH 7.4, 30 mM sodium chloride, 10 mM imizadole.  A 
1.5 molar excess (1.25 mL of GK) was incubated overnight with cobalt in a 1:5 molar ratio of 
GK:cobalt, intended to bind to the His tags to prevent the GK from binding directly to the 
column. 
Cobalt beads with En. faecalis HPr were put into a column and washed with 50 mL of 50 
mM Tris-HCl pH 7.4, 10 mM imidazole, 300 mM sodium chloride, 10 mM imidazole.  The pre-
incubated GK was flowed over the cobalt beads, then washed with another 50 mL of the 
previous buffer.  The beads were eluted with two sets of 10 mL (20 mL total) of 50 mM Tris-
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HCl pH 7.4, 300 mM sodium chloride, 150 mM imidazole.  Fractions were run on a gel to 
confirm copurification.  The proteins were concentrated to 10 mg/mL and used for 96-well trays.  
Conditions which showed crystals or crystalline material were used to create larger drops in 24-
well trays, with 500-800 µL mother liquor in the well and drops containing ratios of 
protein:crystallant between 1:4 and 4:1. 
2.2.8 GK Crystallization 
Initial En. casseliflavus GK was obtained from Dr. Ruth L. Saxl at 10-15 mg/mL.  Protein was 
concentrated in an Amicon filter to 10-15 mg/mL prior to crystallization setup or diluted using 
buffer.  The buffers were exchanged into 50 mM Tris pH 7.5 with or without 10% glycerol.  I 
assisted Dr. Ruth L. Saxl with crystallization setups and crystal optimization.   
Crystallization tests used protein concentrations between 8-20 mg/mL in 50 mM Tris pH 
7.5 with or without 10% glycerol.  All crystals were obtained via vapor diffusion.  Crystallization 
screens were set up in 96-well trays using 80 µL of mother liquor, with 0.5 µL protein and 0.5 
µL of crystallant in the drop.  Initial hits were repeated in 24-well trays with 500-800 µL of 
mother liquor and drops containing between 1:4 and 4:1 ratios of protein:crystallant.  Initial hits 
were optimized by varying the protein:crystallant ratio, concentration of precipitating reagent 
and pH, with the goal of increasing the size of the crystals and the diffraction resolution.  
His232Arg crystals that produced the highest resolution data images were obtained from 0.05 M 
KH2PO4, 17 % w/v PEG 8000 with 10% glycerol and soaked with 23% ethylene glycol.  
His232Glu crystals that produced the highest resolution data images were obtained from 0.1 M 
HEPES pH 6.5, 10 mM ZnSO4, 25 % w/v PEG 550 MME with 10% glycerol, and 0.05 M 
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KH2PO4, 20% w/v PEG 800 soaked with 25% ethylene glycol.  Data collection and processing 
are described in 2.2.10.   
P. aeruginosa GK was thawed on ice and buffer exchanged into 50 mM Tris pH 8.0, 10% 
glycerol.  Protein was concentrated to 8-12 mg/mL and used in crystal screens in 96-well trays, 
using the Honeybee robot to set them up.  Tray setups contained 0.5 µL of protein and 0.5 µL of 
precipitant in the drops, and 80 µL of precipitant in the well.  Crystals were seen within 24 hr.  
For conditions that had initial hits, the conditions were replicated in a larger format containing 
500-800 µL of mother liquor in the well, and drops containing 1:4 to 4:1 ratios of 
protein:precipitant.  Vapor diffusion trays were set up using an electronic pipette with aliquots in 
0.5 µL steps, which gave more consistent results than the manual pipette.  Crystals were obtained 
from these drops and flash cooled in liquid nitrogen before mounting at 100K.  See Figure 2.4 to 
Figure 2.9 for crystal images. 
2.2.9 Cryocooling conditions 
X-ray radiation of protein crystals creates free radicals and damages the biological material in the 
protein crystals.  If unattenuated, radiation damage in protein crystals will significantly limit the 
resolution and the number of exposures a crystal will be able to support before the internal 
components are destroyed.  In order to reduce the amount of radiation damage that is perpetuated 
during the x-ray exposure process, protein crystals are cooled to a temperature around 100K (-
180°C) using liquid nitrogen.  Using the mother liquor, and increasing the concentration of 
glycerol to a final concentration between 20-30%, protected crystals that were crystallized in 
glycerol-containing conditions.  Crystals that did not contain glycerol were cryoprotected in 20-
30% ethylene glycol with mother liquor.  Cryoprotection allowed each structural model to be 
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represented by a single crystal, allowing further determination of which conformational changes 
were a product of the crystallization and which conformational changes were indicative of a 
functional change.   
2.2.10 Data collection and Processing 
En. casseliflavus His232Glu with glycerol was collected at SLS X06A, 1080 images, total of 
270°.  En. casseliflavus His232Arg with glycerol was collected at SLS with a total of 1883 
images, total of 470.75°.  En. casseliflavus His232Arg and His232Glu with ethylene glycol was 
collected using a Rigaku Superbright FRE generator and Saturn 944 CCD detector.  Data was 
processed using d*trek [102] or HKL2000 [103].  Data for the His232Arg with glycerol went to 
1.73Å.  Data for the His232Glu with glycerol went to 1.75Å.  Data for the His232Arg with 
ethylene glycol went to 2.30Å, and data for the His232Glu with ethylene glycol went to 2.65Å.  
Data statistics for the datasets are found in Table 2.1.   
P. aeruginosa glycerol-bound GK data was collected on the HTC using an FRE 
Superbright generator for glycerol data in slices of 1°, 150 images (150° collected total).  Data 
for the P. aeruginosa ethylene glycol-containing model was collected at the GM/CA beamline at 
the Advanced Photon Source at Argonne National Laboratory in Chicago in slices of 1° rotation, 
for a total of 299 images (299° collected total).  Ethylene glycol-bound P. aeruginosa GK data 
was processed in d*trek [102] to 1.75Å.  Glycerol-bound P. aeruginosa GK data was processed 
by Dr. Ruth L Saxl to 1.73Å resolution in d*trek [102].  See Table 2.2 for data processing 
statistics.   
GK:HPr crystals were collected on a Saturn 944 CCD using an FRE Superbright 
generator.  Data was processed using d*trek [102]. Two forms of crystals were examined: one 
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form contains a P21212 spacegroup similar to En. casseliflavus GK, and the second contains a P3 
spacegroup.  See Table 2.3 for statistics. 
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Table 2.1 Data processing statistics for En. casseliflavus His232Arg and His232Glu models 
 His232Arg with 
glycerol 
His232Arg with 
ethylene glycol 
His232Glu with 
glycerol 
His232Glu with 
ethylene glycol 
Total reflections 930,616 335,073 891,523 181,650 
Unique 
reflections 
115,245 92,379 100,197 61,660 
Space group P21212 P21 P21212 P21 
Unit cell 
parameters 
    
a (Å) 96.81 98.89 96.68 98.61 
b (Å) 200.46 103.89 199.55 105.19 
c (Å) 56.51 114.17 56.81 114.30 
 90 90 90 90 
 90 114.3 90 114.55 
 90 90 90 90 
Resolution (Å) 50-1.73 50-2.3 50-1.75 50-2.65 
Rsym (%)
ab
 8.7 (49.8) 8.2 (52.8) 9.5 (47.4) 8.3 (30.4) 
I/()I 9.3 (2.8) 11.1 (2.1) 8.4 (2.5) 7.5 (2.1) 
Redundancy 8.08 (8.06) 3.8 (3.6) 8.9 (2.6) 2.95 (2.90) 
Completeness 
(%) 
99.7 (100) 98.5 (97.0) 97.6 (81.4) 99.7 (99.9) 
Mosaicity 0.695 0.485-0.686 0.701 0.492 
2 0.97 (1.02) 1.01 (1.06) 1.02 0.99 (1.31) 
Number of 
images 
1,080 180 1,080 322 
Number of 
images used 
802 180 1,068 141 
Degrees per 
image (°) 
0.25 1 0.25 1 
Total oscillation 
(°) 
270 180 270 322 
Oscillation used 
(°) 
200.5 180 267 141 
a
 Numbers in parentheses are values for the highest resolution shell (out of ten shells). 
b
 Rsym=ΣhΣi|I(h,i)-<I(h)>|/ΣhΣiI(h,i) where I(h,i) is the intensity values of the ith measurement of h and <I(h)> is the 
corresponding mean values of I(h) for all i measurements. 
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Table 2.2 Data processing statistics for the P. aeruginosa GK with either glycerol or ethylene glycol 
 GK with glycerol GK with ethylene glycol 
Total Reflections 340,717 420,822 
Unique Reflections 66,853 69,431 
Space Group I222 I222 
a (Å) 62.31 62.55 
b (Å) 115.15 114.81 
c (Å) 190.03 190.58 
α (°) 90 90 
β (°) 90 90 
γ (°) 90 90 
Resolution (Å) 50-1.73 50-1.75 
Rsym (%)
ab
 4.5 (48.0) 5.8 (53.5) 
Completeness (%) 91.7 (54.9) 99.9 (99.9) 
I/σ(I) 14.0 (2.1) 11.0 (2.4) 
Redundancy 5.10 (2.95) 6.06 (5.96) 
Mosaicity 1.07 0.75 
2 0.95 (1.25) 0.95 (1.26) 
Total Number of Images 299 150 
Rotation per Image 0.5 1 
Total Rotation 149.5 150 
Number of Images Used 288 150 
Rotation Used 144 150 
a
 Numbers in parentheses are values for the highest resolution shell (out of ten shells). 
b
 Rsym=ΣhΣi|I(h,i)-<I(h)>|/ΣhΣiI(h,i) where I(h,i) is the intensity values of the ith measurement of 
h and <I(h)> is the corresponding mean values of I(h) for all i measurements. 
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Table 2.3 Data processing statistics for representative En. casseliflavus GK-En. faecalis HPr 
cocrystallization trials 
 GK-HPr 1 GK-HPr 2 
Total Reflections 203,740 335,362 
Unique Reflections 102,995 68,241 
Resolution (Å) 50-3.10 50-2.05Å 
Space group P3 P21212 
a (Å) 161.3 95.893 
b (Å) 161.3 200.851 
c (Å) 194.5 56.281 
 (°) 90 90 
 (°) 90 90 
 (°) 120 90 
Completeness (%) 
a
 100 (100) 15.2 (44.1) 
I/(I) 8.09 (1.74) 8.7 (4.1) 
Rsym (%) 
b
 18.1 (47.2) 4.9 (4.9) 
Redundancy 7.9 (7.2) 98.0 (98.6) 
a
 Numbers in parentheses are values for the highest resolution shell (out of ten shells). 
b
 Rsym=ΣhΣi|I(h,i)-<I(h)>|/ΣhΣiI(h,i) where I(h,i) is the intensity values of the ith measurement of 
h and <I(h)> is the corresponding mean values of I(h) for all i measurements. 
2.2.11 Molecular replacement 
The En. casseliflavus His232Ala model determined by Dr. Joanne Yeh, et al (PDB ID 3D7E) 
was modified to contain only protein from residue 5 to residue 499.  Molecular replacement was 
done in PHASER [104] using a script.  The script allowed PHASER to search in multiple point 
groups (command SGALTERNATIVE all) to determine the screw axes.  If a screw axis is 
present, certain periodic reflections will be missing, caused by the asymmetric unit being shifted 
by a fraction of the unit cell (usually shifted by half).  Combining this information with the 
missing reflections allowed for confirmation of the space group.  The rotational and translational 
Z values for each monomer are in Table 2.4.   
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Molecular replacement in PHASER (as a subprogram of PHENIX) for the P. aeruginosa 
GK with glycerol utilized the protein content of E. coli GK model PDB ID 1GLA.  Refinement 
of the glycerol-bound protein was partially completed before using the P. aeruginosa GK as a 
model for molecular replacement in the ethylene glycol-bound structure.  Molecular replacement 
statistics are found in Table 2.5.  
2.2.12 Model refinement 
All structures were refined in CNS [105], CCP4 [106] and PHENIX [107] using alternating 
refinement and manual model fitting in Coot [108].  The Rwork and Rfree of each structure and 
data refinement statistics are listed in Table 2.4 and Table 2.5.  Structures from GK:HPr crystals 
do not contain waters or ligands.   
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Table 2.4 Molecular replacement and refinement statistics for the En. casseliflavus His232ArgR and 
His232Glu models with glycerol or ethylene glycol. 
 His232Arg with 
glycerol 
His232Arg with 
ethylene glycol 
His232Glu with 
glycerol 
His232Glu with 
ethylene glycol 
Molecular 
replacement 
    
Rotation Z 24.0 21.1 30.6 23.9 
Translation Z 33.4 20.4 41.0 18.6 
Rotation Z 29.3 21.3 24.0 27.3 
Translation Z 89.5 59.2 27.6 59.3 
Rotation Z  20.4  23.4 
Translation Z  67.6  69.1 
Rotation Z  22.9  27.0 
Translation Z  82.3  87.5 
Clashes 0 0 0 0 
Rwork (%)  30.95  23.94 
Rfree (%)  31.51  23.62 
Refinement 
statistics 
    
Rwork (%) 20.74 18.14 19.38 20.80 
Rfree (%) 21.61 20.56 22.79 25.13 
Bond angle 
RMSD (°) 
1.27 1.33 1.28 1.36 
Bond length 
RMSD (Å) 
0.005 0.006 0.006 0.007 
Ramachandran 
statistics 
    
Most favored 
(%) 
91.1 82.0 90.0 86.0 
Allowed (%) 8.1 16.2 9.7 12.5 
Generously 
allowed (%) 
0.3 1.4 0.1 0.8 
Disallowed (%) 0.5 0.3 0.2 0.7 
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Table 2.5 Molecular replacement and refinement statistics for P. aeruginosa GK with glycerol or 
ethylene glycol 
 PAGK with glycerol PAGK with ethylene 
glycol 
Molecular 
replacement 
  
Rotation Z 32.3 44.0 
Translation Z 61.7 54.0 
Clashes 0 0 
Rwork (%) -- 30.59 
Rfree (%) -- 30.44 
Refinement 
statistics 
  
Rwork (%) 20.02 17.56 
Rfree (%) 22.93 20.04 
Bond angle 
RMSD (°) 
0.99 1.07 
Bond length 
RMSD (Å) 
0.007 0.007 
Ramachandran 
statistics 
  
Most favored 
(%) 
95.7 93.5 
Allowed (%) 3.3 5.2 
Generously 
allowed (%) 
  
Disallowed (%) 1.0 1.3 
Rotamer outliers 
(%) 
3.6 2.5 
Cβ outliers 0 0 
Clashscore 14.81 20.50 
 
2.2.13 Model analysis 
Coot was used to manually examine structures and calculate distances between specific atoms 
and areas of the model [109].  DDMP was used to determine the relationships between residues 
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of the different models.  It calculates the distances between all of the C atoms in a model, and 
compares those distances to the distances of a second model [110].  This comparison allows 
detection of areas that are shifted relative to other portions of the model and displays results in a 
format that is easily readable. Data was examined using Coot [109], CNS [105] and DDMP 
[110].  Superpositions for comparisons were done in either Coot (for the entire molecule or 
monomer) [109] or CCP4 [106] for superimposing only a portion of the model.  In cases where 
only a portion of the model was superimposed, portions of the model that had a high amount of 
flexibility or variability between the models were omitted from the superposition (the activation 
loop and the termini).  Coot or CCP4 was used to determine distances between atoms.  DDMP 
was used to determine which portions of the models had significant movement relative to other 
portions of the model.  PDB files were modified to omit any secondary conformations or ligands 
and have a consistant number of residues in each model.  
LSQMAN from the DEJAVU package from Uppsala [111, 112] was used to determine 
the RMSD and rotation necessary to superimpose the P. aeruginosa tetramer on the E. coli 
models.  Residues 5 to 490 of the E. coli structures were superimposed onto residues 8 to 498 of 
the P. aeruginosa structures to obtain the RMSD of the O monomer, then comparable residues 
were superimposed for the X, Y and Z monomers to obtain the rotations and RMSD of the other 
monomers in the tetramer.   
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2.3 RESULTS 
2.3.1 Crystal description 
Crystals of the glycerol-bound En. casseliflavus His232Arg were obtained from modified 
Hampton crystal screen I 42 with 0.05 M KH2PO4, 17% PEG 8000 and 10% glycerol (see Figure 
2.4).  Crystals of the ethylene glycol-bound En. casseliflavus His232Arg  and His232Glu were 
obtained from modified Hampton crystal screen I 42 with 0.05 M KH2PO4, 17-20% PEG 8000 
and cryoprotected in ethylene glycol (see Figure 2.5 and Figure 2.6).  Crystals of the glycerol-
bound En. casseliflavus His232Glu were obtained from in Hampton crystal screen II 27, 0.01 M 
ZnSO4, 0.2 M MES pH 6.5, 25% v/v PEG 550 MME and 10% glycerol (see Figure 2.7). Crystals 
were mostly tetrahedral in shape, and approximately 0.05 to 0.2 mm in size along the longest 
axis.  Crystals grown in glycerol were sturdier and easier to loop and cool, whereas ethylene 
glycol-bound crystals had a tendency to crack during cryoprotection. 
Crystals of P. aeruginosa were grown in a variety of conditions with the same I222 space 
group, suggesting that the crystal packing is very stable.  Crystals were clear, but strongly 
dichroic.  Crystals used to determine the structure of P. aeruginosa with glycerol came from 
Hampton cryo screen II 15, consisting of 0.375 M ammonium sulfate, 0.075 M sodium citrate 
tribasic dehydrate pH 5.6, 0.75 M lithium sulfate and 25% v/v glycerol (see Figure 2.8).  The 
glycerol-bound crystal was further cryoprotected in mother liquor with ethylene glycol.  
P.aeruginosa crystals with ethylene glycol were crystallized in Emerald Wizard I 8, consisting of 
2.0 M ammonium sulfate, 0.1 M sodium citrate/citric acid and cryoprotected with 25% ethylene 
glycol (see Figure 2.9).  Crystals were large, between 0.1 to 0.4 mm, and easily looped and flash 
cooled. 
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Figure 2.4 En. casseliflavus His232Arg mutant with glycerol from a modified Hampton crystal screen 
I 42 with 0.05 M KH2PO4, 17% PEG 8000 and 10% glycerol.  Image taken by Dr. Ruth L. Saxl.  
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Figure 2.5 En. casseliflavus His232Arg mutant with ethylene glycol in Hampton crystal screen I 42, 
0.05 M KH2PO4 and 17% PEG 8000.  Image taken by Dr. Ruth L. Saxl. 
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Figure 2.6 En. casseliflavus His232Glu mutant with ethylene glycol in Hampton crystal screen I 42, 
0.05 M KH2PO4 and 20% PEG 8000.  Image taken by Dr. Ruth L. Saxl. 
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Figure 2.7 En. casseliflavus His232Glu with glycerol in Hampton crystal screen II 27, 0.01 M ZnSO4, 
0.2 M MES pH 6.5 and 25% v/v PEG 550 MME.  Image taken by Dr. Ruth L. Saxl. 
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Figure 2.8 P. aeruginosa GK with glycerol in Hampton cryo II 15, consisting of 0.375 M ammonium 
sulfate, 0.075 M sodium citrate pH 5.6, 0.75 M lithium sulfate and 25% v/v glycerol. Image taken by Dr. Ruth 
L. Saxl. 
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Figure 2.9 P. aeruginosa GK with ethylene glycol crystallized in Wizard I 8, consisting of 2.0 M 
ammonium sulfate, 0.1 M sodium citrate pH 5.5.  Image taken by Dr. Ruth L. Saxl. 
2.3.2 Crystallization of GK-HPr 
Crystallization trials of GK:HPr gave crystals that had two distinct morphologies: they either 
looked very similar to the previous En. casseliflavus GK crystals, or had a hexagonal shape to 
them (see Figure 2.4 and Figure 2.10).  The crystals that had the same morphology as previous 
crystals also had unit cells and space groups that were very similar to the previous crystals of 
pure GK monomers (compare the data statistics of Table 2.3 with the data statistics of Table 2.1).  
Hexagonal crystals contained a different orientation of GK in the asymmetric unit.  The 
asymmetric unit contained a full tetramer of GK oriented in a triangular orientation, rather than 
the P2-type orientation found in previous WT and mutant GK crystals. 
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Figure 2.10 Crystals of GK:HPr in Emerald cryo I 41, consisting of 25% v/v 1,2-propanediol, 0.1 M 
sodium phosphate/citrate pH 4.2, 5% w/v PEG 3000, 10% v/v glycerol. 
2.3.3 Overall tetrameric structure 
For all of the En. casseliflavus and P. aeruginosa GK models, an OXYZ tetramer was formed in 
the crystal (see Figure 1.2, nomenclature as in [54]).  The En. casseliflavus glycerol-bound 
models contained the OX dimer in the asymmetric unit; the tetramer could be created by using 
the correct symmetry operations.  The En. casseliflavus models that contain ethylene glycol 
present in the active site contain the OXYZ tetramer in the asymmetric unit.  In the glycerol-
bound tetramer, the OX dimer is identical to the YZ dimer, but when ethylene glycol is present 
there are slight differences between the OX and YZ dimers, namely the ethylene glycol 
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orientation.  The P. aeruginosa GK models contained one monomer in the asymmetric unit, 
denoted as O.  The tetramer could be obtained through using the appropriate symmetry-related 
monomers.   
The P. aeruginosa GK tetramer was compared to previous E. coli models to determine 
whether the model showed a physiologically active or inactive model.  Table 2.6 contains a list 
of models used for comparison, along with bound ligands and select structure characteristics.  
Table 2.7, Table 2.8 and Table 2.9 contain the angles necessary to superimpose the O, Y, and Z 
monomers of each of the tetramers once the X monomer has been superimposed.  This shows 
that the models are closest to 1BU6 [113].  Although the rotation necessary to superimpose the O 
is smaller for 1BO5, the larger rotation necessary to superimpose the Z and Y monomers 
suggests a greater overall difference between the P. aeruginosa GK models and the structure of 
PDB ID 1BO5 [53].   
 
Table 2.6 Escherichia coli models currently in the PDB.  The PDB ID, select molecular statistics, 
mutations, and other ligands are listed for reference. 
PDB ID Resolution (Å) R values (%) Ligands Mutation 
1BWF [57] 3.00 16.8 GOL, ATF, Mg S58W 
3EZW [114] 2.00 16.8 (22.5) GOL, EDO, Cl, 
Mg 
G230D 
1GLJ [57] 3.00 16.6 ATS, GOL, Mg S58W 
1GLL [57] 3.00 17.6 ACP, GOL, Mg S58W 
1BOT [53] 3.05 21.9 EPE, GOL -- 
1BO5 [53] 3.20 21.1 FBP, GOL -- 
1GLF [113] 2.62 14.6 ADP, GOL, PO4 -- 
1BU6 [113] 2.37 16.7 GOL, SO4 none listed, 
A65T in print 
1GLA [54] 2.60 19.1 GOL EIIA
Glc
 
1GLB [54] 2.60 20.5 GOL, ADP EIIA
Glc
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Table 2.7 Comparison of P. aeruginosa GK tetramer with active and inactive E. coli GK tetramers 
 PA GK with glycerol PA GK with ethylene glycol 
 D I 
RMSD
a
 
D II 
RMSD
a
 
angle
b
 DII 
RMSD
c
 
D I 
RMSD
a
 
D II 
RMSD
a
 
angle
b
 DII 
RMSD
c
 
3EZW [114] 1.1 0.6 6.2 2.5 1.1 0.7 6.8 2.7 
1BWF [57] 1.1 0.6 4.9 2.3 1.1 0.6 5.4 2.6 
1BO5 [53] 1.1 0.7 8.7 2.3 1.1 0.8 8.9 2.7 
1GLF [113] 1.1 0.7 6.0 2.5 1.1 0.8 6.6 2.8 
1BU6 [113] 1.1 0.7 4.0 2.3 1.1 0.7 4.3 2.6 
1GLA [54] 1.2 0.7 6.8 2.4 1.2 0.7 7.1 2.7 
a
 RMSD was calculated for C atoms of Domain I residues 8-227, 242-260 and 442-461 or C atoms of Domain II 
residues 265-277, 306-310 and 341-435 after superposition. 
b
 The angle required to superimpose Domain II after superposition of Domain I. 
c
 RMSD was calculated from the PA GK Domain II C of residues 265-277, 306-310 and 341-435 after 
superposition of the Domain I C of residues 8-227, 242-260 and 442-461. 
 
Table 2.8.Rotation necessary to superimpose other monomers onto P. aeruginosa GK with glycerol 
 X RMSD (Å) O Angle (°) Z Angle (°) Y Angle (°) 
1BO5 [53] 1.7 3.2 8.2 8.2 
1BU6 [113] 1.7 5.0 5.9 5.8 
1BWF [57] 1.3 12.1 5.0 11.4 
3EZW [114] 1.6 9.8 12.8 4.8 
1GLF [113] 1.7 4.7 4.7 4.7 
1GLA [54] 1.3 3.5 3.7 4.0 
 
Table 2.9. Rotation necessary to superimpose other monomers onto P. aeruginosa GK with ethylene 
glycol 
 X RMSD (Å) O Angle (°) Z Angle (°) Y Angle (°) 
1BO5 [53] 1.7 2.6 11.1 10.9 
1BU6 [113] 1.8 2.7 8.4 8.8 
1BWF [57] 1.5 11.2 6.8 10.5 
3EZW [114] 1.7 10.7 13.7 7.3 
1GLF [113] 1.8 2.6 7.0 7.6 
1GLA [54] 1.4 2.4 2.5 2.8 
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2.3.4 Glycerol and ethylene glycol interactions 
In all glycerol-bound models, each monomer contains one glycerol in the active site.  In the En. 
casseliflavus structures the glycerol is aligned such that the hydroxyl groups hydrogen bound 
with Arg84, Tyr136, Asp246, Gln247, Glu85, and the carbons form a hydrophobic surface with 
the Trp104 and Phe271 (see Figure 2.11).  The image shows the residues that contribute to the 
hydrogen bonds or charged interactions in blue, while hydrophobic residues are shown in yellow.  
The presence of a hydrophobic and hydrogen bonding region stabilizes and orients the glycerol 
in the active site.  The interactions between the glycerol and active site residues are similar 
regardless of mutant (see Table 2.10 to Table 2.12).  All En. casseliflavus GK structures contain 
a phosphate or sulfate ion present near the active site.  Comparison of E. coli structures shows 
the ion to be positioned where the gamma phosphate of ATP would be present.   
The P. aeruginosa glycerol-bound model shows glycerol hydrogen bonding with Arg87, 
Tyr139, Asp249, Gln250 and Glu88.  The glycerol also interacts with the hydrophobic surface 
created by Trp107 and Phe249.   
The models that contain ethylene glycol show one molecule of ethylene glycol in the 
active site in a conformation very similar to the glycerol in the glycerol-bound model.  In the En. 
casseliflavus models the ethylene glycol hydrogen bonds with Arg84, Tyr136, Glu85, and Asp 
246.  The hydrophobic pocket created by Phe271 and Trp104 holds the two carbons (see Figure 
2.12).  Because the third carbon and hydroxyl is not present in ethylene glycol as it is in glycerol, 
the hydrogen bonds created by those atoms are not present in the ethylene glycol models.  The P. 
aeruginosa model only contains one monomer per asymmetric unit, so only one set of 
interactions is observed, rather than the variants that are observed in the En. casseliflavus model.  
The ethylene glycol hydrogen bonds with residues Arg87, Tyr139, Asp249 and Glu88, with a 
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hydrophobic interaction with Trp107 and Phe274.  The interactions between the glycerol and 
glycerol kinase closest to the entrance of the catalytic cleft help to close the glycerol kinase 
active site.  The ethylene glycol mutants show variability in the contacts created between the 
ethylene glycol and the GK mutants.  Table 2.13 to Table 2.15 list the hydrogen bonding 
distances between the En. casseliflavus GK active site residues and the ethylene glycol.  Each 
monomer in the asymmetric unit uses a slightly different hydrogen bonding distance between the 
active site residues and the O2.  The hydroxyl group furthest from the active site opening appears 
to be held by the same interactions regardless in the glycerol-bound and ethylene glycol-bound 
structures.  The conformation of the ethylene glycol makes the interactions between the O2 and 
the protein to be more inconsistent.  This affects the closure of the active site (see 2.3.6 for more 
details).   
The glycerol molecule is oriented so that C1 and O1 are furthest back in the active site, 
away from the active cleft opening, and C3 and O3 are closest to the active cleft opening where 
the γ phosphate of ATP would be placed.  The residues that interact with glycerol in the mutants 
are the same residues found to interact with glycerol in the WT structure.  As is noted in Table 
2.12, the hydrogen bonding distances between glycerol and the active site residues are not 
significantly affected by the mutations, producing hydrogen bonding distances that are consistent 
between the models.   
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Figure 2.11 En. casseliflavus glycerol-bound active site Hydrophobic residues are shown in yellow, 
while hydrophilic residues are shown in blue.  The phosphate in magenta is at the entrance to the active cleft. 
 
 
Figure 2.12 En. casseliflavus ethylene glycol active site.  Hydrophobic residues are shown in yellow, 
while hydrophilic residues are shown in blue.  The phosphate in magenta is at the entrance to the active cleft. 
 48 
Table 2.16 lists the hydrogen bonding distances between the P. aeruginosa active site 
residues and the bound glycerol or ethylene glycol.  Although the ethylene glycol-bound 
structure does not show any variation in the interactions between the ethylene glycol and the 
active site residues, the O1 atom is anchored as in the En. casseliflavus GK and the interactions 
with residues closest to the active cleft opening are absent. 
 
Table 2.10 En. casseliflavus His232Arg hydrogen bonding distances between glycerol and active site 
residues 
Glycerol Kinase Atom (Å) Glycerol Atom Distance in Monomer 
O (Å) 
Distance in Monomer 
X (Å) 
Glu85 OE1 O1 2.5 2.5 
Glu85 OE2 O1 3.3 3.3 
Tyr136 OH O1 2.7 2.8 
Arg84 NE O1 3.2 3.2 
Arg84 NH O1 3.0 3.0 
Arg84 NE O2 3.0 3.0 
Arg84 N O2 3.0 2.9 
Asp246 OD1 O2 2.6 2.7 
Asp246 OD2 O2 3.4 3.4 
Asp246 OD1 O3 3.4 3.5 
Asp246 OD2 O3 2.5 2.7 
Gln247 NE2 O3 3.1 3.1 
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Table 2.11 En. casseliflavus His232Glu hydrogen bonding distances between the glycerol and glycerol 
kinase active site residues 
Glycerol Kinase Atom (Å) Glycerol Atom Distance in Monomer 
O (Å) 
Distance in Monomer 
X (Å) 
Glu85 OE1 O1 2.6 2.7 
Glu85 OE2 O1 3.3 3.5 
Tyr136 OH O1 2.6 2.6 
Arg84 NE O1 3.3 3.3 
Arg84 NH O1 2.8 2.8 
Arg84 NE O2 3.0 3.0 
Arg84 N O2 2.9 2.9 
Asp246 OD1 O2 2.6 2.6 
Asp246 OD2 O2 3.3 3.6 
Asp246 OD1 O3 3.3 3.3 
Asp246 OD2 O3 2.6 2.7 
Gln247 NE2 O3 3.0 3.0 
 
 
Table 2.12 Average hydrogen bonding distances (Å) between glycerol and glycerol kinase active site 
residues in En. casseliflavus mutants. 
Glycerol Kinase 
Atom 
Glycerol Atom His232Arg 
Distance (Å) 
His232Glu 
Distance (Å) 
Glu85 OE1 O1 2.5 2.6 
Glu85 OE2 O1 3.3 3.4 
Tyr136 OH O1 2.7 2.6 
Arg84 NE O1 3.2 3.3 
Arg84 NH O1 3.0 2.8 
Arg84 NE O2 3.0 3.0 
Arg84 N O2 3.0 2.9 
Asp246 OD1 O2 2.7 2.6 
Asp246 OD2 O2 3.4 3.5 
Asp246 OD1 O3 3.5 3.3 
Asp246 OD2 O3 2.6 2.7 
Gln247 NE2 O3 3.1 3.0 
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Table 2.13 En. casseliflavus His232Arg hydrogen bonding distances between ethylene glycol and 
glycerol kinase active site residues. 
Glycerol 
Kinase 
Residue and 
Atom 
Ethylene 
Glycol Atom 
Distance in 
Monomer O 
(Å) 
Distance in 
Monomer X 
(Å) 
Distance in 
Monomer Y 
(Å) 
Distance in 
Monomer Z 
(Å) 
Glu85 OE1 O1 2.7 3.0 2.7 3.0 
Glu85 OE2 O1 3.6 --- 3.9 --- 
Tyr136 OH O1 2.7 2.6 2.8 2.8 
Arg84 NE O1 3.4 3.7 3.6 3.3 
Arg84 NH O1 3.2 3.3 3.5 3.1 
Asp246 OE1 O2 3.0 3.2 2.9 2.8 
Asp246 OE2 O2 --- 3.4 3.6 3.4 
Gln247 NE2 O2 3.9 3.7 3.8 3.8 
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Table 2.14 En. casseliflavus His232Glu hydrogen bonding distances between ethylene glycol and 
glycerol kinase active site residues 
Glycerol 
Kinase 
Residue and 
Atom 
Ethylene 
Glycol Atom 
Distance in 
Monomer O 
(Å) 
Distance in 
Monomer X 
(Å) 
Distance in 
Monomer Y 
(Å) 
Distance in 
Monomer Z 
(Å) 
Glu85 OE1 O1 2.8 2.9 2.6 3.0 
Glu85 OE2 O1 --- --- --- --- 
Tyr136 OH O1 2.7 3.1 2.8 2.8 
Arg84 NE O1 3.3 3.6 3.3 3.8 
Arg84 NH O1 3.0 3.4 3.1 3.4 
Asp246 OE1 O2 3.1 3.1 2.9 3.0 
Asp246 OE2 O2 3.7 3.6 3.5 3.5 
Gln247 NE2 O2 3.6 3.3 --- 3.7 
 
 
Table 2.15 Average hydrogen bonding distances between ethylene glycol and En. casseliflavus 
glycerol kinase active site residues 
Glycerol Kinase 
Residue and Atom 
Ethylene Glycol Atom His232Arg Distance 
(Å) 
His232Glu Distance 
(Å) 
Glu85 OE1 O1 2.8 ±0.2 2.8±0.2 
Glu85 OE2 O1 3.7±0.4 --- 
Tyr136 OH O1 2.7±0.1 2.9±0.2 
Arg84 NE O1 3.5±0.2 3.5±0.3 
Arg84 NH O1 3.3±0.2 3.2±0.2 
Asp246 OE1 O2 3.0±0.2 3.0±0.2 
Asp246 OE2 O2 3.5±0.1 3.6±0.1 
Gln247 NE2 O2 3.8±0.1 3.5±0.2 
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Table 2.16. Hydrogen bonding distances between P. aeruginosa active site residues and glycerol (GOL) or 
ethylene glycol (EDO). 
GK Residue and atom Atom (GOL
a
) Distance (Å) Atom (EDO) Distance (Å) 
Tyr133 OH O1 2.6 O1 2.6 
Glu88 OE1 O1 2.5 O1 2.7 
Glu88 OE1 O1 3.4 O1 3.5 
Arg87 NH2 O1 3.1 O1 2.9 
Arg87 NE O1 3.4 O1 3.4 
Arg87 NE O2 3.0 O2 3.0 
Arg87 O O2 3.0 O2 2.7 
Asp249 OD1 O2 2.6 O2 2.7 
Asp249 OD2 O2 3.4 --  
Asp249 OD2 O3 2.7 --  
Asn250 NE2 O3 3.2 --  
H2O O3 2.9 --  
a
 The O1 atom is the oxygen atom furthest inside the active site cleft. Numbering 
proceeds incrementally to the entrance of the activation cleft. 
 
2.3.5 En. casseliflavus activation loop 
The activation loops of the His232Arg and His232Glu mutants show significant differences (see 
Figure 2.13).  The His232Arg activation loop contains interactions between Arg232 and Asp176 
that stabilizes the activation loop.  The electron density for the His232Arg loop is much more 
apparent than for the His232Glu electron density, also reflected in the B factors.  B factors give 
information about the relative movement of regions of the model.  Higher B values demonstrate 
that the particular region of the structure samples more conformations than other regions of the 
model.   
Arg232 has a charged interaction with Asp176.  In the phosphorylated activated GK, the 
phosphorylated His232 would have the opposite charge, being negative instead of positive.  This 
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would be repulsed by the Asp176 if the Asp is the only amino acid capable of interacting with 
the His232.  However, there is a lysine within the same area that would be positively charged.  
This lysine would be close enough to the activation loop to interact with the negatively-charged 
phosphorylated His232, creating the same stabilization effects that would occur in the 
His232Arg mutant.  Figure 2.8 shows the differences between the activation loop position caused 
by this stabilization.  The activation loop of mutants with higher activity are positioned further 
into the space between the X and O dimer.  Comparison between the His232Glu and His232Arg 
mutants show that the small changes in the activation loop result in a 2° closure of the binding 
site cleft.  The closure also rotates the OX dimer so that the distance between Domain II in the 
OX dimer closes by 6 Å at the point furthest from the activation loop.   
In the His232Glu mutant, the distance difference in amino acid length between the 
phosphorylated His232 and the mutated Glu232 is large enough that it is unable to interact with 
anything on Domain I near the activation loop.  The distance from the Cα to the charged 
phosphate at the WT His232 is larger than the distance from the Cα to the charge in the mutated 
His232Glu.  The distance between the Cα and the phosphate in the phosphorylated histidine is 
between 6-7Å, depending on the orientation of the histidine and whether you calculate from the 
phosphorus or the oxygen atom.  However, the distance between the Cα and the oxygen atoms of 
glutamate are between 3.5-5Å, depending on the geometry, a much shorter distance.  This 
distance is enough to prevent interaction with critical residues on Domain I, rendering the protein 
inactive.  Without stabilization of the activation loop, the large aromatic residues in the 
activation loop become very disordered due to steric clashes.  The clashes actually increase the 
distance between the O and X monomers, leading to a decrease in activity.   
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Figure 2.13 Comparison of E. casseliflavus GK loops shows the large changes in the hydrophobic residues caused by the His232Arg and 
His232Glu mutations 
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2.3.6 The relationship between active cleft volume and activation 
In order to identify differences across multiple GK crystallization conditions and 
activation states, I used the program 
3
V through the web interface to determine the channel size 
of the activation cleft in GK models [115].  Smaller channels would theoretically indicate that 
the model showed a more active GK or a model that was closer to the transition state than 
models with a larger channel.  
3
V was used to determine the channel size of the top two or three 
channels in the GK models, denoted as c1 (channel 1), c2 (channel 2) and c3 (channel 3) in Table 
2.4 to 2.16.  
3
V uses a grid system to identify the channels size.  
3
V splits up the unit cell into 1Å 
cubes, and then determines how cubes are involved in the channel described by the inner and 
outer dimensions (3Å and 10Å in the default case).  Unfortunately, using the entire deposited 
PDB for channel searches gives results that are not comparable from model to model (see Table 
2.17).  In cases where two channels are approximately the same size, 
3
V outputs the data for both 
channels plus a third channel so that the user can identify which channels are relevant to 
analysis.  Initial calculations were done with the deposited PDBs, with the hope that 
3
V would be 
able to identify and output the channels in each monomer.  Results varied, with some monomer 
channels being identified, but other cases showed the entire area between the monomers as a 
channel.  Some monomers in the PDB are separated enough from each other so the program 
identifies each monomer as having its own channel.  Some PDBs have monomers that are close 
enough so the program calculates the entire inside area between the monomers as a channel.  The 
inconsistency creates statistics that are not comparable. In order to obtain comparable numbers 
and ensure that the described channel included the active site, the PDBs were split into separate 
monomers.  The results are listed in Table 2.18.  
3
V outputs the channel volume and surface area 
for the largest two channels, as well as the coordinates for the center of each calculated channel.  
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The program provides image files that can be loaded into a visualization program to show the 
channel placement in the model.  The channel images show that the described channels did not 
always extend to the glycerol molecule, suggesting that the entire channel size was not 
determined.  In order to determine the channel size back to the glycerol molecule, the minimum 
radius was decreased to 2 Å, a little bit larger than the radius of 1.5 Å that water can enter.  The 
results are shown in Table 2.19.   
RMSD analysis of the P. aeruginosa GK tetramer suggests that it is closest to the 
structure of the inactive tetramer PDB ID 1BU6.  The smallest rotation is necessary to 
superimpose Domain II after superposition of Domain I.  The rotation necessary to superimpose 
the ethylene glycol-bound GK suggests that the active site of the ethylene glycol-bound P. 
aeruginosa GK is more open than the glycerol-bound structure, which matches the results of the 
En. casseliflavus GK. 
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Table 2.17. Volume and surface area of channels in deposited PDB, calculated by 
3
V. 
 Volume
a
 
(Å
3
) 
Surface Area
b
 
(Å
2
) 
Center of Mass
c
  
(x, y, z) 
Reduced Center of Mass
d
 
(x, y, z) 
1BWF c1 911 577 (35.2, 14.7, 36.3) (35.1, 15.0, 37.1) 
1BWF c2 1167 886 (24.9, 47.0, 27.4) (22.7, 46.7, 23.1) 
1BOT c1 899 583 (46.9, 31.6, 118.8) (45.0, 33.3, 117.3) 
1BOT c2 336 301 (15.1, 38.5, 110.2) (14.9, 38.1, 110.3) 
1BO5 c1 696 557 (64.9, 34.6, 103.4) (62.7, 36.9, 104.4) 
1GLF c1 538 414 (39.3, 12.9, 51.7) (40.0, 11.0, 53.0) 
1GLF c2 1757 7353 (20.7, -1.1, 10.1) (3.6, -6.8, 6.5) 
1BU6 c1 14500 6642 (-24.2, 1.4, 60.5) (-40.0, 1.5, 66.0) 
1BU6 c2 523 418 (-8.1, -11.8, 27.1) (-9.0, -10.5, 28.0) 
1GLA c1 2347 1112 (-34.9, 62.2, -7.7) (-35.4, 62.3, -7.9) 
1GLA c2 2347 1112 (47.9, 62.2, -5.3) (48.4, 62.3, -5.1) 
1GLA c3 73664 23705 (1.0, 62.5, -1.0) (-26.0, 64.9, -6.6) 
1GLB c1 1975 948 (-37.1, 62.5, -5.1) (-39.1, 64.2, -6.0) 
1GLB c2 1975 948 (44.1, 62.5, -1.9) (41.9, 60.6, -1.0) 
1GLB c3 73722 24253 (3.0, 62.4, -3.0) (-25.0, 65.0, -8.5) 
1GLJ c1 870 555 (34.9, 14.2, 36.2) (34.0, 11.0, 33.0) 
1GLJ c2 1032 755 (36.4, 18.6, 8.6) (36.4, 17.9, 7.6) 
1GLL c1 875 555 (34.8, 14.8, 36.5) (34.0, 12.0, 35.0) 
1GLL c2 926 657 (34.4, 18.5, 8.3) (34.9, 18.1, 7.9) 
1XUP c1 2839 1337 (-6.9, -14.6, -16.7) (-7.0, -15.9, -17.0) 
1XUP c2 662 435 (-14.0, -33.3, -42.5) (-14.2, -33.6, -43.1) 
1R59 c1 4317 2051 (22.2, 63.8, 97.4) (21.1, 64.7, 100.1) 
1R59 c2 718 461 (32.7, 97.0, 72.8) (31.6, 98.3, 72.8) 
3H3N c1 747 572 (-14.9, 40.3, 32.9) (-15.0, 40.5, 32.0) 
3H3N c2 4915 2607 (-1.9, 19.6, 14.6) (-8.9, 17.7, 4.0) 
3H3O c1 609 451 (-44.5, 23.4, 54.5) (-44.7, 23.4, 54.7) 
3H3O c2 5369 2652 (-11.5, 14.5, 49.2) (-14.0, 14.0, 48.0) 
3H45 c1 577 424 (-43.5, 2.7, 52.0) (-45.0, 3.0, 53.0) 
3H45 c2 5503 2835 (-13.6, -6.2, 49.8) (-12.4, -6.5, 49.8) 
3H46 c1 5259 2602 (-1.1, 20.5, 15.0) -3.0, 23.0, 15.0) 
PAGK EG 2014 1161 (-2.0, 11.5, 24.3) (-1.7, 9.3, 27.0) 
PAGK GOL 
c1 
541 415 (-6.5, -9.4, 18.2) (-6.5, -9.4, 18.2) 
PAGK GOL 
c2 
427 306 (7.1, -15.5, 10.4) (8.0, -16.0, 11.0) 
a
 The PDB ID delineates that PDB used to calculate the two largest channels.  c1 and c2 describe 
the first and second channel, respectively, calculated. 
b
 Volume of the channel is calculated by determining the number of 1Å
3
 cubes that are occupied 
by the channel. 
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c
 Surface area of the channel is calculated by counting the number of 1Å
3
 cubes on the surface of 
the channel that are occupied, multiplied by a weighting factor (see [115]). 
d
 The center of mass is the (x, y, z) position of the average point of all of the 1Å
3
 cubes that 
comprise the channel.  Because it is an average position, the point may reside outside of the 
calculated channel if the channel is sufficiently curved.  Positions are in Å coordinates, not 
fractional coordinates. 
e
 The reduced center of mass is the (x, y, z) position that results when the 1Å
3
 cubes are 
iteratively removed from the surface of the channel.  The remaining cube is the position of the 
reduced center of mass.  Positions are in Å coordinates, not fractional coordinates. 
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Table 2.18. Volume and surface area of channels in GK monomers determined via 
3
V with an inner 
radius of 2Å 
 Volume
a
 (Å
3
) Surface Area
b
 
(Å
2
) 
Center of Mass
c
 (x, 
y, z) 
Reduced Center of 
Mass
d
 (x, y, z) 
1BWF mon1 c1 785 502 (52.2, 52.2, 13.5) (53.8, 50.7, 14.3) 
1BWF mon1 c1 911 577 (35.2, 14.7, 36.3) (35.1, 15.0, 37.1) 
1BWF mone c2 303 239 (42.4, 18.7, 15.4) (42.7, 18.5, 15.2) 
1GLJ mon1 c1 198 188 (32.1, 44.6, 23.0) (32.0, 45.2, 22.7) 
1GLJ mon1 c2 186 180 (20.6, 51.1, 20.6) (20.4, 50.9, 21.1) 
1GLJ mon1 c3 766 498 (52.1, 52.4, 13.3) (53.6, 51.2, 14.3) 
1GLJ mon2 c1 870 555 (34.9, 14.2, 36.2) (34.0, 11.0, 33.0) 
1GLJ mon2 c2 370 284 (41.8, 18.9, 16.2) (42.0, 18.0, 16.0) 
1GLL mon1 c1 210 202 (32.5, 43.9, 21.7) (31.0, 43.0, 20.0) 
1GLL mon1 c2 790 519 (51.3, 52.2, 14.4) (52.6, 50.6, 15.4) 
1GLL mon2 c1 875 555 (34.8, 14.8, 36.5) (34.0, 12.0, 35.0) 
1GLL mon2 c2 393 280 (41.3, 18.5, 15.8) (42.0, 18.0, 16.0) 
1BOT mon1 940 601 (27.8, 45.8, 86.4) (26.0, 46.0, 82.0) 
1BOT mon2 c1 163 162 (67.9, 61.7, 122.7) (67.6, 61.5, 122.9) 
1BOT mon2 c2 756 494 (64.7, 36.6, 103.2) (62.0, 38.0, 102.0) 
1BO5 mon1 c1 207 192 (22.9, 39.2, 100.4) (22.6, 39.5, 100.2) 
1BO5 mon1 c2 577 411 (30.4, 45.1, 87.3) (29.0, 46.0, 85.0) 
1BO5 mon2 c1 186 193 (62.9, 55.5, 111.6) (63.0, 54.0, 111.0) 
1BO5 mon2 c2 498 358 (64.7, 36.2, 102.5) (64.6, 36.9, 102.4) 
1GLF mon1 c1 503 359 (13.4, 9.0, 34.1) (13.0, 8.0, 34.0) 
1GLF mon1 c2 215 207 (0.1, -6.9, 29.5) (-1.0, -6.0, 27.0) 
1GLF mon2 c1 238 215 (-5.4, 4.0, 9.3) (-6.3, 3.8, 9.7) 
1GLF mon2 c2 493 398 (5.7, -11.8, -4.0) (6.2, -11.0, -4.1) 
1GLF mon3 c1 203 205 (33.0, -6.6, -0.8) (32.4, -6.7, -1.7) 
1GLF mon3 c2 558 397 (18.8, 8.5, -5.3) (19.0, 7.3, -5.7) 
1GLF mon4 c1 163 155 (49.3, -26.9, 29.2) (49.4, -26.9, 29.1) 
1GLF mon4 c2 466 349 (29.6, -9.9, 29.4) (30.0, -9.3, 28.3) 
1BU6 mon1 559 385 (-25.9, -8.1, 85.8) (-26.5, -8.0, 86.6) 
1BU6 mon2 516 369 (-16.9, 10.9, 51.1) (-16.4, 9.8, 46.2) 
1BU6 mon3 c1 219 180 (-56.8, -25.9, 46.4) (-57.2, -25.6, 46.2) 
1BU6 mon3 c2 531 392 (-32.6, -7.9, 46.0) (-37.0, -10.0, 48.0) 
1BU6 mon4 c1 491 343 (-44.6, 9.7, 82.0) (-44.5, 9.4, 82.2) 
1BU6 mon4 c2 213 184 (-63.0, -13.0, 72.4) (-63.1, -13.1, 72.2) 
1XUP mon1 566 384 (-12.2, -22.1, 17.4) (-12.0, -22.0, 16.5) 
1XUP mon2 c1 264 267 (-14.7, -35.4, -33.2) (-16.9, -36.6, -
35.6) 
1XUP mon2 c2 662 435 (-14.0, -33.3, -42.5) (-14.2, -33.6, -
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43.1) 
1R59 mon1 c1 221 188 (7.1, 62.5, 102.0) (7.3, 62.4, 101.8) 
1R59 mon1 c2 163 161 (26.5, 66.7, 98.8) (25.0, 65.0, 99.0) 
1R59 mon1 c3 423 311 (35.9, 52.7, 93.5) (35.0, 52.5, 94.0) 
1R59 mon2 c1 718 461 (32.7, 97.0, 72.8) (31.6, 98.3, 72.8) 
1R59 mon2 c2 658 403 (14.6, 72.8, 68.3) (14.3, 74.1, 67.5) 
3H3N mon1 c1 628 423 (8.3, 21.2, 22.9) (7.0, 20.5, 22.9) 
3H3N mon1 c2 591 428 (29.0, 16.2, 2.5) (29.0, 16.7, 2.5) 
3H3N mon2 c1 626 438 (-33.4, 8.0, 30.2) (-33.8, 8.8, 29.5) 
3H3N mon2 c2 585 384 (-10.8, 17.6, 4.9) (-11.8, 17.9, 4.9) 
3H3O mon1 c1 456 351 (10.0, 10.1, 56.1) (10.0, 10.0, 56.0) 
3H3O mon1 c2 854 540 (4.7, 23.9, 43.1) (5.5, 22.5, 43.1) 
3H3O mon2 c1 609 451 (-44.5, 23.4, 54.5) (-44.7, 23.4, 54.7) 
3H3O mon2 c2 690 459 (-17.3, 5.5, 42.8) (-16.5, 6.8, 42.6) 
3H3O mon3 c1 697 474 (49.5, 5.9, -18.9) (48.4, 7.4, -18.7) 
3H3O mon3 c2 443 338 (68.1, 30.0, -26.7) (68.7, 30.1, -26.9) 
3H3O mon4 590 382 (23.9, 17.8, -20.0) (23.6, 17.1, -19.7) 
3H45 mon1 c1 417 310 (8.5, -10.9, 55.2) (8.1, -10.8, 55.1) 
3H45 mon1 c2 967 615 (1.9, 2.9, 44.2) (0.0, 6.0, 42.0) 
3H45 mon2 c1 577 424 (-43.5, 2.7, 52.0) (-45.0, 3.0, 52.0) 
3H45 mon2 c2 692 456 (-18.6, -15.2, 40.8) (-16.6, -14.4, 41.6) 
3H45 mon3 c1 650 407 (49.3, -13.5, -17.9.) (47.3, -13.1, -18.6) 
3H45 mon3 c2 626 440 (69.2, 8.9, -26.8) (70.0, 9.0, -27.1) 
3H45 mon4 c1 613 391 (22.4, -3.8, -18.8) (20.5, -4.2, -17.8) 
3H45 mon4 c2 542 376 (9.1, -25.2, -31.5) (10.4, -25.5, -32.1) 
3H46 mon1 c1 509 347 (12.8, 19.5, 19.7) (11.9, 19.0, 20.0) 
3H46 mon1 c2 779 527 (30.2, 11.3, 0.6) (30.0, 12.2, 0.4) 
3H46 mon2 c1 638 431 (-29.6, 12.1, 29.3) (-29.5, 13.7, 29.7) 
3H46 mon2 c2 671 492 (-8.3, 21.2, 3.7) (-7.0, 19.4, 3.9) 
1GLA c1 744 508 (18.1, 56.1, 12.1) (16.0, 58.0, 11.0) 
1GLA c2 181 179 (10.4, 44.7, -2.9) (10.0, 43.0, -3.0) 
1GLA c3 221 186 (16.7, 33.9, -8.5) (16.7, 33.7, -8.4) 
1GLB c1 628 433 (17.0, 57.4, 13.5) (15.0, 57.5, 13.0) 
1GLB c2 205 201 (8.8, 44.7, -1.7) (8.7, 45.6, -0.8) 
1GLB c3 183 159 (18.1, 34.4, -9.1) (18.3, 34.0, -9.4) 
a
 The PDB ID delineates that PDB used to calculate the two largest channels.  c1 and c2 describe 
the first and second channel, respectively, calculated. 
b
 Volume of the channel is calculated by determining the number of 1Å
3
 cubes that are occupied 
by the channel. 
c
 Surface area of the channel is calculated by counting the number of 1Å
3
 cubes on the surface of 
the channel that are occupied, multiplied by a weighting factor (see [115]). 
d
 The center of mass is the (x, y, z) position of the average point of all of the 1Å
3
 cubes that 
comprise the channel.  Because it is an average position, the point may reside outside of the 
calculated channel if the channel is sufficiently curved.  Positions are in Å coordinates, not 
fractional coordinates. 
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e
 The reduced center of mass is the (x, y, z) position that results when the 1Å
3
 cubes are 
iteratively removed from the surface of the channel.  The remaining cube is the position of the 
reduced center of mass.  Positions are in Å coordinates, not fractional coordinates 
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Table 2.19. Volume and surface area of channels in GK monomers, determined via 
3
V with an inner 
radius of 3Å 
PDB Volume
a
 
(Å
3
) 
Surface Area
b
 
(Å
2
) 
Center of Mass
c
 (x, y, 
z) 
Reduced Center of 
Mass
d
 (x, y, z) 
1BOT mon1 c1 381 339 (24.2, 38.5, 97.8) (19.0, 41.0, 100.0) 
1BOT mon1 c2 1208 741 (28.8, 45.7, 85.5) (27.0, 46.0, 81.0) 
1BOT mon2 c1 527 480 (66.8, 56.0, 106.4) (62.5, 57.0, 105.0) 
1BOT mon2 c2 1343 934 (67.9, 38.0, 102.6) (65.6, 37.4, 102.4) 
1BO5 mon1 c1 429 378 (23.4, 37.9, 99.9) (22.6, 39.9, 99.4) 
1BO5 mon1 c2 942 622 (26.4, 45.2, 88.5) (26.7, 45.7, 88.2) 
1BO5 mon2 c1 541 486 (66.9, 55.7, 107.4) (68.8, 52.7, 107.8) 
1BO5 mon2 c2 1037 698 (65.3, 36.5, 105.4) (62.0, 38.0, 103.0) 
1BU6 mon1 c1 1088 685 (-24.8, -8.6, 87.8) (-28.0, -8.0, 87.5) 
1BU6 mon1 c2 423 395 (-11.7, 6.1, 81.1) (-13.0, 6.0, 83.5) 
1BU6 mon2 c1 985 652 (-14.6, 11.2, 50.1) (-13.4, 10.0, 49.4) 
1BU6 mon2 c2 388 345 (-2.8, 29.9, 49.8) (-8.0, 31.0, 46.5) 
1BU6 mon3 c1 355 290 (-57.1, -26.2, 47.6) (-59.0, -28.0, 50.0) 
1BU6 mon3 c2 806 572 (-31.2, -8.7, 43.9) (-30.8, -7.0, 42.2) 
1BU6 mon4 c1 919 577 (-45.9, 10.5, 82.5) (-46.4, 9.2, 83.6) 
1BU6 mon4 c2 388 345 (-48.0, -3.9, 67.2) (-50.0, -4.0, 65.0) 
1BWF mon1 c1 482 416 (32.0, 45.3, 24.2) (30.0, 38.0, 23.0) 
1BWF mon1 c2 1085 651 (49.5, 52.3, 15.1) (51.7, 50.7, 15.9) 
1BWF mon2 c1 1910 1262 (50.3, 16.0, 16.5) (41.0, 19.0, 18.0) 
1BWF mon2 c2 476 445 (28.6, 12.8, 9.5) (26.5, 13.8, 6.2) 
1GLF mon1 c1 704 445 (13.0, 9.0, 34.7) (12.8, 7.2, 33.6) 
1GLF mon1 c2 436 399 (3.0, -5.8, 26.6) (-2.0, -3.0, 24.0) 
1GLF mon2 c1 409 350 (-6.3, 3.2, 10.0) (-10.0, 0.2, 11.8) 
1GLF mon2 c2 809 546 (5.4, -12.3, -4.8) (6.5, -10.0, -4.5) 
1GLF mon3 c1 411 677 (33.3, -5.8, -0.6) (31.9, -6.1, -1.8) 
1GLF mon3 c2 804 528 (18.5, 9.0, -4.8) (18.6, 7.3, -4.2) 
1GLF mon4 c1 957 682 (34.1, -10.6, 27.0) (32.0, -8.0, 28.0) 
1GLF mon4 c2 452 377 (43.3, 3.6, 14.6) (41.0, 4.0, 16.0) 
1GLJ mon1 c1 506 443 (29.3, 45.3, 26.9) (28.0, 43.0, 23.0) 
1GLJ mon1 c2 1074 666 (51.4, 52.0, 13.1) (53.6, 51.0, 14.0) 
1GLJ mon2 c1 220 212 (25.6, 37.9, 36.1) (25.3, 37.6, 35.3) 
1GLJ mon2 c2 2430 1688 (49.5, 15.4, 11.6) (45.5, 19.0, 14.0) 
1GLL mon1 c1 395 358 (30.2, 45.1, 24.8) (29.0, 43.0, 22.5) 
1GLL mon1 c2 1095 664 (50.6, 51.9, 14.2) (48.0, 56.0, 11.0) 
1GLL mon2 c1 1187 713 (35.7, 15.0, 34.9) (34.5, 11.0, 32.0) 
1GLL mon2 c2 1359 1054 (39.3, 15.9, 11.9) (27.0, 13.0, 4.0) 
1R59 mon1 c1 673 431 (31.5, 51.6, 97.1) (30.0, 51.5, 99.0) 
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1R59 mon1 c2 815 662 (9.4, 60.3, 94.5) (13.0, 62.0, 96.0) 
1R59 mon2 c1 1490 910 (36.0, 96.4, 68.0) (37.4, 98.4, 67.0) 
1R59 mon2 c2 3122 2021 (22.3, 72.6, 68.2) (19.3, 74.1, 60.9) 
1XUP mon1 c1 677 450 (-11.3, -21.8, 16.7) (-11.0, -22.0, 15.0) 
1XUP mon1 c2 571 441 (-16.9, 6.6, 3.5) (-21.0, 3.5, 3.0) 
1XUP mon2 c1 592 449 (-6.7, -15.6, -28.5) (-6.9, -15.1, -29.0) 
1XUP mon2 c2 817 557 (-11.7, -32.9, -44.3) (-12.3, -33.6, -45.9) 
3H3N mon1 c1 830 575 (29.7, 16.7, 3.2) (29.0, 17.1, 2.5) 
3H3N mon1 c2 1268 812 (9.2, 22.3, 23.9) (6.7, 20.7, 23.5) 
3H3N mon2 c1 993 716 (-38.8, 8.7, 33.6) (-38.4, 9.3, 34.3) 
3H3N mon2 c2 1190 738 (-13.6, 18.6, 4.4) (-12.1, 17.7, 5.4) 
3H3O mon1 c1 1105 910 (9.0, 9.3, 59.7) (9.0, 11.0, 56.0) 
3H3O mon1 c2 1299 804 (5.5, 24.2, 43.2) (6.4, 22.6, 42.6) 
3H3O mon2 c1 1410 1039 (-44.2, 20.2, 60.1) (-46.0, 24.0, 57.0) 
3H3O mon2 c2 1233 769 (-23.1, 5.1, 46.3) (-21.5, 6.7, 47.5) 
3H3O mon3 c1 1126 706 (51.1, 6.0, -18.8) (49.3, 7.1, -19.6) 
3H3O mon3 c2 1430 1121 (56.3, 24.6, -20.0) (55.5, 30.0, -14.0) 
3H3O mon4 c1 1200 768 (22.1, 18.6, -18.0) (20.6, 16.9, -17.1) 
3H3O mon4 c2 1981 1518 (-1.3, 0.6, -18.4) (-2.0, -4.9, -19.3) 
3H45 mon1 c1 685 517 (9.7, -10.3, 54.6) (9.0, -11.0, 55.0) 
3H45 mon1 c2 1363 822 (3.3, 3.3, 43.9) (0.0, 2.0, 47.0) 
3H45 mon2 c1 1412 1059 (-44.3, -0.6, 58.3) (-46.0, 3.0, 54.0) 
3H45 mon2 c2 1149 695 (-20.7, -15.9, 42.5) (-25.0, -15.0, 41.0) 
3H45 mon3 c1 1254 758 (51.5, -15.0, -19.9) (49.6, -13.0, -20.0) 
3H45 mon3 c2 1477 1092 (56.6, 4.3, -19.8) (57.9, 9.0, -14.9) 
3H45 mon4 c1 1212 737 (22.7, -2.6, -19.2) (20.6, -4.4, -18.4) 
3H45 mon4 c2 1514 1107 (6.0, -21.1, -24.8) (7.3, -25.4, -28.7) 
3H46 mon1 c1 1043 680 (12.5, 20.8, 21.9) (10.9, 18.8, 21.2) 
3H46 mon1 c2 1691 1166 (22.8, 11.1, 7.8) (19.1, 12.4, 11.1) 
3H46 mon2 c1 1602 1178 (-31.2., 12.4, 30.0) (-29.0, 12.0, 27.0) 
3H46 mon2 c2 1068 724 (-10.5, 21.2, 4.8) (-9.1, 19.4, 5.6)) 
1GLA c1 1026 677 (15.7, 55.4, 15.3) (13.8, 56.4, 14.1) 
1GLA c2 362 318 (16.9, 33.8, -7.3) (17.1, 33.8, -8.1) 
1GLB c1 867 566 (16.1, 56.6, 14.4) (14.0, 54.0, 13.0) 
1GLB c2 363 336 (17.2, 34.2, -6.5) (16.0, 33.0, -2.0) 
PAGK EG c1 3149 1987 (-5.4, 15.1, 25.7) (-4.6, 9.6, 29.8) 
PAGK EG c2 196 205 (6.8, 29.7, -0.4) (6.0, 30.0, -3.0) 
PAGK GOL c1 175 148 (-5.4, -9.2, 5.5) (-5.3, -9.1, 5.5) 
PAGK GOL c2 1748 1373 (-3.2, -13.4, 15.9) (-4.3, -14.3, 22.0) 
a
 The PDB ID delineates that PDB used to calculate the two largest channels.  c1 and c2 describe 
the first and second channel, respectively, calculated. 
b
 Volume of the channel is calculated by determining the number of 1Å
3
 cubes that are occupied 
by the channel. 
c
 Surface area of the channel is calculated by counting the number of 1Å
3
 cubes on the surface of 
the channel that are occupied, multiplied by a weighting factor (see [115]). 
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d
 The center of mass is the (x, y, z) position of the average point of all of the 1Å
3
 cubes that 
comprise the channel.  Because it is an average position, the point may reside outside of the 
calculated channel if the channel is sufficiently curved.  Positions are in Å coordinates, not 
fractional coordinates. 
e
 The reduced center of mass is the (x, y, z) position that results when the 1Å
3
 cubes are 
iteratively removed from the surface of the channel.  The remaining cube is the position of the 
reduced center of mass.  Positions are in Å coordinates, not fractional coordinates.
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2.3.7 Interaction between En. casseliflavus GK and En. faecalis HPr and effects on 
crystallization 
Crystals that were obtained from the En. casseliflavus GK-En. faecalis HPr cocrystallization 
only contained GK.  However, unlike the previous WT GK structure, the activation loop is in the 
down position close to domain I.  Having the loop close to the domain shows that the HPr that is 
present affects the GK, priming it for catalysis even when GK is not phosphorylated.  Initial 
refinement of these crystals shows electron density is present for the GK, but electron density for 
HPr is not easily visible at sigma levels of 1.0.   
Initially, En. casseliflavus GK and HPr were combined in the same tube before 
crystallization screening.  Because those trials did not lead to a cocrystal, the association and 
dissociation constants of GK and HPr in the presence of various glycerol concentrations were 
tested by surface plasmon resonance (SPR, see Table 2.20).  Previous SPR experiments by Dr. 
Ruth L. Saxl and Dr. Haibin Shi were done without glycerol, but crystallization trials were 
conducted in the presence of 10% glycerol.  However, glycerol affects the SPR results such that 
the binding appears to be negative under all conditions except those with high HPr 
concentrations.  A second experiment of SPR was done to account for the extra binding to the 
reference channel of the chip.  The binding was causing negative readings of HPr binding to GK 
at high concentrations of glycerol.  By using a different reference channel that already contained 
protein that the HPr would not bind to, the binding of HPr to GK at high concentrations of 
glycerol could be determined.  The reference channel contained 1260 RU of full-length HIV 
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capsid protein.  Using the reference channel that already contained protein, a positive RU was 
obtained during HPr binding with high glycerol concentrations, giving binding and dissociation 
constants (see Table 2.20).   
Table 2.20 Association and Dissociation of En. casseliflavus GK and En. faecalis HPr using SPR 
 ka (M) kd (M) KA (M) KD (M) 
No glycerol 5.8x10
2
 3.3x10
-3
 1.8x10
5
 5.7x10
-6
 
1% glycerol 370 7.26x10
-3
 5.09x10
4
 1.96x10
-5
 
5% glycerol 24 0.01 2.3x10
3
 4.3x10
-4
 
5% glycerol* 354 0.0186 1.9x10
4
 5.26x10
-5
 
10% glycerol 5.2x10
2
 7.9x10
-5
 6.6x10
6
 1.5x10
-7
 
10% glycerol* 58.4 3.24x10
-3
 1.8x10
4
 5.56x10
-5
 
10% glycerol** 5.71x10
3
 7.71x10
-3
 7.41x10
5
 1.35x10
-6
 
*Constants were determined from a separate run using the three highest concentrations of HPr.  This contained only 
results with positive values of GK-reference.   
** Constants determined by using a channel containing immobilized protein (full-length HIV capsid) as the 
reference.  This eliminated the negative responses seen in the previous tests. 
 
The presence of HPr affects the position of the GK activation loop in the crystals.  
Although HPr interacts and binds to GK at micromolar concentrations, it is not visible in the 
crystals.  The WT En. casseliflavus GK has loop contacts that are stabilizing the interactions 
between the activation loop and Domain I, including the stacking interactions between the 
aromatic amino acids as is seen in the mutants.  This suggests that HPr changes the stacking 
interactions in the OX activation loop interface, allowing the interacting activation loops to 
dissociate from each other and create new stacking interactions with Domain I.   
2.3.8 Interactions between GK and GlpD or GlpO and crystallization trials 
Crystallization screens contained P. aeruginosa GlpD and P. aeruginosa GK in a 1:1 molar ratio.  
Crystals that were obtained from initial screens contained P. aeruginosa GK only, showing that 
the interaction was not stable enough under the crystallization conditions.  When using a His-
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tagged GlpD and a non-His tagged GK, the P. aeruginosa GlpD does not associate strongly with 
the P. aeruginosa GK, even in low salt.  The flow through and wash of copurification trials 
contained a significant amount of GK that is not seen in the eluted fractions.  Most of the protein 
in the eluted fractions are GlpD, which makes sense because the GK does not have a His tag, so 
there should not be spurious His-tag association of GK.  Consultation with Dr. Haibin Shi, who 
ran the initial SPR experiments showing an interaction between the GK and GlpD in both E. coli 
and P. aeruginosa, and with Dr. Xinmin Li and Dr. Shoucheng Du, who are working on the E. 
coli GK-GlpD cocrystals, showed that the E. coli GK does not associate with the E. coli GlpD in 
the presence of Tris buffer.  Crystallization in HEPES pH 7.0 provided 19 hits from four 
different crystallization screens.  Many of these crystals were in the hits in the first round and the 
new hits contain crystals with the same morphology as the previously determined GK.   
 Buffer conditions under which the GlpD and GK will interact via a pulldown assay were 
tested to determine buffer dependence of the GlpD-GK interaction.  If a specific buffer prevents 
the interaction between the two proteins, the proteins would be more likely to crystallize as a 
single protein and not as a complex.  Identifying conditions of association increases the 
possibility of cocrystals and indentifies possible screening conditions to avoid.  The GlpD 
contains a His tag, and we have constructs of GK either with or without His tag.  Testing CHES 
pH 8.8 and CHES pH 9.0 gave inconclusive results on a native gel.   
GlpO was also tested in a pull-down assay with P. aeruginosa GK because GlpD and 
GlpO both perform a similar function converting G3P into DHAP.  This bypasses multiple 
difficulties with the GK-GlpD interaction pulldown: 1) the known transient interaction between 
the affinity columns and the GK, 2) the instability of the GlpD, 3) the expense of the β-
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octylglucoside used in the GlpD protein preparation and 4) the necessity of purifying GlpD, 
regenerating the beads, and running the pulldown during the same day.   
Streptococcus pyogenes (S. pyogenes) GlpO, purified from a commercially purchased 
source by Dr. Unmesh Chinte, was tested with a cobalt resin for the pulldown with P. aeruginosa 
GK containing a His tag.  Trichloroacetic acid (TCA) precipitation and SDS-PAGE gels were 
run to determine which proteins were present.  The TCA precipitation concentrates the proteins 
so that small amounts can be detected on a gel without using large amounts of sample.  HEPES 
pH 6.5 and MES pH 6.5 both show interaction between the P. aeruginosa GK and S. pyogenes 
GlpO. 
2.4 DISCUSSION 
All of the GK structures show a tetrameric orientation, like previous E. coli structures [53, 54, 
57, 58, 113].  Unlike the E. coli structures, the En. casseliflavus GK tetramer shifts to bring the 
bottom of Domain II of the O and X monomers closer together during activation.  This shift is 
reflected in the entire tetramer, initiated by the loop structures and the movement of Domain I at 
the OX interface.  All of the mutants show the same tetrameric conformation, even with multiple 
space groups represented, showing that crystallization contacts are not a determining factor in the 
tetrameric orientation.  With the assumption that the P. aeruginosa GK is controlled similarly to 
the E. coli GK, the tetramers can be examined to determine whether or not this is an active 
tetramer.  The tight association between the O and X monomers and comparison of the 
orientation of the P. aeruginosa and E. coli monomers suggest that the P. aeruginosa GK is in 
the inactive conformation.  The prevalence of the inactive conformation, seen in multiple 
 69 
crystallization conditions, and the stability of the crystals suggests that trapping the P. 
aeruginosa GK in the inactive conformation by stabilizing the OX dimer will be a good 
approach to GK inhibition.   
2.4.1 Activation caused by activation loop stabilization 
Activation of the Gram positive GK has been a question since mutations revealed activation 
linked to the activation loop [37, 59].  Previous mutations in Bacillus subtilis GK were analyzed 
with the knowledge of the Escherichia coli GK structure [97], but without the knowledge of the 
two type of tetramers that were shown to affect activity in Gram negative bacteria [57, 114] or 
that the activation is regulated via the activation loop rather than the interaction between GK and 
EIIA
Glc
 [54].  The En. casseliflavus structures shed light on the method of activation in the B. 
subtilis mutants.  Whejte et al. had described mutants that were contained in the activation loop 
[97].  According to the E. coli models ar the time, they had proposed that the mutants either 
stabilize or destabilize the interaction between the O and X monomers.  However, we can now 
identify that the mutants would have affected the position and stability of the activation loop, and 
therefore the activity of the B. subtilis GK.   
2.4.2 Glycerol placement and activation 
The glycerol-bound models have a more closed catalytic cleft than the ethylene glycol models, 
suggesting that interactions specific for glycerol affect the catalysis and orientation of the active 
glycerol kinase.  The ethylene glycol models do not contain consistent interactions with Glu85 or 
Asp246, and hydrogen bonding distances between the ethylene glycol and Tyr136 are larger than 
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in the glycerol-bound models.  Larger distances are also seen in the interactions that are present 
with Asp246 and Glu85.  The differences in the hydrogen bonding distances are indicative of 
weaker interactions.  Weaker interactions are going to cause a smaller closure between Domain I 
and Domain II, preventing correct alignment of the active site constituents.  
The P. aeruginosa GK activates in part by the addition of ATP.  In these structures 
lacking ATP a larger region from residues 315-340 are difficult to trace. The absence of ATP 
demonstrates that part of the activation control in the P. aeruginosa GK comes from the disorder 
to order transition of this region, as in the E. coli structures [57].  We are currently attempting to 
cocrystallize the P. aeruginosa GK with ATPS in order to confirm this hypothesis.  The 
electron density is low and the B values are higher than the structural average, suggesting a high 
amount of movement in this region.  In the E. coli models, the corresponding region of GK is 
structured when in the presence of ATP.  The ATP binding site is composed of those residues, 
and superposition of the E. coli GK and the P. aeruginosa GK shows the ATP from the E. coli 
models would fit in the high movement region of the P. aeruginosa GK.   
While ATP is necessary for the activity of En. casseliflavus and P. aeruginosa GK, the 
differences in the activation regulation demonstrate the necessary differences in the 
physiologically active dimer.  In the E. coli GK, and presumably the P. aeruginosa GK, the 
OXYZ tetramer dissociates into an OY dimer, which is the active form.  Mutations in OX dimer 
interface that disrupt the OX interactions showed no reduction in activity and a very different 
tetrameric form than previous WT models [57, 114].  However, the En. casseliflavus GK is 
physiologically active in the OX dimer.  These structures demonstrate that the interactions 
created by the OX dimer are necessary for the domino effect caused by phosphorylating His232.   
 
 71 
2.4.3 Controlling activation – drug targets 
The difference in the GK activation mechanisms of Gram positive and Gram negative bacteria 
show that the interface between the O and X monomers is a prime target for control GK 
activation.  In the Gram negative bacteria, such as the P. aeruginosa, stabilization of the OX 
dimer inhibits the activity.  The fact that P. aeruginosa appears to consistently form the inactive 
tetramer in numerous crystallization conditions, creating crystals with the same space group, unit 
cell, and tetramer orientation, suggests that stabilization of the inactive P. aeruginosa GK is 
extremely feasible.  Activation of P. aeruginosa GK also seems to be affected by ATP binding to 
Domain II, where a region of the protein is not visible in current structures.  Inhibitors that would 
prevent ATP binding could use this disorder-to-order transition to their advantage.   
In the En. casseliflavus GK, tactics that would dissociate the OX dimer and disrupt the 
OX interface would inhibit GK activation.  Promoting disorder of the activation loop would also 
decrease GK activation.  The information gleaned from the differences in the activation of the 
En. casseliflavus GK versus the P. aeruginosa GK suggest that focusing on the dimerization and 
tetramerization of GK would help identify various drug targets able to specifically inhibit GK 
activation. 
2.4.4 Summary and Future Directions 
I have shown that the mutation of the En. casseliflavus His232Arg creates a domino effect that 
closes the active cleft and leads to activation of the GK.  Although the His232Glu mutation is the 
same charge as a phosphorylated histidine it is not long enough to reach the positively-charged 
lysine, preventing loop stabilization and activation.  The presence of En. faecalis HPr is enough 
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to position the activation loop between the X-O dimer, but cocrystallization attempts have thus 
far been unsuccessful.   
The presence of glycerol closes the active site more than ethylene glycol in both the E. 
casseliflavus and P. aeruginosa GK.  These models are the first models that contain ethylene 
glycol, and comparison of the P. aeruginosa GK with E. coli GK shows that even in the inactive 
tetrameric conformation the contacts between the substrate and the protein affect the opening of 
the catalytic cleft.   
Preliminary pull-down binding data for the P. aeruginosa GK and GlpD, as well as the P. 
aeruginosa GK and S. pyogenes GlpO, demonstrate interactions between GK and GlpD/GlpO.  
However, the GK crystallization is so robust that crystals large enough to diffract are P. 
aeruginosa GK only.  Initial pull-downs discussed in this chapter and SPR assays by Dr. Haibin 
Shi suggest that HEPES buffers stabilize the interaction between P. aeruginosa GK and 
GlpD/GlpO.  Further cocrystallization attempts should be undertaken utilizing this information to 
determine the regulation and interaction between GK and GlpD/GlpO.   
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3.0   OCTAMERIC HEMOGLOBIN 
3.1 INTRODUCTION 
Human hemoglobin is a tetrameric oxygen carrier found in blood cells.  It is the component 
responsible for delivering oxygen to tissues, and must be able to obtain oxygen from oxygenated 
lungs.  The monomers of adult human hemoglobin (HbA) is very similar in structure to 
myoglobin, the monomeric oxygen-storage protein found in muscles.  With myoglobin, 
hemoglobin was one of the first x-ray crystallographic structures determined.   
3.1.1 Hemoglobin structure organization and nomenclature 
Hemoglobin is listed as an α protein, meaning that the majority of the secondary structure 
consists of α helices.  The α and β monomers have the same number of helices, listed 
alphabetically from A to H [3, 4].  Table 3.1 shows the helix designation and residues.   
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Table 3.1 Helix designations for α and β chains adapted from references. [3, 4] 
Helix designation α helix residues β helix residues 
A 3-17 5-17 
AB 18-22 18-22 
B 23-35 23-34 
C 36-43 35-42 
CD 44-52 43-49 
D -- 50-56 
E 53-70 57-77 
EF 71-74 78-79 
F′ 75-79 80-84 
F 80-90 85-95 
FG 91-97 96-103 
G 98-112 104-117 
GH 113-117 118-122 
H 118-124 123-139 
 
The porphyrin group sits in a hydrophobic pocket in each subunit, with its carboxyl tails 
exposed to the solvent.  The large mobile tails on the same side of the hydrophobic porphyrin 
reinforce the correct orientation of the heme within each subunit.   
3.1.2 Mutants affecting views of allostery and hemoglobin activity 
HbA undergoes a series of transitions when binding ligand.  HbA can bind oxygen or carbon 
monoxide each heme group when the heme iron is reduced to the Fe
2+
 state, and is able to bind 
cyanide, water, or hydroxide when oxidized in the Fe
3+
 state.  When unliganded, the heme adopts 
a T state structure.  The iron is coordinated with the four nitrogens of the porphyrin group and 
the NE of the proximal histidine (αHis87 and βHis92), but is slightly out of the plane of the 
porphyrin [2, 12].  Binding of a ligand, whether oxygen, carbon monoxide, cyanide, water, of 
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hydroxyl, will cause the heme group to adopt the R conformation, where the iron is in the plane 
of the porphyrin [2-4, 7, 12].  The T and R states also demonstrate a large change in the relative 
positions of the α1β1 and α2β2 dimers.  Superposition of the T state α1β1 dimer and the R state 
α1β1 dimer shows that a 15° rotation of the α2β2 dimer would be necessary to superimpose the 
second dimer [2-4, 7, 12].  Further crystallization demonstrated that the simple T-R dichotomy of 
HbA structures is incorrect, identifying an R2 and R3 state [6, 17].  The R2 state contains an α2β2 
dimer rotation in the same relative direction as the T to R rotation, but rotates the α2β2 dimer a 
further 5 degrees [17].  The R3 state shows a different rotation of the α2β2 dimer, showing that 
the tetrameric HbA can adopt a series of conformations [6].  A fourth structure, RR2, has an 
intermediate α2β2 dimer rotation between the R and R2 structures [6].  Research has shown that 
each of these conformations can be stabilized by crystallization conditions [2-4, 6, 7, 10, 12, 16, 
17, 116].  Solution state research by Dr. Ho and coworkers shows that HbA adopts a series of 
conformations across the R, RR2 and R2 states, suggested as the R ensemble or R
e
 state [117, 
118]. 
Comparing the high-salt R structure to the R2 structure obtained from high molecular 
weight PEG, the R2 structure shows an increased rotation of dimers in comparison to the T state, 
but has an alternate 2His97 conformation that allows more water in the 12 interface than the R 
structure [17, 116].  The high salt RR2 structure, obtained from a more physiological pH of 6.4-
7.1, is an intermediate structure between R and R2 [6].  NMR work on HbA and relevant mutants 
demonstrated that HbA adopts an ensemble of states between R and R2, and the most likely 
structural transitions during ligand binding are T->R->RR2->R2 [117, 118]. 
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3.1.3 Blood substitutes 
The shelf life of donated blood is approximately 4-6 weeks, and recent research suggests that 
degradation of components leading to adverse reactions start as soon as two weeks after 
donation.  Additional complications include antigen reactivity and Rh factors that necessitate 
matching the donor blood to the blood type of the recipient.  The storage conditions necessary 
for keeping blood also pose a challenge to places that are far from storage such as military units 
or emergencies [33]  Multiple strategies have been used to attempt to create oxygen carriers: 
membrane vesicles, polymerization, designed multimers and various cross-linkage reactions [34, 
119-128].  Researchers have been examining hemoglobin-based oxygen carriers (HBOC’s) as a 
solution to the challenges posed by some of the current oxygen carriers.  By creating HBOC’s 
that can be produced when necessary, the need for blood donation is eliminated, prevents 
reactivity seen in normal blood donation, and reduces the requirements for storage.  The Hb must 
have a low enough affinity for oxygen that the oxygen will be released, but not so low that the 
Hb will quickly oxidize to methemoglobin (metHb) or aquamethemoglobin (aquametHb).  
Unfortunately, the oxygen affinity is inversely correlated with the propensity of the heme group 
to become oxidated [129, 130]. 
The United States Navy is interested in designing blood substitutes that would be able to 
have an extended life span and increased availability [33].  Current trials of blood substitutes 
have been stopped because current blood substitutes are not advantageous over the current 
techniques [33].  They require a high concentration of blood substitute and show vasoactivity 
that can lead to heart attacks when used in the field [33].  Vasoactivity can be defined as either 
an expansion or contraction of blood vessels, which often puts more strain on the 
cardiovasculature.  Vasoactivity problems seem to stem from the fact that unsequestered Hb 
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interacts with nitric oxide.  Current proposals suggest adding nitroglycerin to avoid these 
difficulties but research is ongoing [33].  Increasing the size of hemoglobin or hemoglobin 
vesicles decreases the vasoactivity.  Another difficulty in obtaining a hemoglobin-based blood 
substitute is the dissociation of tetrameric Hb at low concentrations.  Octamerization of HbA 
could prevent dissociation, as discussed in Section 3.1.4. 
Previous cross-linked hemoglobin structures used linkers to cross between the α1β1 and 
α2β2 dimers in the same tetramer and prevent dimer dissociation.  Hemoglobin linkers were 
connected through either 1Lys82-2Lys82, 1Lys82-2Val1, 1Val1-2Lys99 or 1Lys99-
2Lys99 [18, 131-145].  Previous structures that were cross-linked at the  subunits eliminated 
access to the 2,3-BPG binding pocket; the linker crossed over the binding pocket, in each case 
covalently bonding to at least one of the necessary lysines from the 2,3-BPG pocket [131-137, 
145].  Using the  subunits to cross-link and stabilize the tetrameric form also greatly reduced or 
eliminated binding and the biochemical effects of 2,3-BPG [143, 144]. 
3.1.4 Octameric hemoglobin 
One tactic for creating HBOC’s is to link multiple tetramers together.  At low concentrations, 
HbA will dissociate into  dimers which are cleared from the blood by interacting with 
haptoglobin (Hpt) [146].  Hpt binds to HbA dimers to prevent nitric oxide scavenging.  Hb-
bound Hpt signals to macrophages to clear the HbA from the blood.  By creating mutations that 
stabilize a larger multimer, dissociation, Hpt scavenging, and nitric oxide should be decreased. 
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3.1.5 Mutant rationale 
Only one example of a naturally-occurring octameric Hb has been discovered.  A natural 
mutation in the β subunit (Gly83Cys) was discovered in 1971 [147], which was found to 
octamerize the hemoglobin.  The octamer was presumed to occur via a disulfide bridge created 
between the two  monomers [119, 148].  Other naturally-occurring mutations to Cys include Hb 
Porto Alegre (βSer9Cys), Hb Whitmire (βGly16Cys), Hb Kent (βTrp37Cys), Hb Ilmenau 
(βPhe41Cys), βPhe42Cys, Hb Mississippi (βSer44Cys), Hb Arta (βPhe45Cys), Hb Colima 
(βSer49Cys), Hb Leeds (βGly56Cys), Hb Harrow (βPhe118Cys), Hb Montfermeil 
(βTyr130Cys), Hb Visayan (βGly136Cys), Hb Rainier (βTyr145Cys), Hb Teterboro (αSer3Cys), 
Hb Bladensburg (αTrp14Cys), Hb Nigeria (αSer81Cys), Hb Cap d’Agde (αSer131Cys), Hb 
Nunobiki (αArg136Cys), Hb St. Rose (αGly15Cys), Hb Lima (αGly18Cys), Hb Ramona 
(αTyr24Cys) and Hb Ecuador (αSer138Cys) [149].  However, only Hb Ta-Li (βGly83Cys) 
creates a controlled octameric system, in part because many of the Cys mutations are not at the 
outer surface of Hb.  Dr. Chien Ho and coworkers created a plasmid with the βGly83Cys 
mutation, which yields octameric Hb that is refractory to dissociating into tetramers [34, 119], 
The presence of the stable octameric hemoglobin eliminated the problem of hemoglobin 
dissociation that would occur if HbA was just injected into blood vessels.  A mutation from 
glycine to a cysteine was introduced at 83, creating disulfide bridges between Hb tetramers 
[119].  A secondary mutation was introduced at 41, from phenylalanine to tyrosine, which 
further altered the oxygen binding properties [34].  Both mutants are stable in octameric form, do 
not react with Hpt, and are not reduced to tetrameric hemoglobin in plasma [34, 119].  What is 
more interesting is that the octameric mutants also have altered biochemical properties.  Both 
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mutants have slightly less cooperativity than HbA, as demonstrated by the Hill coefficient [34, 
119].  Normal HbA has a Hill coefficient of around 2.6, where higher Hill coefficients are 
indicative of more cooperativity and a Hill coefficient of 1 indicates no cooperativity [150].  
Early biochemical tests suggested that the mutation increased the relative oxygen affinity of the 
βGly83Cys mutant, so a secondary mutation was designed at the βPhe41 position to give a 
double mutant of βGly83Cys-Phe41Tyr.  The βPhe41Tyr mutation decreased the oxygen affinity 
relative to HbA.  A third mutant was designed to create octamers using the  subunit by 
mutating the comparable residue in the  subunit to Cys (Asn78Cys).  The α mutation is in the 
same relative placement as the βGly83Cys mutation – on helix F, position 7.  I have determined 
the X-ray crystallographic structure of octameric hemoglobin in its oxidized water-bound 
aquamet state.  Comparison of those structures with two separately determined structures of 
cyanomet octameric hemoglobin demonstrates how the octamerization affects the overall 
structure, and hence binding of ligands.   
3.2 MATERIALS AND METHODS 
3.2.1 Expression and Purification of rHb 
Ho and coworkers expressed recombinant βGly83Cys, βGly83Cys-Phe41Tyr, and αAsn78Cys in 
an IPTG-inducible plasmid in E. coli as in Shen et al. [151].  In brief, cells were grown and 
induced with IPTG, sonicated and centrifuged.  The supernatant was saturated with CO, and the 
nucleic acids were precipitated with addition of 10% polyethyleneimine to a final concentration 
of 0.5%.  After centrifugation, the hemoglobin in the supernatant was purified using three 
 80 
columns: Q-Sepharose fast flow with 20 mM Tris-HCl, 0.1 mM TETA, pH 7.4; Q-Sepharose fast 
flow with 20 mM Tris-HCl, 0.1 mM TETA pH 8.3, using a salt gradient to a final salt 
concentration of 160 mM NaCl; after dialysis into 10 mM sodium phosphate, the third column 
was a Mono S with a pH gradient from 10 mM sodium phosphate, 0.1 mM EDTA, pH 6.8 to 20 
mM sodium phosphate, 0.1 mM EDTA, pH 8.3. The hemoglobin was further purified with a 
Sephadex 200 column in sodium phosphate buffer pH 7.0.  All buffers were bubbled with CO 
prior to purification to prevent heme oxidation. 
3.2.2 Secondary purification of oHb after freezing 
Gly83Cys, βGly83Cys-Phe41Tyr and αAsn78Cys were obtained from Dr. Chien Ho and 
coworkers, purified as in Shen et al. [151].  Protein was stored at -80°C until use.  Protein was 
thawed on ice and buffer exchanged using a Superdex 200 column.  Previous work by Dr. 
Shoucheng Du had suggested that the octameric hemoglobin contained multiple forms of 
octamers and that the resulting heterogeneity affected the crystals.  Plate-like crystals diffracted 
poorly (approximately 4-8 Å resolution) and the size and quality varied between preparations.  
Gly83Cys eluted from the column at a volume consistent with octameric hemoglobin.  Protein 
was concentrated to 50 mg/mL using a 50 kDa cutoff Amicon centrifuge filters, centrifuging in 
an eppendorf 5810R for 10-20 min each time.  Whenever possible, protein was used the day that 
it was purified and concentrated.  Excess protein was flash frozen in liquid nitrogen at 100 K and 
stored at -80°C for future use.   
7.5% polyacrylamide native gels of the Superdex eluent showed that the βGly83Cys and 
βGly83Cys-Phe41Tyr mutants were most stable in 10-50 mM Tris pH 7.5, and αAsn78Cys was 
most stable in 10-50 mM sodium phosphate pH 7.5 (see Figure 3.2 for an example of the 
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dissociation of αAsn78Cys).  Native gels were used instead of denaturing SDS gels because the 
SDS gels would only give the presence of α and β monomers in the presence of SDS and BME.  
Identification of octamers and tetramers requires that the multimers are not dissociated in the 
preparation and gel running.  Native gels were run at constant voltage of 100 V to prevent the 
gels from heating and denaturing the hemoglobin.  After determining the stable buffer 
conditions, proteins were buffer exchanged using 4 mL Amicon filters with a 50 kDa cutoff, 
which did not affect the multimerization of the protein as demonstrated by native gels. 
3.2.3 Crystallization 
Hemoglobin protein was concentrated to 50 mg/mL prior to crystallization.  96-well crystal trays 
were originally set up using drops of 0.5 µL of protein and 0.5 µL of crystallant, and 80 µL of 
precipitant in the well.  Initial crystallization hits included the Emerald Wizard II 18, consisting 
of 20% w/v PEG 3000, 0.1 M Tris pH 7.0, 0.2 M calcium acetate.  Crystals of Gly83Cys came 
from drops of 20% w/v PEG 3000, 0.1 M Tris pH 10.0, 0.2 M calcium acetate, and crystals of 
Gly83Cys-Phe41Tyr came from drops of 20% w/v PEG 3000, 0.1 M Tris pH 9.0, 0.2 M 
calcium acetate (see Figure 3.3 and Figure 3.4).  Early crystals were plates and difficult to 
cryoprotect and freeze without causing undue damage to them and obtaining poorly diffracting 
crystals.  For further screening, large drops were produced using 50 mg/mL protein and 
manipulating the pH and PEG concentrations (see Table 3.2).  Additive screens did not improve 
the crystal morphology or diffraction for the Gly83Cys or the Gly83Cys-Phe41Tyr proteins.  
αAsn78Cys was crystallized in 0.17 M lithium sulfate, 85 mM Tris-HCl pH 8.5, 25.5% PEG 
4000, and 15% glycerol (see Figure 3.5). 
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Seeding trials using crushed βGly83Cys crystals did not improve the crystals.  Seeds 
were created using a seeding kit from Hampton Research and approximately 10 βGly83Cys 
crystals from a 25% PEG 3350, 0.1 M Tris pH 10.0, 0.2 M sodium chloride condition into about 
50 µL of crystallant.  The seeds were created by centrifuging the stock solution in the 1.5 mL 
eppendorf tube with the plastic bead supplied by the kit.  Dilutions of the seed stock varied from 
5X to 50X.  1 µL of diluted seed stock would be combined with 4 µL of 50 mg/mL protein and 5 
µL of crystallant.  Seeds increased the number of single crystals present in the drops but did not 
improve the resolution or morphology of the crystals.   
Crystal optimization screens from Hampton research, additive screens from commercial 
sources and the lab and seed beads were used to attempt to improve the crystals.  Noting that 
these mutants initially crystallized in mother liquor that contained PEG as a precipitant, a PEG 
pH screen was created to optimize pH and buffer conditions.  Initial results also showed that the 
βGly83Cys mutants crystallized readily in the presence of phosphate, but phosphate inhibited 
αAsn78Cys crystallization.  The rationale behind the PEG screen was to test different buffers at 
different pH’s in order to determine how much the buffer content rather than the buffer pH 
affected the crystals (see Table 3.2 for buffer conditions).  All solutions contained 25% PEG 
3350 as a precipitant, allowing the solutions to have a salt of choice added to them without 
significantly decreasing the concentration of PEG.   
3.2.4 Creation of oHbCN mutants and crystallization 
Early results demonstrated that the crystals did not contain carbon monoxide (see results); 
instead, the models showed an oxidized recombinant Hb (oHb).  A wavelength scan from 420 
nm to 750 nm suggested that the protein was already partially oxidized after thawing (see Figure 
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3.1 for oxidation spectra).  In order to attempt to obtain reduced recombinant Hb, various 
reducing agents were added to the gel filtration and crystallization steps to try to keep the protein 
reduced.  One challenge of working with the octameric hemoglobin was the assumption that the 
octameric hemoglobin is stabilized in the octameric state by disulfide bridges.  This assumption 
meant that using a reducing agent that was too harsh would dissociate the octamers into 
tetramers.   
Other attempts at obtaining rHb with ligands consisted of bubbling carbon monoxide 
(CO) through the mother liquor (also used as the crystallant) for 20 min prior to use.  Crystals 
that were obtained from these conditions were oxidized.   
Cyanide-bound hemoglobin was created by first completely oxidizing the hemoglobin 
using potassium ferricyanide in a 5:1 molar ratio to heme.  The potassium ferricyanide was 
buffer exchanged using Amicon filters as described in 3.2.2, and the protein was put into Tirs or 
phosphate buffer pH 7.5 with 10 µM sodium cyanide for crystallization.  Protein was 
concentrated to 50 mg/mL and used to set up crystallization trays as in 2.2.8.   
Cyanide–bound βGly83Cys crystals were obtained from Wiz I 33 (2.0 M ammonium 
sulfate, 0.1 M CAPS pH 10.5, 0.2 M lithium sulfate) and Wiz I 28 (20% PEG 3000, 0.1 M 
HEPES pH 7.5, 0.2 M sodium chloride).  Crystals were cryoprotected with 30% ethylene glycol 
and 22% ethylene glycol, respectively (see Figure 3.6 and Figure 3.7).   
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Figure 3.1 Spectra from 400 nm to 600 nm of βGly83Cys after thawing, oxidation, and treatment 
with cyanide. 
 85 
 
Table 3.2 PEG pH and buffer screen 
Buffer number Precipitate Buffer type (0.1 M) Buffer pH 
1 25% PEG 3350 Sodium citrate 4.2 
2 25% PEG 3350 Sodium citrate 4.5 
3 25% PEG 3350 Sodium citrate 5.0 
4 25% PEG 3350 Sodium citrate 5.5 
5 25% PEG 3350 Sodium acetate 4.2 
6 25% PEG 3350 Sodium acetate 4.5 
7 25% PEG 3350 Sodium acetate 5.0 
8 25% PEG 3350 Sodium acetate 5.4 
9 25% PEG 3350 Sodium acetate 5.5 
10 25% PEG 3350 Sodium phosphate/citrate 4.2 
11 25% PEG 3350 Sodium phosphate 6.0 
12 25% PEG 3350 Sodium phosphate 6.5 
13 25% PEG 3350 Sodium phosphate 7.0 
14 25% PEG 3350 Sodium phosphate 7.5 
15 25% PEG 3350 Sodium phosphate 8.3 
16 25% PEG 3350 Bis-Tris 5.5 
17 25% PEG 3350 Bis-Tris 6.0 
18 25% PEG 3350 Bis-Tris 6.5 
19 25% PEG 3350 Bis-Tris 7.0 
20 25% PEG 3350 Bis-Tris 7.5 
21 25% PEG 3350 BTP 5.5 
22 25% PEG 3350 BTP 6.5 
23 25% PEG 3350 BTP 7.0 
24 25% PEG 3350 BTP 7.5 
25 25% PEG 3350 BTP 8.0 
26 25% PEG 3350 BTP 8.5 
27 25% PEG 3350 BTP 9.0 
28 25% PEG 3350 BTP 9.5 
29 25% PEG 3350 Tris 6.5 
30 25% PEG 3350 Tris 7.0 
31 25% PEG 3350 Tris 7.5 
32 25% PEG 3350 Tris 8.0 
33 25% PEG 3350 Tris 8.2 
34 25% PEG 3350 Tris 8.5 
35 25% PEG 3350 Tris 9.0 
36 25% PEG 3350 Tris 9.5 
37 25% PEG 3350 Tris 10.0 
38 25% PEG 3350 HEPES 6.0 
39 25% PEG 3350 HEPES 6.5 
40 25% PEG 3350 HEPES 7.0 
 86 
41 25% PEG 3350 HEPES 7.5 
42 25% PEG 3350 HEPES 8.0 
43 25% PEG 3350 Bicine 7.5 
44 25% PEG 3350 Bicine 8.0 
45 25% PEG 3350 Bicine 8.5 
46 25% PEG 3350 Bicine 8.9 
47 25% PEG 3350 TAPS 8.0 
48 25% PEG 3350 TAPS 8.5 
49 25% PEG 3350 TAPS 8.8 
50 25% PEG 3350 CHES 8.8 
51 25% PEG 3350 CHES 9.5 
52 25% PEG 3350 CHES 10.0 
53 25% PEG 3350 CAPS 9.5 
54 25% PEG 3350 CAPS 10.0 
55 25% PEG 3350 CAPS 10.5 
 
3.2.5 Data Collection 
The Gly83Cys datasets were originally collected on the home source, a Rigaku Superbright 
generator.  However, the cell length of the c axis was around 400Å, meaning that depending on 
the orientation, the reflections would be so close together that they would not be resolvable by 
the processing programs.  Crystals were taken to Argonne National Laboratory to be exposed to 
the beam from SERCAT ID and BM lines, as well as the GM/CA ID line.  The initial 
Gly83Cys-Phe41Tyr datasets contained a long axis of approximately 400 Å and radiation 
damage similar to the Gly83Cys datasets.  Initial datasets were collected on the Raxis IV++ and 
HTC image plates using the Rigaku Superbright FRE generator.  The βGly83Cys and 
βGly83Cys-Phe41Tyr datasets that were used to determine the final models were collected at 
wavelength 1.03317 Å (12000 keV) at GMCA beamline ID-2 at the Advanced Photon Source at 
Argonne National Laboratory.   
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The Asn78Cys crystals were collected on both the home source and at Argonne 
National Laboratory APS beamline SERCAT on the BM and ID lines. αAsn78Cys data was 
collected using the BM beamline at APS with 1.000 Å wavelength (12398 keV).  Both 
βGly83CysCN datasets were collected using 1.000 Å wavelength (12398 keV) at the SER-CAT 
ID beamline at the Advanced Photon Source at Argonne National Laboratory.   
Crystals of βGly83Cys with cyanide were collected at the ID beamline at the APS SER-
CAT.  Datasets oC and oHG83CW were collected at 12398. eV (1.000 Å wavelength).   
3.2.6 Data processing 
oHb data was processed in d*trek [102] for the βGly83Cys and βGly83Cys-Phe41Tyr mutants to 
2.65 Å and 2.30 Å, respectively.  HKL2000 [103] was used to process the αAsn78Cys data to 
2.25 Å.  Data statistics are listed in Table 3.3. 
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Table 3.3 Data processing statistics for oHb and oHbCN data sets 
 rHb 
(αAsn78Cys) 
rHb 
(βGly83Cys) 
rHbCN 
(βGly83Cys) 
rHb 
(βGly83Cys-
Phe41Tyr) 
rHbCN 
(βGly83Cys) 
Total 
Reflections 
94,397 125,792 303,216 203,349 206,352 
Unique 
Reflections 
56,819 71,950 47,907 105,477 20,058 
Resolution 
(Å) 
50-2.25 50-2.65 50-2.5 50-2.30 50-2.93 
Space group P212121 P1 P41212 P1 P6522 
a (Å) 55.3 82.8 85.2 83.2 121.8 
b (Å) 114.0 83.1 85.2 83.2 121.8 
c (Å) 207.6 106.2 369.4 104.3 197.3 
α (°) 90 115 90 93 90 
β (°) 90 95 90 110 90 
γ (°) 90 90 90 91 120 
Completeness 
(%)
a
 
90.4 (64.9) 98.0 (95.3) 98.6 (99.4) 93.4 (75.1) 100 (99.8) 
I/σ(I) 9.46 (1.9) 9.7 (2.0) 19.2 (2.7) 10.4 (2.0) 21.3 (4.3) 
Rsym (%)
b
 14.3 (37.9) 7.7 (37.3) 8.3 (51.8) 8.6 (41.6) 9.3 (56.4) 
Redundancy 2.7 (1.7) 1.9 (1.8) 6.4 (5.2) 2.6 (2.3) 10.3 (9.9) 
Mosaicity 0.372-2.936 0.512-1.649 0.331-0.543 0.533-0.777 0.300-0.787 
2 1.044 (0.996) 1.054 (1.066) 1.016 (0.961) 1.013 (1.040) 1.005 (1.004) 
Oscillation 0.5 1 0.5 1 1 
Number of 
Images 
360 180 300 240 170 
Total 
Oscillation 
180 180 150 240 170 
Number of 
images used 
198 175 170 240 84 
Oscillation 
Used 
99 175 85 240 84 
a
 Numbers in parentheses are values for the highest resolution shell (out of ten shells). 
b
 Rsym=ΣhΣi|I(h,i)-<I(h)>|/ΣhΣiI(h,i) where I(h,i) is the intensity values of the ith measurement of h and <I(h)> is the 
corresponding mean values of I(h) for all i measurements. 
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3.2.7 Molecular replacement and Model refinement 
Molecular replacement was done in Phaser [152] using the protein component of a dimeric 
model of CO-bound hemoglobin (PDB ID 1BBB) [17], the R2 structure determined in the 
presence of PEG.  This dimer model should be closest to the dimer model of the octameric 
hemoglobin because the mutant crystals also used PEG as a precipitant.   
Two initial cycles of realspace refinement in Coot were followed by restrained 
refinement with NCS in Refmac5 [153] and  simulated annealing in PHENIX [154], before 
addition of hydroxyl ligands.  The models were refined in PHENIX [154] before addition of 
waters using PHENIX [154] or Coot [109].  Three cycles of water checking/ligand addition and 
validation using MolProbity [155] were done.  After each cycle of manual adjustment, models 
were refined in PHENIX [154], monitoring Rwork and Rfree [156].  Before adding waters and 
ethylene glycol, Rwork/Rfree for the Gly83Cys, Gly83Cys-Phe41Tyr and Asn78Cys structures 
was 20.2/28.2%, 23.6/25.3% and 21.7/26.4%, respectively.  Waters were added to density over 
2.5 in non-protein areas 2.5-4.0Å from hydrogen-bonding atoms (nitrogen, oxygen and sulfur) 
using water picking in PHENIX and Coot [109].  Ethylene glycol, ions, and Tris were added to 
peaks with the appropriate electron density shape and sigma level.  oHb structures were 
manually checked using validation available in Coot [109], stand-alone and PHENIX packaged 
MolProbity [155], and SFcheck [157] and Procheck [158] in CCP4 [106].  Statistics can be 
found in Table 3.4. 
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3.2.8 Model analysis 
Distances and angles between individual atoms were determined in Coot [108, 109].  DDMP was 
used to determine the relative movement of some models [110].  In order to compare the models 
accurately to previous models and methods, a combination of RMSD and superposition was used 
to compare the various models.  For the complete tetramers, Cα atoms after tetrameric 
superposition were compared using RMSD.  This procedure takes the distance between each pair 
of Cα atoms and averages all of the distance vector lengths.  Because many of the differences 
determined between the T state and various R state models can be determined by a rotational 
shift of the α2β2 dimer relative to the α1β1 dimer, this can also be compared using a series of 
superposition and RMSD calculations.  In this case, lsqman, part of the dejavu package from 
Uppsala, was used to superimpose the α1β1 dimer Cα atoms and calculated the RMSD [111, 
112].  The RMSD for the α2β2 dimer was then determined using the command rmsfit without a 
second superposition.  The RMSD then gives an overview of how large the αβ dimer rotation is 
between the two models, but does not give the direction of rotation. 
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Table 3.4 Data refinement statistics of oHb mutants and oHbCN mutants 
 rHb 
(αAsn78Cys) 
rHb 
(βGly83Cys) 
rHbCN 
(βGly83Cys) 
1 
rHb 
(βGly83Cys-
Phe41Tyr) 
rHbCN 
(βGly83Cys) 
2 
Molecular 
Replacement 
     
Rotational Z 11.0 11.5 9.8 18.0 9.8 
Translational 
Z 
16.6 100.0 31.7 100.0 41.0 
Rotational Z 9.6 13.3 11.5 14.0 9.3 
Translational 
Z 
29.6 19.8 55.9 24.8 64.6 
Rotational Z 9.6 10.7 8.9 13.8  
Translational 
Z 
42.5 27.8 56.6 31.7  
Rotational Z 11.5 14.9 9.8 15.2  
Translational 
Z 
51.6 34.8 62.5 43.3  
Rotational Z  11.5  18.3  
Translational 
Z 
 34.7  54.3  
Rotational Z  16.0  17.6  
Translational 
Z 
 47.0  57.0  
Rotational Z  16.2  23.6  
Translational 
Z 
 48.9  70.7  
Rotational Z  13.7  21.2  
Translational 
Z 
 47.4  76.1  
Clashes 0 0 6 0 1 
After 
Refinement 
     
Rwork (%) 19.02 19.95 19.56 18.20 19.94 
Rfree (%) 23.31 24.63 25.64 22.24 23.81 
Ramachandran 
Statistics 
     
Bond Lengths 
(Å) 
0.013 0.009 0.003 0.008 0.009 
Bond Angles 
(°) 
1.124 1.055 0.69 1.016 1.12 
Most Favored 92.1 91.9 97.0 92.8 95.9 
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Additionally 
Allowed 
7.9 8.1 2.8 7.2 3.0 
Disallowed 0 0 0.2 0 1.1 
Clashscore  17.46 21.15 14.80 15.89 
Cβ Outliers  0 0 0 0 
3.3 RESULTS 
3.3.1 Determining acceptable buffer conditions 
Initial crystallization attempts gave small crystals that contained a highly variable unit cell in the 
βGly83Cys mutants, and very small, poorly-diffracting (8-10 Å) crystals of the αAsn78Cys 
mutant.  In order to determine how buffer conditions were affecting the crystallization, the 
protein was run on a Superdex 200 gel filtration column.  All proteins showed results indicative 
of two peaks, one of the major octameric component, and one of the dissociated tetrameric 
component.  Running the fractions on a 7.5% polyacrylamide native gel confirmed the presence 
of both components (See Figure 3.2 for an example of the αAsn78Cys dissociation gels).  Results 
from the Superdex 200 columns showed that the βGly83Cys and βGly83Cys-Phe41Tyr mutants 
were stable in 50 mM sodium phosphate pH 7.5, while the αAsn78Cys mutant was stable in 50 
mM Tris-HCl pH 7.5.  For future crystallization, the proteins were buffer exchanged using 
Amicon filtration centrifuge tubes.   
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Figure 3.2 Polyacrylamide native gels (7.5%) of Superdex 200 fractions of αAsn78Cys.  Fractions 
show that one peak consists of stable octameric αAsn78Cys, while the other peak consists of tetrameric 
αAsn78Cys.  βGly83Cys and βGly83Cys-Phe41Tyr mutants show the same feature. 
3.3.2 Crystallization and data refinement 
Crystallization attempts with the βGly83Cys and βGly83Cys-Phe41Tyr mutants created plate-
like crystals that were difficult to loop (see Figure 3.3 and Figure 3.4).  After determining stable 
buffer conditions (see 3.2.2), larger crystals that were slightly thicker than the original crystals 
were obtained for data collection.  Prior to optimization, approximately 1 out of 30 crystals 
diffracted to at least 3.0 Å, whereas after optimization 1 out of every 16 diffracted to at least 3.0 
Å.  The hemoglobin unit cell statistics varied significantly from crystal to crystal, regardless of 
whether or not the crystal came from the same drop or different crystallization conditions.  Unit 
cells contained anywhere from 8 monomers to 64 monomers, depending on the crystal.  This 
created difficulties in obtaining high resolution, complete datasets.  Many of the crystals 
resolution only went between 8-10Å, and only about one out of 16 diffracted better than 4Å.   
Crystal hits came from high pH buffers, suggesting that the pH rather than the buffer 
itself is the main determinant of crystallization.  However, resolution and data from the new hits 
were not improved.   
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Figure 3.3 βGly83Cys crystals obtained from of 20% w/v PEG 3000, 0.1 M Tris pH 10.0, 0.2 M 
calcium acetate. 
 
Figure 3.4 βGly83Cys-Phe41Tyr crystals 20% w/v PEG 3000, 0.1 M Tris pH 9.0, 0.2 M calcium 
acetate. 
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Figure 3.5 αAsn78Cys crystals obtained from 0.17 M lithium sulfate, 85 mM Tris-HCl pH 8.5, 25.5% 
PEG 4000, and 15% glycerol. 
 
Figure 3.6 βGly83Cys CN in Wizard I 33, consisting of 2.0 M ammonium sulfate, 0.1 M CAPS pH 
10.5, 0.2 M lithium sulfate. 
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Figure 3.7 βGly83Cys CN in Wiz I 28, consisting of 20% PEG 3000, 0.1 M HEPES pH 7.5, 0.2 M 
sodium chloride.  
3.3.3 Octameric nomenclature 
Tetrameric hemoglobin is usually designated with two  dimers, 11 and 22.  Octameric 
hemoglobin necessitates expansion of these designations (see Figure 3.8).  For the purposes of 
discussion, the octamer is said to consist of two tetramers, T1 and T2, combined by a disulfide 
bridge.  Junction between the two tetramers may exist on either the  or the  subunits.  Each 
tetramer contains two  dimers.  T1 contains 11 and 22, and T2 contains 1′1′ and 2′2′.  
In the case of the βGly83Cys and βGly83Cys-Phe41Tyr mutants, each asymmetric unit 
contained two octamers.  The second octamer is described as containing tetramers T3 and T4.  In 
cases where differentiating between the two octamers is necessary, T3 consists of α3β3 and α4β4 
dimers, and T4 consists of α3′β3′ and α4′β4′ dimers.  In places where just the tetramers are 
compared, for example in comparison with HbA models, the dimer of α1’β1’, α3β3 and α3’β3’ are 
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considered as the α1β1 dimer.  The dimers of α2’β2’, α4β4 and α4’β4’ are considered as the α2β2 
dimer.  
In both the Gly83Cys and the Gly83Cys-Phe41Tyr, the octamer is produced by 
disulfide bridges between the 83Cys of 1 and 83Cys of 1,′ and a second disulfide bridge 
between the 83Cys of 2 and the 83Cys of 2′.  The orientation of the disulfide bridges in 
these tetramers creates two tetramers that are related by a pseudo 180° rotation across the 
disulfide bridge, followed by a secondary rotation of 90° through the α1β1-α2β2 interface (see 
Figure 3.9).   
  
 
Figure 3.8 Nomenclature of Octameric Hemoglobin 
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The Asn78Cys contains two tetramers linked by two separate disulfide bridges, one 
between 1 and 1′, the other between 2 and 4′ (see Figure 3.9 and Figure 3.11).  The 
tetramers of αAsn78Cys are related by a 180° rotation about a non-crystallographic axis going 
through the two disulfide bridges at the interface of the two tetramers.   
The distances between the two tetramers of the Asn78Cys mutant are much smaller than 
the Gly83Cys mutants.  This provides a structural rationale for the difference in reduction 
ability between the two mutants (Dr. Chien Ho, personal communication).  The Gly83Cys 
mutants are much more likely to dissociate into tetramers when in the presence of reducing 
agents than the Asn78Cys mutant.  The structures demonstrate that the increased distance 
between the Cys C atoms allows greater accessibility for the reducing agents (see Table 3.5).   
Superposition of the βGly83Cys and αAsn78Cys disulfide bridges demonstrate the 
differences in disulfide bridge geometry and the relative rotation of the two tetramers.  Even 
when in the same asymmetric unit, the changes at the disulfides alter the relative tetramer 
conformation (see Figure 3.10).  Superimposing one tetramer of the βGly83Cys octamer against 
the other octamer from the same asymmetric unit (i.e. superimposing tetramer α1β1α2β2 against 
α3β3α4β4) shows that the second tetramer does not superimpose well.  The second tetramer may 
have an RMSD between 4Å and 8Å, depending on the orientation of the first superposition. 
Comparison of the mutants show little differences in the tetrameric structures.  
Superposition of the tetramers to determine the RMSD of the tetramers shows that the tetramers 
have an RMSD of 0.4 Å (see Table 3.10 and Table 3.11).  This RMSD is true regardless of 
which mutants are compared.  RMSD of the βGly83Cys and βGly83Cys-Phe41Tyr octamers also 
show small RMSD (see Table 3.9).  If only the α1β1 dimer is superimposed, the RMSD of the 
second dimer is around 0.4 Å, showing that the two dimers superimpose very well, regardless of 
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mutant.  Slightly higher RMSD is seen when comparing the βGly83Cys mutants to the 
αAsn78Cys mutant.  The higher RMSD shows that the position of the cysteine bridge slightly 
changes the tetrameric conformation of the αAsn78Cys mutant.   
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Figure 3.9 Overall octemeric structure of oHb mutants demonstrates the difference in relative 
tetramer orientation in α and β mutants.α monomers are in shades of red, β monomers are in shades of blue. 
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Figure 3.10 Superposition of the two βGly83Cys octamers found in the same asymmetric unit shows 
changes between the two tetramers are caused by changes in the disulfide bridge geometry. 
3.3.4 Stability of the octameric hemoglobin 
Octameric hemoglobin was shown to be very stable in the presence of mild reducing agents [34, 
119] but the causality was unknown.  The octameric structure was presumed to be stabilized by 
interaction of the two tetramers via two disulfide bridges.  The crystal structures of all mutants 
show distinct electron density between the tetramers indicative of disulfide bridges.  The 
geometry of the disulfide bridges constrains the octamer and the tetramer orientations, with the α 
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mutant tetramers being at approximately 180° rotation from each other with an axis 
perpendicular the disulfide bridge.  The β mutants have an approximate 90° rotation on an axis 
parallel to the disulfide bridges, as well as the approximate 180° rotation that allows the mutated 
cysteines to form covalent bonds.   
Comparison of the octameric mutants as dimers and tetramers shows a significant 
similarity in the relative position of the dimers.  Any two mutants have an RMSD of around 0.3 
Å for a superimposed α1β1 dimer (see Table 3.6 and Table 3.7).  If the RMSD of the α2β2 dimer 
is determined after α1β1 superposition without superimposing the second dimer, the RMSD is 
still below 1.0 Å for all mutants (see Table 3.6 and Table 3.8).  The two βGly83Cys mutants are 
the most similar, with RMSD values consistently around 0.3 Å, and both mutants have a higher 
RMSD when compared to αAsn78Cys.   
Table 3.5: Disulfide bridge geometry of the three oHb mutants and rHbCN(βGly83Cys) and rHb 
(βGly83Cys-Phe41Tyr) demonstrates changes that affect the relative position and reduction of these mutants 
 S-S distance (Å) Cα-Cα distance 
(Å) 
Angle 1 (°) Angle 2 (°) 
rHb 
(αAsn78Cys) 
    
α1-α1′ 2.0 6.1 93 121 
α2-α2′ 2.1 6.0 121 92 
rHb (βGly83Cys)     
β1-β1′ 2.1 5.5 115 104 
β2-β2′ 2.0 5.9 93 106 
β3-β3′ 2.0 5.9 122 106 
β4-β4′ 2.0 5.2 98 112 
rHbCN 
(βGly83Cys) 
    
β1-β1′ 2.0 5.5 64 47 
β2-β2′ 2.0 5.3 60 94 
rHb (βGly83Cys-
Phe41Tyr) 
    
β1-β1′ 2.0 5.1 108 99 
β2-β2′ 2.0 5.5 107 110 
β3-β3′ 2.0 5.4 108 110 
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β4-β4′ 2.0 5.5 109 108 
 
 
Figure 3.11 Differences in the αAsn78Cys (red) and βGly83Cys (green) disulfide bridges cause 
changes in the relative orientations of the tetramers. The inset shows an expanded view of the superimposed 
disulfide bridges. 
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Table 3.6 RMSD between α1β1 and α2β2.  Cα atoms of the α1β1 dimer were superimposed and the 
RMSD calculated (bottom portion).  RMSD of α2β2 Cα atoms were calculated after superposition of the α1β1 
dimer, shown in the upper portion of the table. βGly83Cys (G83C), βGly83Cys-Phe41Tyr (F41Y) and 
αAsn78Cys (N78C) tetramers are shown. 
 F41Y 
T1 
F41Y 
T2 
F41Y 
T3 
F41Y 
T4 
G83C 
T1 
G83C 
T2 
G83C 
T3 
G83C 
T4 
N78C 
T1 
N78C 
T2 
F41Y 
T1 
--- 0.4 0.3 0.1 0.4 0.4 0.5 0.4 0.8 0.8 
F41Y 
T2 
0.1 --- 0.2 0.4 0.6 0.4 0.5 0.5 1.1 1.1 
F41Y 
T3 
0.1 0.1 --- 0.3 0.5 0.4 0.5 0.5 1.0 1.0 
F41Y 
T4 
0.0 0.1 0.1 --- 0.4 0.4 0.5 0.4 0.9 0.8 
G83C 
T1 
0.3 0.3 0.3 0.2 --- 0.3 0.3 0.4 0.7 0.6 
G83C 
T2 
0.2 0.3 0.3 0.2 0.1 --- 0.1 0.3 1.0 0.8 
G83C 
T3 
0.3 0.3 0.3 0.3 0.1 0.1 --- 0.3 0.9 0.8 
G83C 
T4 
0.3 0.3 0.3 0.3 0.1 0.1 0.1 --- 0.8 0.8 
N78C 
T1 
0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 --- 0.7 
N78C 
T2 
0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 --- 
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Table 3.7 Average RMSD (Å) of the α1β1 Cα atoms. 
 Asn78Cys  Gly83Cys  Gly83Cys-
Phe41Tyr  
Gly83Cys-
Phe41Tyr  
  0.1 
0.02 
Gly83Cys   0.1 
0.02 
0.3 
0.01 
Asn78Cys  0.2 0.3 
0.02 
0.3 
0.02 
 
Table 3.8 Average RMSD (Å) of the α2β2 Cα atoms after superposition of the α1β1 Cα atoms. 
 Asn78Cys  Gly83Cys  Gly83Cys-
Phe41Tyr  
Gly83Cys-
Phe41Tyr  
0.9 
0.13 
0.5 
0.05 
0.3 
0.11 
Gly83Cys  0.8 
0.10 
0.3 
0.07 
 
Asn78Cys  0.5   
 
Table 3.9 RMSD (Å) of the Cα atoms of the βGly83Cys and βGly83Cys-Phe41Tyr octamers. 
 Gly83Cys-
Phe41Tyr 
O1  
Gly83Cys-
Phe41Tyr 
O2  
Gly83Cys 
O1 
Gly83Cys 
O2 
Gly83Cys-
Phe41Tyr 
O1 
---    
Gly83Cys-
Phe41Tyr 
O2 
0.4 ---   
Gly83Cys 
O1 
0.8 1.0 ---  
Gly83Cys 
O2 
1.0 0.8 1.2 --- 
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Table 3.10 RMSD (Å) of the tetramers of each of the oxidized mutants after superposition of the 
tetramer Cα atoms.  βGly83Cys (G83C), βGly83Cys-Phe41Tyr (F41Y) and αAsn78Cys (N78C). 
 F41Y 
T1 
F41Y 
T2 
F41Y 
T3 
F41Y 
T4 
G83C 
T1 
G83C 
T2 
G83C 
T3 
G83C 
T4 
N78C 
T1 
N78C 
T2 
F41Y 
T1 
---          
F41Y 
T2 
0.2 ---         
F41Y 
T3 
0.1 0.1 ---        
F41Y 
T4 
0.0 0.2 0.1 ---       
G83C 
T1 
0.3 0.3 0.3 0.3 ---      
G83C 
T2 
0.3 0.3 0.3 0.4 0.2 ---     
G83C 
T3 
0.3 0.3 0.3 0.4 0.2 0.1 ---    
G83C 
T4 
0.3 0.3 0.3 0.3 0.2 0.2 0.2 ---   
N78C 
T1 
0.4 0.5 0.5 0.4 0.4 0.4 0.4 0.4 ---  
N78C 
T2 
0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.4 0.5 --- 
 
Table 3.11 Average RMSD (Å) of the Cα atoms after superposition of the mutant tetramers. 
 Gly83Cys-
Phe41Tyr  
Gly83Cys  Asn78Cys  
Gly83Cys-
Phe41Tyr  
0.1 
0.05 
  
Gly83Cys  0.3 
0.02 
0.2 
0.04 
 
Asn78Cys  0.4 
0.04 
0.4 
0.04 
0.3 
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3.3.5 Comparison of octameric mutants and previously-determined models 
A large question about the relative reactivity between the octameric mutants and previously-
identified hemoglobin models has to do with the large overall structural changes that occur with 
the addition of the mutations.  As of May 2012, over 240 models of human hemoglobin were 
present in the PDB, many of which are mutants.  Table 3.12 shows models that were used to 
compare the octameric oHb.  These models are more recent than earlier models that showed 
oxidized Hb, and are more likely to be refined with programs that have more physiologically 
relevant restraints.  Using these models should prevent problems inherent in comparing apples to 
oranges, giving inconsistent comparison lengths.   
Table 3.12 PDB ID and Characteristics of HbA Models Used for Comparison 
PDB ID Characteristics 
1A3N [12] 1.25 Å T state 
1GZX [10] 2.10 Å Oxygen-bound T state 
2DN3 [2] 1.25 Å Carbon monoxy-bound R state 
2DN1 [2] 1.25 Å Oxygen-bound R state 
1BBB [17] 1.7 Å Carbon monoxy-bound R2 state, low salt 
1MKO [6] 2.18 Å Carbon monoxy-bound RR2 state 
1YZI [6] 2.07 Å Carbon monoxy-bound R3 state 
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There are multiple ways to compare the various models.  One way is using root mean 
square deviation (RMSD), which takes the distances between comparable atoms in the two 
models and averages the distances.  A larger RMSD means that the sections have a larger 
conformational difference.  RMSD can be affected by outlying sections of a model.  Previous 
research has shown that Hb changes that are a consequence of ligand binding can be examined 
by RMSD and described by a relative rotation of the α2β2 dimer relative to the α1β1 dimer.  A 
comparison of the required rotations and RMSD shows that all of the models are closest to the 
R2-state model PDB ID 1BBB.  Table 3.13 to Table 3.18 show the RMSD and angles 
determined by comparing the octameric structures against previously-published HbA structures.  
All models are close to the R2 state shown in PDB ID 1BBB regardless of crystallization 
condition.  While the PEG-crystallized aquamet mutants would be expected to be in the R2 state, 
this is the first high-salt structure that is close to the R2 state.  The results of the high salt 
structure suggest that this conformation is not entirely determined by the crystallization 
conditions, and that the disulfide bridge is constraining the tetramers into the R2 conformation.  
Table 3.19 to Table 3.24 give the distances between residues of the α1β1 and α2β2 dimers.  The 
interactions that are listed are support the R-state interpretation and demonstrate that the 
disulfide bridges do not alter the distances between the αβ dimers.  The movement of the 
tetramers is due to the disulfide bridges, which appear to alter their geometry to accommodate 
any strain on the tetramers.   
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Table 3.13 Comparison of cyanide-bound high salt βGly83Cys with published HbA structures. 
Dimers were superimposed separately to obtain the RMSD (Å).  In places where only one dimer is listed, the 
second dimer is obtainable by symmetry relations and would give the same RMSD as the α1β1 dimer. 
 2DN3 
[159] 
1BBB  
[160] 
11 
1BBB 
22 
1GZX  
[161] 
11 
1GZX 
22 
1YZI 
[6] 
1A3N 
[12] 
11 
1A3N 
22 
1MKO 
[6] 
11 
1MKO 
22 
2DN1 
[159] 
11 0.93 0.34 0.31 1.19 1.17 1.16 1.23 1.25 0.71 0.53 0.97 
22 0.89 0.40 0.32 1.13 1.11 1.15 1.17 1.19 0.70 0.50 0.92 
1′1′ 0.91 0.38 0.34 1.16 1.14 1.14 1.20 1.22 0.71 0.54 0.93 
2′2′ 0.92 0.37 0.30 1.18 1.17 1.17 1.22 1.23 0.73 0.52 0.96 
 0.91 
±0.02 
0.37 
±0.03 
0.32 
±0.02 
1.16 
±0.01 
1.15 
±0.03 
1.16 
±0.01 
1.20 
±0.03 
1.22 
±0.03 
0.72 
±0.01 
0.52 
±0.02 
0.95 
±0.02 
  0.34±0.03 1.16±0.02  1.21±0.03 0.62±0.11  
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Table 3.14 βGly83Cys comparison against various tetrameric HbA models.  The entire tetramer was 
superimposed to obtain the tetramer RMSD.  The α1β1 dimer was superimposed to obtain the α1β1 RMSD, 
after which the RMSD of the nonsuperimposed α2β2 dimer and the angle necessary to superimpose the second 
dimer were determined. 
Tetramer Tetramer 
RMSD (Å) 
α1β1 RMSD 
(Å) 
α2β2 RMSD 
(Å) 
α2β2 angle (°) α2β2 RMSD 
(Å) 
1A3N 
T1 3.4 1.2 8.5 25.6 1.3 
T2 3.5 1.2 8.8 26.2 1.3 
T3 3.4 1.2 8.7 25.7 1.3 
T4 3.4 1.2 8.6 25.5 1.2 
1GZX 
T1 3.6 1.2 9.1 27.0 1.2 
T2 3.7 1.2 9.4 27.6 1.2 
T3 3.6 1.2 9.3 27.1 1.2 
T4 3.6 1.2 9.3 26.9 1.2 
2DN3 
T1 1.6 1.0 3.8 8.2 1.0 
T2 1.6 1.0 4.0 8.5 1.0 
T3 1.6 1.0 4.0 8.0 1.0 
T4 1.6 1.0 3.9 8.1 1.0 
2DN1 
T1 1.7 1.0 4.1 8.9 1.0 
T2 1.7 1.0 4.3 9.1 1.0 
T3 1.4 1.0 4.3 8.6 1.0 
T4 1.7 1.0 4.2 8.7 1.0 
1BBB 
T1 0.6 0.5 0.9 6.0 0.4 
T2 0.5 0.4 0.7 5.4 0.4 
T3 0.5 0.4 0.8 5.8 0.4 
T4 0.6 0.4 0.9 6.1 0.4 
1MKO 
T1 1.0 0.8 2.0 5.3 0.6 
T2 1.0 0.8 2.2 5.4 0.5 
T3 0.9 0.8 2.2 5.0 0.6 
T4 0.9 0.8 2.1 5.2 0.6 
1YZI 
T1 2.5 1.2 5.6 17.1 1.1 
T2 2.5 1.1 5.7 17.4 1.1 
T3 2.5 1.2 5.7 16.9 1.1 
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T4 2.4 1.1 5.6 16.9 1.2 
 
Table 3.15 βGly83Cys-Phe41Tyr comparison against various HbA models.  The entire tetramer was 
superimposed to obtain the tetramer RMSD.  The α1β1 dimer was superimposed to obtain the α1β1 RMSD, 
after which the RMSD of the nonsuperimposed α2β2 dimer and the angle necessary to superimpose the second 
dimer were determined. 
Tetramer Tetramer 
RMSD (Å) 
α1β1 RMSD 
(Å) 
α2β2 RMSD 
(Å) 
α2β2 angle (°) α2β2 RMSD 
(Å) 
1A3N 
T1 3.4 1.2 8.6 27.8 1.3 
T2 3.5 1.2 8.9 28.4 1.2 
T3 3.5 1.2 8.8 28.3 1.2 
T4 3.5 1.2 8.7 28.0 1.3 
1GZX 
T1 3.6 1.2 9.3 29.2 1.2 
T2 3.7 1.2 9.6 29.8 1.1 
T3 3.6 1.2 9.5 29.7 1.1 
T4 3.6 1.2 9.3 29.3 1.1 
2DN3 
T1 1.6 1.0 3.9 8.7 1.0 
T2 1.7 1.0 4.2 9.3 1.0 
T3 1.7 1.0 4.1 9.3 1.0 
T4 1.6 1.0 4.0 8.8 1.0 
2DN1 
T1 1.7 1.0 4.2 9.3 1.0 
T2 1.8 1.0 4.5 10.0 1.0 
T3 1.8 1.0 4.4 9.9 1.0 
T4 1.7 1.0 4.3 9.4 1.0 
1BBB 
T1 0.5 0.4 0.9 3.8 0.4 
T2 0.5 0.4 0.9 3.2 0.4 
T3 0.5 0.4 1.0 3.6 0.4 
T4 0.5 0.4 0.9 3.6 0.4 
1MKO 
T1 0.9 0.8 2.0 5.5 0.6 
T2 1.0 0.8 2.4 6.1 0.6 
T3 1.0 0.8 2.3 6.1 0.5 
T4 1.0 0.8 2.1 5.6 0.6 
1YZI 
T1 2.5 1.2 5.6 17.8 1.2 
T2 2.6 1.2 5.9 18.5 1.2 
 112 
T3 2.6 1.2 5.8 18.4 1.2 
T4 2.5 1.2 5.6 18.0 1.2 
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Table 3.16 αAsn78Cys comparison with various HbA models.  The entire tetramer was superimposed 
to obtain the tetramer RMSD.  The α1β1 dimer was superimposed to obtain the α1β1 RMSD, after which the 
RMSD of the nonsuperimposed α2β2 dimer and the angle necessary to superimpose the second dimer were 
determined. 
Tetramer Tetramer 
RMSD (Å) 
α1β1 RMSD 
(Å) 
α2β2 RMSD 
(Å) 
α2β2 angle (°) α2β2 RMSD 
(Å) 
1A3N 
T1 3.2 1.2 7.9 24.8 1.2 
T2 3.4 1.2 8.2 26.0 1.2 
1GZX 
T1 3.3 1.1 8.5 26.2 1.1 
T2 3.5 1.1 8.8 27.3 1.1 
2DN3 
T1 1.4 0.9 3.2 8.1 1.0 
T2 1.5 1.0 3.3 7.4 0.9 
2DN1 
T1 1.5 1.0 3.5 8.3 1.0 
T2 1.6 1.0 3.6 7.8 1.0 
1BBB 
T1 0.6 0.4 1.2 6.8 0.4 
T2 0.6 0.5 1.2 5.6 0.4 
1MKO 
T1 0.8 0.7 1.5 5.3 0.5 
T2 0.9 0.8 1.5 4.3 0.5 
1YZI 
T1 2.5 1.2 5.3 16.8 1.2 
T2 2.4 1.2 5.1 16.4 1.2 
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Table 3.17 Average Cα RMSD (Å) of the tetramers 
 1A3N 1GZX 2DN1 2DN3 1MKO 1BBB 1YZI 
βGly83Cys 3.4±0.0 3.6±0.0 1.6±.1 1.6±0.0 0.9±0.0 0.5±0.0 2.5±0.0 
βGly83Cys-
Phe41Tyr 
3.5±0.0 3.6±0.0 1.8±0.1 1.7±.1 1.0±0.0 0.5±0.0 2.6±0.0 
αAsn78Cys 3.5±0.7 3.4±2 1.5±0.1 1.4±.1 0.8±0.0 0.6±0.0 2.4±0.1 
 
Table 3.18 Average angle necessary to superimpose α2β2 dimers after superposition of α1β1 dimers 
 1A3N 1GZX 2DN1 2DN3 1MKO 1BBB 1YZI 
βGly83Cys 25.8±0.3 27.1±0.3 8.8±0.2 8.2±0.2 5.2±0.2 5.8±0.3 17.1±0.2 
βGly83Cys-
Phe41Tyr 
28.1±0.3 29.5±.3 9.6±0.4 9.0±0.4 5.8±0.4 3.6±0.2 18.2±0.4 
αAsn78Cys 25.4±1.2 26.8±1.2 8.1±0.5 7.8±0.7 4.8±1.0 6.2±1.3 16.6±0.4 
 
Table 3.19 Hydrogen bonding contacts (Å) between α1β1 dimers for αAsn78Cys dimers 
α atom β atom α1-β1 α2-β2 α1′-β1′ α2′-β2′ 
Arg31 NH Gln127 OE1 2.7 2.9 3.0 2.9 
Arg31 NH Phe122 O 3.2 3.2 3.1 3.1 
Arg31 NH The123 O 3.8 3.8 3.9 3.7 
Arg31 NH Pro124 N 3.6 3.5 3.6 3.5 
Arg31 NH Phe122 O 2.9 2.9 2.9 2.8 
Ser35 OG Gln127 NE2 3.9 3.8 3.7 3.8 
Ser35 OG Ala128 N 3.6 3.5 3.5 3.4 
His103 NE2 Asn108 OD1 3.6 3.7 3.7 3.6 
His103 NE2 Gln131 OE1 2.8 2.8 2.8 2.7 
His103 NE2 Gln127 NE2 4.0 3.9 3.9 4.0 
Cys104 SG Gln127 NE2 3.9 3.8 3.8 3.8 
Ala110 O Ala115 O 3.9 3.9 4.0 3.9 
Pro114 O His116 NE2 2.8 2.7 2.9 2.8 
Phe117 O Arg30 NH1 3.4 3.4 3.4 3.4 
Phe117 O Arg30 NH2 3.0 2.8 2.8 3.0 
Phe117 O His116 NE2 3.4 3.3 3.5 3.6 
Thr118 O Arg30 NH 3.5 3.4 3.5 3.5 
Pro119 N Arg30 NH1 3.7 3.6 3.7 3.7 
Pro119 N Arg30 NH2 3.7 3.6 3.7 3.7 
His112 ND1 Arg30 NH 3.0 2.9 2.9 3.1 
Asp126 OD Tyr35 OH 3.4 3.4 3.4 3.4 
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Table 3.20 Hydrogen bonding contacts (Å) between α1-β2 dimers in αAsn78Cys mutant 
α atom β atom α1-β2 α2-β1 α1′-β2′ α2′-β1′ 
Thr41 O Arg40 NH 3.3 3.1 3.0 3.4 
Arg92 O Trp37 O 3.8 3.7 3.8 3.9 
Asp94 OD1 Trp37 NE1 3.9 3.9 3.7 3.9 
Asp94 OD2 Trp37 NE1 3.4 3.5 3.3 3.5 
Asp94 OD2 Asn102 OD1 3.6 3.6 3.8 3.7 
Asp94 OD2 Asn102 ND2 2.8 2.7 3.0 2.9 
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Table 3.21 Hydrogen bonding contacts (Å) between the α1 and β1 subunits in the βGly83Cys mutant 
α atom β atom α1-β1 α2-β2 α1′-β1′ α2′-β2′ α3-β3 α4-β4 α3′-β3′ α4′-β4′ 
Arg31 NE Gln127 
OE1 
4.0 3.7 3.8 3.8 3.7 3.9 3.8 3.9 
Arg31 NH Gln127 
OE1 
2.8 2.6 2.7 2.7 2.7 2.8 2.7 2.7 
Arg31 NH Phe122 O 3.3 3.4 3.3 3.3 3.3 3.3 3.3 3.4 
Arg31 NH The123 O 4.0 3.8 3.8 3.9 3.7 -- 3.8 -- 
Arg31 NH Pro124 N 3.5 3.5 3.4 3.5 3.4 3.5 4.0 3.5 
Arg31 NH Phe122 O 2.8 2.8 2.7 2.8 2.7 2.8 2.8 3.0 
Ser35 OG Gln127 
NE2 
3.8 3.9 4.0 3.8 3.9 3.8 3.9 3.9 
Ser35 OG Ala128 N 3.6 3.5 3.4 3.5 3.5 3.5 3.5 3.7 
Lys99 NZ Glu101 
OE 
3.8 3.5 3.6 3.6 3.8 3.5 3.7 3.8 
His103 
NE2 
Asn108 
OD1 
3.9 3.8 3.8 3.8 3.8 3.9 3.8 3.9 
His103 
NE2 
Gln131 
OE1 
2.8 2.8 2.7 2.8 2.8 2.7 2.8 2.8 
Cys104 
SG 
Gln127 
NE2 
3.8 3.7 3.6 3.7 3.7 3.7 3.8 3.9 
Ala110 O Ala115 O 3.7 3.7 3.7 3.8 3.6 3.8 3.7 3.6 
Pro114 O His116 
NE2 
2.8 2.8 2.8 2.9 2.8 2.9 2.9 2.8 
Phe117 O Arg30 
NH1 
2.8 2.9 2.7 2.9 2.9 2.9 2.9 2.8 
Phe117 O Arg30 
NH2 
3.4 3.3 3.4 3.4 3.3 3.5 3.5 3.4 
Phe117 O His116 
NE2 
3.6 3.7 3.7 3.7 3.6 3.8 3.6 3.6 
Thr118 O Arg30 NH 3.6 3.6 3.5 3.6 3.5 3.8 3.7 3.5 
Pro119 N Arg30 
NH1 
3.6 3.7 3.7 3.7 3.7 3.8 3.7 3.6 
Pro119 N Arg30 
NH2 
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.4 
His112 
ND1 
Arg30 NH 3.1 3.2 3.2 3.1 3.2 3.8 3.1 3.2 
Asp126 
OD 
Tyr35 OH 3.3 3.1 3.1 3.3 3.3 3.2 3.2 3.2 
 
 117 
Table 3.22 Hydrogen bonding (Å) distances between the α1 and β2 monomers in βGly83Cys mutant 
α atom β atom α1-β1 α2-β2 α1′-β1′ α2′-β2′ α3-β3 α4-β4 α3′-β3′ α4′-β4′ 
Thr41 
OG1 
Arg40 NH 3.8 4.0 3.8 3.8 3.9 3.6 3.9 3.1 
Thr41 O Arg40 NH 3.6 3.4 3.5 3.5 3.5 3.4 3.5 3.0 
Tyr42 OH Arg40 NH 3.7 3.9 3.7 3.9 3.7 4.0 3.9 4.0 
Arg92 
NH1 
Gln39 
OE1 
3.6 3.5 3.6 3.5 3.6 3.3 3.5 3.0 
Arg92 NH Glu43 OE 3.9 3.7 3.8 3.8 3.9 -- 3.8 -- 
Arg92 O Trp37 O 3.7 3.6 3.7 3.8 3.9 3.8 3.7 3.7 
Asp94 
OD1 
Trp37 
NE1 
3.9 3.9 3.9 3.9 3.9 3.8 3.8 3.6 
Asp94 
OD2 
Trp37 
NE1 
3.7 3.6 3.8 3.6 3.7 3.5 3.6 3.3 
Asp94 
OD1 
Asn102 
OD1 
3.9 3.6 3.8 3.8 3.8 3.8 3.7 3.7 
Asp94 
OD2 
Asn102 
ND2 
2.9 2.7 2.8 3.0 2.8 3.1 2.8 3.0 
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Table 3.23 Hydrogen bonding distances (Å) between α1 and β1 monomers in the βGly83Cys-
Phe41Tyr mutant 
α atom β atom α1-β1 α2-β2 α1′-β1′ α2′-β2′ α3-β3 α4-β4 α3′-β3′ α4′-β4′ 
Arg31 NE Gln127 
OE1 
3.9 4.0 3.9 4.0 3.9 3.9 3.9 3.9 
Arg31 NH Gln127 
OE1 
2.8 2.9 2.9 3.0 2.9 2.9 2.9 2.9 
Arg31 NH Phe122 O 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Arg31 NH The123 O 3.6 3.8 3.6 3.6 3.7 3.6 3.7 3.6 
Arg31 NH Pro124 N 3.6 3.6 3.6 3.5 3.6 3.4 3.6 3.5 
Arg31 NH Phe122 O 2.8 2.8 2.8 2.8 2.8 2.7 2.8 2.8 
Ser35 OG Gln127 
NE2 
3.9 3.8 3.8 3.8 3.7 3.9 3.7 3.8 
Ser35 OG Ala128 N 3.4 3.5 3.4 3.5 3.5 3.4 3.5 3.5 
Lys99 NZ Glu101 
OE 
        
His103 
NE2 
Asn108 
OD1 
3.8 3.9 3.9 4.0 3.9 3.9 3.9 3.8 
His103 
NE2 
Gln131 
OE1 
2.8 2.8 2.8 2.8 2.9 2.7 2.7 2.7 
Cys104 
SG 
Gln127 
NE2 
3.8 3.9 3.8 3.9 3.8 3.8 3.7 3.8 
Ala110 O Ala115 O 4.0 -- 4.0 3.9 4.0 3.9 -- -- 
Pro114 O His116 
NE2 
2.7 2.8 2.7 2.7 2.8 2.7 2.8 2.7 
Phe117 O Arg30 
NH1 
3.5 3.4 3.5 3.5 3.5 3.5 3.5 3.4 
Phe117 O Arg30 
NH2 
2.8 2.7 2.7 2.7 2.7 2.7 2.8 2.7 
Phe117 O His116 
NE2 
3.8 3.8 3.6 3.5 3.7 3.5 3.8 3.8 
Thr118 O Arg30 NH 3.6 3.5 3.4 3.5 3.6 3.4 3.6 3.6 
Pro119 N Arg30 
NH1 
3.5 3.6 3.5 3.5 3.6 3.4 3.6 3.6 
Pro119 N Arg30 
NH2 
3.8 3.9 3.7 3.7 3.8 3.6 3.9 3.9 
His112 
ND1 
Arg30 NH 3.2 3.2 3.0 3.0 3.0 3.1 3.1 3.1 
Asp126 
OD 
Tyr35 OH 3.1 3.2 3.1 3.2 3.2 3.1 3.2 3.2 
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Table 3.24 Hydrogen bonding distances (Å) between α1 and β2 monomers in the βGly83Cys-
Phe41Tyr mutant 
α atom β atom α1-β1 α2-β2 α1′-β1′ α2′-β2′ α3-β3 α4-β4 α3′-β3′ α4′-β4′ 
Thr41 
OG1 
Arg40 NH 3.5 3.9 3.4 3.2 3.6 3.5 3.3 3.4 
Tyr42 OH Arg40 NE 3.8 3.7 3.6 3.6 3.7 3.5 3.8 3.5 
Arg92 
NH1 
Gln39 
OE1 
3.1 3.0 3.0 3.0 2.9 3.0 3.0 3.1 
Arg92 NH Glu43 OE 3.5 3.6 3.7 3.7 3.7 3.7 3.5 3.6 
Arg92 O Trp37 O 3.7 3.6 3.6 3.6 3.6 3.6 3.8 3.7 
Asp94 
OD1 
Trp37 
NE1 
4.0 4.0 3.9 3.9 3.9 3.9 -- 3.9 
Asp94 
OD2 
Trp37 
NE1 
3.8 3.7 3.8 3.8 3.6 3.8 3.8 3.7 
Asp94 
OD1 
Asn102 
OD1 
4.0 3.9 -- -- 3.9 4.0 4.0 3.9 
Asp94 
OD2 
Asn102 
ND2 
2.9 2.8 2.9 2.9 2.8 2.8 2.9 2.8 
Asp94 OD Tyr41 OH 3.0 2.9 2.9 2.8 3.0 2.8 3.1 3.0 
Neither the Gly83Cys-Phe41Tyr nor the Gly83Cys structures contain the interactions 
between His146 and Asp94 that are indicative of the low-affinity T state.  While the lack of 
salt bridge is expected in the liganded Gly83Cys-Phe41Tyr model, the lack of interaction 
between these two residues in the Gly83Cys model suggests that the disulfide bridge between 
the two tetramers breaks the interaction, bringing the structure closer to the R state.  The 
positioning of the terminal regions stabilizes a liganded octameric hemoglobin rather than an 
unliganded, increasing the affinity for CO or O2.  Restraints put on the protein by lattice contacts 
may also contribute some of the stabilization force.  The lack of interaction explains the decrease 
in cooperativity of oxygen binding.  Mutants where the terminal histidine has been deleted show 
less cooperativity than HbA, presumably because the interactions between His146 and Asp94 
stabilize the T state.  While the His146-Asp94 interaction is not seen in the Asn78Cys 
mutant, a compensatory interaction is seen between the oxygen of Asp94 and the Lys144 
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nitrogen (2.9 Å).  The hydrogen bond is not seen in the Gly83Cys structure, and instead a weak 
interaction (4.2 Å) between the oxygen of Glu90 and nitrogen of Lys144 is present.   
 The Gly83Cys-Phe41Tyr mutant contains an additional hydrogen bonding 
interaction between 1Tyr41 and 2Asp94.  The hydroxyl group also interacts with the  main 
chain, hydrogen bonding with the Asp99 nitrogen and the His97 carbonyl.  The above listed 
interactions would affect the position of Phe42 at the heme pocket, thus affecting ligand 
binding.   
3.3.6 Comparison of Heme Pockets 
The heme pockets of the α chain show more consistency in the relative placement of the 
histidines.  See Table 3.25 and Table 3.26 for the geometry of the ligand and histidines that 
coordinate the heme iron.  The αAsn78Cys model has the distal histidine closer to the center of 
the monomer.  The βGly83Cys-Phe41Tyr distal histidines are pushed the furthest from the center 
of the heme group, while the βGly83Cys histidines adopt a conformation in between that of the 
αAsn78Cys and βGly83Cys-Phe41Tyr histidine positions.  The differences in the distal histidine 
positions in the βGly83Cys-Phe41Tyr may be due to the presence of hydroxyl ligand.  The 
ligand coordinates between the iron and the nitrogen of the distal histidine and increases the 
distance between the two when present.  The αAsn78Cys structure has the same change in 
histidine position depending on heme ligand state, but shows a conformation closer to the 
condensed R state seen in previous crystal structures.   
The electron density of the oxidized octameric mutants shows that all of the mutants have 
only some heme groups bound to ligands.  Figure 3.12 to Figure 3.14 show representative images 
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of the electron density of the α and β heme pocket.  The images show the 2Fo-Fc electron density 
at a contour level of 3σ.  The α heme pockets contain hydroxyl ligand the majority of the time, 
with only the βGly83Cys mutant containing α monomers without ligand present.  The β heme 
pockets were much more variable, containing a mixture of liganded and unliganded pockets.   
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Figure 3.12 Electron density of representative heme pockets demonstrating the aquamet form of 
βGly83Cys-Phe41Tyr. 
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Figure 3.13 Electron density of the heme pocket in βGly83Cys demonstrating the ligand-bound and 
unbound forms of the aquamet model. 
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Figure 3.14 Electron density of the αAsn78Cys aquamet model with representative images of the α 
and β heme pockets. 
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Table 3.25 Distance from heme iron to various planes in the heme pocket.  All numbers are in 
Ångstroms.  Shown are distances from the iron to the proximal histidine (Prox His), distal histidine (Dist His), 
hydroxyl ligand (OH), the plane described by the 4 pyrrol nitrogens (Pyr N plane), and the plane described 
by the outer carbon atoms of the porphyrin ring (Por C plane). 
 Prox His Dist His OH Por N plane Por C plane 
αAsn78Cys 1 2.1 4.2 2.2 0.0 -0.2 
αAsn78Cys 2 2.1 4.3 2.3 0.2 0.2 
αAsn78Cys 3 2.1 4.3 2.2 0.1 0.2 
αAsn78Cys 4 2.0 4.3 2.1 -0.1 -0.2 
αAsn78Cys 1 2.2 4.2 2.3 0.0 -0.1 
αAsn78Cys 2 2.2 4.2 --- 0.1 0.1 
αAsn78Cys 3 2.2 4.2 --- 0.0 0.1 
αAsn78Cys 4 2.1 4.3 --- -0.1 -0.2 
      
βGly83Cys 1 2.2 4.2 --- -0.1 -0.2 
βGly83Cys 2 2.3 4.2 --- 0.0 0.1 
βGly83Cys 3 2.2 4.2 --- 0.1 0.2 
βGly83Cys 4 2.3 4.2 --- 0.0 -0.1 
βGly83Cys 1’ 2.3 4.1 --- 0.0 -0.1 
βGly83Cys 2’ 2.1 4.3 --- 0.1 0.2 
βGly83Cys 3’ 2.2 4.2 2.22 0.1 0.0 
βGly83Cys 4’ 2.2 4.2 --- -0.4 -0.2 
βGly83Cys 1 2.3 4.1 --- -0.1 0.0 
βGly83Cys 2 2.2 4.1 --- 0.1 0.0 
βGly83Cys 3 2.0 4.3 2.2 0.1 0.2 
βGly83Cys 4 2.1 4.2 --- -0.1 -0.2 
βGly83Cys 1’ 2.1 4.3 --- 0.0 -0.1 
βGly83Cys 2’ 2.1 4.2 --- 0.0 0.1 
βGly83Cys 3’ 2.1 4.2 --- 0.1 -0.1 
βGly83Cys 4’ 2.1 4.3 2.2 0.0 0.2 
      
βGly83Cys-
Phe41Tyr 1 
2.1 4.2 2.3 0.0 0.0 
βGly83Cys-
Phe41Tyr 2 
2.1 4.2 2.4 0.0 -0.1 
βGly83Cys-
Phe41Tyr 3 
2.1 4.2 2.2 0.1 0.0 
βGly83Cys- 2.1 4.2 2.3 0.0 0.1 
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Phe41Tyr 4 
βGly83Cys-
Phe41Tyr 1’ 
2.1 4.2 2.5 0.0 0.0 
βGly83Cys-
Phe41Tyr 2’ 
2.1 4.1 2.2 -0.1 0.0 
βGly83Cys-
Phe41Tyr 3’ 
2.2 4.1 2.4 -0.1 0.0 
βGly83Cys-
Phe41Tyr 4’ 
2.1 4.2 2.4 0.1 0.0 
βGly83Cys-
Phe41Tyr 1 
2.1 4.3 --- 0.1 0.0 
βGly83Cys-
Phe41Tyr 2 
2.1 4.3 2.3 0.0 0.1 
βGly83Cys-
Phe41Tyr 3 
2.1 4.3 2.4 0.1 0.0 
βGly83Cys-
Phe41Tyr 4 
2.1 4.3 2.2 0.0 0.1 
βGly83Cys-
Phe41Tyr 1’ 
2.2 4.3 2.4 0.1 0.0 
βGly83Cys-
Phe41Tyr 2’ 
2.1 4.3 2.4 0.0 0.0 
βGly83Cys-
Phe41Tyr 3’ 
2.1 4.3 2.3 0.0 -0.1 
βGly83Cys-
Phe41Tyr 4’ 
2.1 4.3 2.3 0.0 0.1 
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Table 3.26 Average heme pocket geometry in the oxidized octameric mutants. 
 Asn78Cys Asn78Cys Gly83Cys Gly83Cys Gly83Cys-
Phe41Tyr 
Gly83Cys-
Phe41Tyr 
       
Prox His 2.1 
0.05 
2.2 
0.06 
2.2 
0.05 
2.1 
0.06 
2.1 
0.02 
2.1 
0.03 
Dist His 4.3 
0.02 
4.2 
0.07 
4.2 
0.06 
4.2 
0.07 
4.2 
0.03 
4.3 
0.03 
OH  2.2 
0.04 
2.3 2.22 2.2 
0.00 
2.3 
0.08 
2.3 
0.09 
Pyr N 
plane 
0.0 
0.14 
0.0 
0.07 
0.0 
0.12 
0.0 
0.05 
0.0 
0.06 
0.0 
0.04 
Pyr 
plane 
0.0 
0.27 
0.0 
0.17 
0.0 
0.17 
0.1 
0.12 
0.0 
0.01 
0.0 
0.07 
 
In the βGly83Cys-Phe41Tyr mutant, the α-chain distal histidines are very similarly 
placed.  The heme residues were superimposed on each other in order to get the best fit of the 
heme pocket for comparison.  The distance between the nitrogens in the distal histidine is less 
than 0.2 Å, suggesting that the nitrogen placement is stabilized by the presence of hydroxyl in 
the heme pocket.  
The β-chain distal histidines in the βGly83Cys mutant vary in placement in the heme 
pocket.  Table 3.26 compares the distances between the iron and the proximal and distal 
histidines, as well as the displacement of the iron from the porphyrin ring plane.  All mutants 
have the iron well in the plane of the porphyrin ring, regardless of whether the porphyrin 
nitrogens or the carbon pyrrole ring is used to create the plane (see Table 3.25 and Table 3.26).  
While little difference is seen among the mutants for iron positioning, the proximal and distal 
histidines vary in their positioning from the iron and the hydroxyl group (see Figure 3.12 to 
Figure 3.14 and Table 3.26).   
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The αAsn78Cys β heme pocket does not have a consistent conformation, suggesting both 
positive and negative forces in ligand binding.  Half of the β chain heme pockets show a more 
closed conformation, where the distal histidine is closer to the iron and the aromatic residues 
around the heme are closer to the porphyrin.  The other half adopts a conformation that is slightly 
distended outwards towards the outside of the tetramer.  The heme pockets with the longer 
distance between the distal histidine and the iron would be more sterically favorable for ligand 
binding, whereas the shorter distance in the other monomers would inhibit ligand binding. 
3.3.7 Effects of the βPhe41Tyr mutation 
The βPhe41Tyr mutation has been shown to decrease the oxygen and carbon monoxide affinity 
of HbA.  Ho and coworkers have shown that addition of the βPhe41Tyr mutation to the 
octameric βGly83Cys mutant also decreases the affinity of the octameric Hb.  The βTyr41 adds 
additional hydroxyl group that has the capability to hydrogen bond and stabilize interactions that 
would decrease the oxygen affinity.  The hydroxyl group of β1Tyr41 hydrogen bonds with 
β1Val98, β1Asp99, β1Asn102 and α2Asp 94 (see Figure 3.15, Figure 3.16 and Table 3.27).  Table 
3.27 shows the hydrogen bonding distances between the βTyr41 hydroxyl and the other residues.  
Also note the proximity of βTyr41 to the heme pocket.  Any changes that occur near this 
mutation, especially interactions with βVal98, would affect the accessibility and stability of the 
heme pocket.  In HbA, the βPhe41 is stabilized by hydrophobic interactions, which are much 
weaker than hydrogen bonds.  The weaker hydrophobic val der Waals interactions allow βPhe41 
to move more freely than the βTyr41.   
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Figure 3.15 Hydrogen Bonding Interactions of the Mutated βTyr41 in βGly83Cys-Phe41Tyr 
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Figure 3.16 Proximity of βTyr41 and Interacting Residues to the β Heme 
Table 3.27 Hydrogen bonding distances of mutant βPhe41Tyr interactions 
Monomer β1Asp99 N β1His97 O β1Asn94 ND2 α2Asp94 OD 
β1 3.3 3.7 3.9 2.9 
β2 3.4 3.7 3.9 3.0 
β1′ 3.4 3.7 3.9 2.8 
β2′ 3.3 3.7 3.9 2.9 
β3 3.3 3.7 4.0 2.8 
β4 3.4 3.7 3.9 3.0 
β3′ 3.4 3.7 3.9 3.0 
β4′ 3.4 3.7 3.9 3.1 
Average 3.4±0.0 3.7±0.0 3.9±0.0 2.9±0.1 
 
3.3.8 Cysteine positioning and activity 
In the βGly83Cys-Phe41Tyr mutant, βCys93 has different positions, suggesting that it controls 
the activity of βGly83Cys-Phe41Tyr.  Previous research has shown that trapping the βCys93 in 
the outward-facing state by binding to NEM or IAA changes the T-to-R transition and stabilizes 
the T state.  The βCys93 does not adopt multiple conformations in the other mutants.  The 
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βGly83Cys mutant contains the βCys93 pointing inwards, towards the core of the protein.  
αAsn78Cys mutant contains the outward-facing βCys93 conformation.   
3.3.9 oHb vs. HbCN 
The oxidized hemoglobin contains water molecules at many of the heme pockets.  In an effort to 
obtain hemoglobin that is more like the oxygenated hemoglobin that would be used as blood 
substitutes, the octameric hemoglobin was purposefully oxidized and reacted with cyanide (CN
-
).  
Cyanide is a two-atom ligand, like oxygen, where the carbon interacts with the porphyrin iron 
and the nitrogen, with its lone pair of electrons, can interact and hydrogen bond with the distal 
histidine, much like oxygen molecules in HbO2.   
Although the tetramers do not have a lot of change, the presence of CN
-
 appears to 
stabilize the disulfide bridge.  In the oHb βGly83Cys, the large changes in the disulfide bridge 
geometry affected the relationship between the tetramers, causing the crystallization to be more 
variable.  This is not seen in the cyanide-bound oHb, and allows the protein to form more stable 
interactions and crystallize in a higher space group. Figure 3.17 shows a superposition of the 
oxidized βGly83Cys and the cyanide-bound high salt βGly83Cys structure.  The two tetramers 
are adopting slightly different conformations.  The presence of cyanide appears to stabilize one 
particular conformation of the disulfide bridge, resulting in only one octamer conformation.  This 
cyanide octamer conformation tilts the second tetramer 24° further than the oxidized form after 
superpositioning the tetramer.  However, the presence of cyanide does not appear to affect the 
relative dimer position.  Comparison of the tetramers with previously published structures shows 
that the cyanide-bound βGly83Cys are most similar to the PEG-crystallized structure of 1BBB 
(see Table 3.29 and Table 3.30).   
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The cyanide appears to bind only  monomers (see Table 3.28 and Figure 3.18).  The 
distal histidine moves further away from the iron to accommodate the larger ligand.  The 
presence of the disulfide bridge between the  monomers possibly destabilizes the cyanide 
binding in the β monomers.  If the  monomers would need more flexibility at the ligand binding 
site due to constraints caused by - interactions, the average ligand binding to the  monomers 
may be similar to HbA but not consistant enough to see in crystallography.  This may also be 
affecting the ability to crystallize the Gly83Cys-Phe41Tyr.  If the cyanide introduces alot of 
quaternary changes in the  monomers that would then get distributed through the entire octamer 
it may be affecting the octameric structure of the Gly83Cys-Phe41Tyr and inhibiting 
crystallization.  The small size of the hydroxyl in the oxidized mutants may not be enough to 
cause these disturbances in the octamer. 
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Figure 3.17 Superposition of one tetramer of the βGly83Cys CN (green) and oβGly83Cys (blue) 
shows the large difference in the position of the second tetramer due to changes in the disulfide bridge 
geometry.  The second tetramer is shifted by 24°. 
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Figure 3.18 Cyanide-bound βGly83Cys heme compared to hydroxyl-bound βGly83Cys heme.  The 
distal His moves away from the heme pocket to accommodate the cyanide. 
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Table 3.28 Heme group geometry of the high salt βGly83Cys CN structure. All numbers are in 
Ångstroms.  Shown are distances from the iron to the proximal histidine (Prox His), distal histidine (Dist His), 
hydroxyl ligand (OH), the plane described by the 4 pyrrol nitrogens (Pyr N plane), and the plane described 
by the outer carbon atoms of the porphyrin ring (Por C plane). 
 Por plane Por N plane Ligand Proximal 
His 
Distal His 
with CYN      
α1 -0.01 0.18 2.25 2.26 4.54 
α2 -0.03 0.10 2.25 2.38 4.80 
α1′ 0.27 0.26 2.25 2.33 4.34 
average 0.08±0.20 0.18±0.08 2.25±0.00 2.32±0.07 4.56±0.24 
with OH      
α2′ 0.10 -0.09 2.50 2.25 4.23 
      
β1 -0.05 -0.12 2.51 2.26 4.11 
β2 0.06 0.00 2.58 2.36 4.23 
β2′ -0.04 0.05 2.55 2.26 4.31 
average -0.01±0.07 -0.35±0.08 2.55±0.037 2.29±0.07 4.22±0.11 
no ligand      
β1′ -0.01 -0.13 NA 2.26 4.29 
 
Table 3.29 RMSD of dimers of the high salt octameric βGly83Cys CN and previously published 
structures (by chain) after α1β1 dimer superposition.  Where only one dimer comparison is listed, the second 
dimer is related by the asymmetric unit and would give identical RMSD values. 
 2DN3 1BBB 
α1β1 
1BBB 
α2β2 
1GZX 
α1β1 
1GZX 
α2β2 
1YZI 1A3N 
α1β1 
1A3N 
α2β2 
1MKO 
α1β1 
1MKO 
α2β2 
2DN1 
α1β1 0.93 0.34 0.31 1.19 1.17 1.16 1.23 1.25 0.71 0.53 0.97 
α2β2 0.89 0.40 0.32 1.13 1.11 1.15 1.17 1.19 0.70 0.50 0.92 
α1′β1′ 0.91 0.38 0.34 1.16 1.14 1.14 1.20 1.22 0.71 0.54 0.93 
α2′β2′ 0.92 0.37 0.30 1.18 1.17 1.17 1.22 1.23 0.73 0.52 0.96 
 0.91 
±0.02 
0.37 
±0.03 
0.32 
±0.02 
1.16 
±0.01 
1.15 
±0.03 
1.16 
±0.01 
1.20 
±0.03 
1.22 
±0.03 
0.72 
±0.01 
0.52 
0.02 
0.95 
±0.02 
  0.34±0.03 1.16±0.02  1.21±0.03 0.62±0.11  
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In order to compare the cyanide-bound βGly83Cys with the previously published HbA 
structures, the RMSD of the dimers was compared in the same way as the oxidized mutants (see 
Table 3.29 and Table 3.30).  The 11 dimer was superimposed and the RMSD obtained (column 
α1β1), then the RMSD for 22 was obtained (column α2β2).  The angle denotes the rotation angle 
necessary to superimpose the vector between the first and last C of each α2β2 dimer.  Both the 
α1β1->α2β2 rotation and the α2β2->α1β1 rotation were calculated because intrinsic differences in 
the RMSD and superpositions of each dimer would affect the RMSD and angle rotation 
calculated for the second dimer.  The first two letters (i.e. in α1β1->α2β2 the α1β1) indicate the 
chains that were used as the 11 dimer and the second two letters (i.e. in α1β1->α2β2 the α2β2) 
indicate the chains that were used as the 22 dimer.  As in the oxidized mutants, βGly83Cys CN 
is closest to the structure 1BBB, which was crystallized in PEG.  The fact that all of the mutants 
are closest to the 1BBB structure, regardless of the crystallization conditions, demonstrates the 
propensity of the disulfide bridge to restrict the conformations that are available for the 
octameric hemoglobin.  The crystallization conditions of the high salt structure are closest to the 
crystallization conditions of the original R structure, so the expected conformation of the high 
salt βGly83Cys would be closer to the R structure.   
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Table 3.30 Comparison of high salt βGly83Cys with previously published structures.  See text for 
detailed methods. 
1A3N 
 α1β1 (Å) α2β2 (Å) Angle (°) 
α1β1 -> α2β2 1.23 8.62 29.8 
α2β2 -> α1β1 1.17 8.55 29.9 
α1′β1′ -> α2′β2′ 1.20 8.53 30.3 
α2′β2′ -> α1′β1′ 1.22 8.45 29.9 
Average 1.20±0.03 8.54±0.07 30.0±0.2 
1GZX 
 α1β1 (Å) α2β2 (Å) Angle (°) 
α1β1 -> α2β2 1.19 9.27 31.1 
α2β2 -> α1β1 1.13 9.18 31.2 
α1′β1′ -> α2′β2′ 1.16 9.15 31.6 
α2′β2′ -> α1′β1′ 1.18 9.08 31.3 
average 1.16±0.02 9.17±0.07 31.3±0.2 
2DN1 
 α1β1 (Å) α2β2 (Å) Angle (°) 
α1β1 -> α2β2 0.97 4.17 10.1 
α2β2 -> α1β1 0.92 4.04 10.1 
α1′β1′ -> α2′β2′ 0.93 4.00 10.5 
α2′β2′ -> α1′β1′ 0.96 3.96 10.1 
average 0.95±0.02 4.04±0.08 10.2±0.2 
2DN3 
 α1β1 (Å) α2β2 (Å) angle (°) 
α1β1 -> α2β2 0.93 3.88 9.5 
α2β2 -> α1β1 0.89 3.76 9.5 
α1′β1′ -> α2′β2′ 0.91 3.72 9.8 
α2′β2′ -> α1′β1′ 0.92 3.69 9.4 
average 0.91±0.02 3.76±0.08 9.5±0.2 
1MKO 
 α1β1 (Å) α2β2 (Å) Angle (°) 
α1β1 -> α2β2 0.71 2.10 6.4 
α2β2 -> α1β1 0.70 1.93 6.4 
α1′β1′ -> α2′β2′ 0.71 1.94 6.7 
α2′β2′ -> α1′β1′ 0.73 1.98 6.3 
average 0.72±0.01 1.99±0.08 6.5±0.2 
1BBB 
 α1β1 (Å) α2β2 (Å) Angle (°) 
α1β1 -> α2β2 0.31 0.73 1.8 
α2β2 -> α1β1 0.40 0.83 1.7 
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α1′β1′ -> α2′β2′ 0.38 0.69 1.3 
α2′β2′ -> α1′β1′ 0.37 0.70 1.7 
average 0.37±0.03 0.74±0.06 1.6±0.2 
1YZI 
 α1β1 (Å) α2β2 (Å) Angle (°) 
α1β1 -> α2β2 1.16 5.58 18.6 
α2β2 -> α1β1 1.15 5.44 18.7 
α1′β1′ -> α2′β2′ 1.14 5.44 18.9 
α2′β2′ -> α1′β1′ 1.17 5.45 18.5 
average 1.16±0.01 5.48±0.07 18.7±0.2 
 
3.4 DISCUSSION 
While currently a search for human hemoglobin models in the PDB will bring up over 200 
entries (214 as of March 2012), none of the entries has been solved under crystallization 
conditions that have such a high pH value.  Previous researchers have looked for patterns in 
crystallization and pH, and have supported a conclusion that the overall surface charge of the 
crystallized protein must be close to 0 in order for crystallization to be successful.  This makes 
sense because protein-protein contacts must occur in crystallization, where typically positively-
charged amino acids interact with typically negatively-charged amino acids.  Tetrameric 
hemoglobin has a pI (7.89 according to Protparam [98]) higher than physiological pH (7.2-7.4). 
HbA contains 44 lysines, the majority of which protrude into the solution.  In the tetrameric 
form, these lysines can interact with a comparative portion of the hemoglobin tetramer.  
However, when restricted by the addition of disulfide bridges across two tetramers, it forces the 
positive areas of hemoglobin to interact with other lysine-containing regions.  This necessitates 
 139 
crystallization at a higher pH, where the lysines would be partially protonated.  This also may 
explain the structural stabilization of particular R states in tetrameric hemoglobin.   
The presence of two disulfide bridges per octamer allows temporary reduction of either 
of the two disulfide bridges without dissociation of the entire complex.  If one disulfide bridge 
becomes reduced, the proximity and orientation of the two tetramers allows the disulfide bridge 
to reform at a rate higher than would be expected if only one covalent interaction stabilized the 
octamer.  The octamerization allows for some amount of “give” in the dimers without a total 
dissociation.   
3.4.1 Effects of the βPhe41Tyr mutation 
The βPhe41Tyr mutation has been shown to decrease oxygen binding in the single mutant, 
however the mechanism was unknown because a crystal structure was nonexistent for this 
particular mutant.  In HbA, βPhe41 is part of the hydrophobic pocket that accepts the heme 
group in the β subunit.  When superimposing the α1β1 dimer of 1A3N, the T state tetramer, and 
2DN3, the carbonmonoxy tetramer, the Cα atom of βPhe41 moves 0.8 Å.  In the βGly83Cys-
Phe41Tyr mutant, the βTyr41 instead interacts with backbone atoms from the β subunit, 
stabilizing the structure.  This stabilization affects the oxygen binding properties but does not 
seem to affect the disulfide bridge, as the bridge still has a significant amount of motion as the 
single βGly83Cys mutant does.  The interactions with β1Asp99 backbone, β1His97 backbone, 
α2Asp94, and β1Asn102 stabilize the R state conformation.  If the βPhe41 is mutated and 
modeled as a Tyr in the PDB 1A3N, the hypothesis can be made that the T state and lower 
affinity is stabilized by interactions between β1Tyr41 and β1Asp99 backbone, β1His97 backbone, 
β1Asn102.  Note that the shift that occurs to bring βTyr41 closer to the α2 subunit comes at the 
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expense of the hydrogen bonds between βTyr41 and the interacting residues on the β1 subunit 
(see Figure 3.15 and Figure 3.16).   
3.4.2 Effects of cyanide on crystallization 
One of the problems experienced in crystallization of rHb is the movement possible from the 
disulfide bridge.  While this could be independent of the ligand-bounding state, the fact that the 
rHb crystallized in a higher space group in the presence of CN suggests that the ligand binding 
stabilizes a specific octameric conformation.  Interestingly, CN only bound to the α monomers, 
which has been shown to bind more tightly to carbon monoxide and oxygen.   
3.4.3 Comparison to HbA 
The octameric hemoglobin tetramers are closest in quaternary structure to the R2 ligand-bound 
state.  Comparison shows similarities in ligand-binding state and crystallization conditions.  The 
crystal structure closest to oHb is 1BBB.  oHb and 1BBB crystals were grown in PEG 
conditions, which has been shown to affect the adopted R state.  However, NMR research by Ho 
and coworkers has shown that these R state models are adopted by HbA in solution, and that 
crystallized models show individual conformational states that are part of the R ensemble.   
One concern is the fact that these models were determined at a much higher pH than 
physiological pH and much higher than the normal 6.5-7.5 pH range that is usually seen in 
crystallized models.  The higher pH brings into question how much of the models are affected by 
crystallization conditions.  The similarities of the overall structure of octameric hemoglobin in 
the presence and absence of cyanide suggests that the crystallization conditions are not affecting 
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the model any more than previously determined HbA, but that the ligand binding state has a 
much greater effect on the adopted structure.   
Even when oxidized, the Asn78Cys model shows structural aspects of the T state.  The 
models of the Asn78Cys do not show Cys93, directly adjacent to the proximal histidine 
His92, to be in the same conformation in all monomers.  In half of the  chains, Cys93 is 
pointing inwards, whereas in the other half of the model, Cys93 is pointing towards the outside 
of the model.  Previous research has shown that the T-R transition is accompanied by a flipping 
of Cys93 from the core to the surface of the Hb.  Indeed, Hb can be forced to keep the R 
conformation by linking the Cys93 with large sulfide linkers that keep Cys93 pointing 
towards the solvent.  In the T state, Cys93 is sequestered and does not react easily with 
cysteine-altering compounds such as IAA and NEM.  However, once hemoglobin is in the R 
state, the Cys93 is readily available for reaction with cysteine-altering compounds.  
Hemoglobin can be stabilized in the R state by reacting Cys93 with IAA prior to stripping the 
heme groups of ligands.  The changes suggest that ligand affinity is modulated by restraining the 
Cys93 position, affecting the heme environment. 
3.4.4 Summary and Future Directions 
The disulfide bridges stabilize an octameric hemoglobin and prevent dissociation of the 
cooperative tetramer into dimers.  The disulfide bridge in the βGly83Cys and βGly83Cys-
Phe41Tyr mutants can adopt a wider range of geometry than the disulfide bridges in the 
αAsn78Cys, which are more restricted in part due to the steric interactions between the two 
linked tetramers.  The disulfide bridge can also be stabilized by the presence of cyanide, 
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suggesting that the oxygen-bound octameric hemoglobin would also have less relative motion 
across the disulfide bridge.  The presence or absence of ligand in the heme pockets, specifically 
the α heme pockets, have a significant effect on the overall octameric structure.   
The presence of cyanide appears to stabilize the disulfide bridge conformations by 
stabilizing the α heme pockets and affecting the rest of the model through αβ interactions.  The β 
heme pockets do not appear to contain cyanide, suggesting that the disulfides destabilize the 
tetramer.   
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4.0  RAP1B 
4.1 INTRODUCTION 
Rap1b is a protein that is phosphorylated on Ser179 in order to activate it.  Previous attempts at 
crystallization have shown the core structure to be an alpha-beta protein [87-89].  Rap1 is an 
integral protein in cell-cell adhesion [162].  In order to identify the regulation of this protein, we 
must examine the full-length Rap.  However, all of the previous models were terminated between 
residues 166-168, eliminating the portion of the protein crucial for regulation by phosphorylation 
and isoprenyl group addition [80, 81].  In the Rap proteins, Rap1A and Rap1B differ only in nine 
residues in the C terminal tail.  This gives them a 95% sequence identity.  Both proteins contain a 
phosphorylated serine, Ser180 in Rap1A and Ser179 in Rap1B.  Because the first 171 residues of 
Rap1A and Rap1B are identical, the determined structures of Rap1 in complex with other 
proteins have been determined with little analysis of the conformations of the C terminus.   
A portion of Rap1 between residues 32-44 has been shown to be necessary for interaction 
with Ras and GAP [163].  Subsequent mutations of Gly12Val and Ala59Thr were shown to 
increase its “reversion-inducing activity” [164].  Cys181 was mutated to Gly to remove the 
isoprenylation site.  Two separate mutations were added to the double-mutant Gly12Val-
Cys181Gly: Ser179Asp and Ser179Ala.  The Ser179Asp mutation mimics the phosphorylation 
of Ser179 by adding a negative charge to residue 179.  Aspartic acid was used instead of 
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glutamic acid because the aspartic acid contains a distance and geometrical restriction that is 
similar to a phosphorylated serine.  Using a glutamic acid instead of an aspartic acid would 
extend the distance between the Cα and the negative charge and add a second area of rotation 
between the Cβ and C atoms that would not be present in the phosphorylated serine.  The other 
mutation is a Ser179Ala mutation, which would eliminate whatever interactions exist from the 
presence of the normal Ser179.   
4.2 MATERIALS AND METHODS 
4.2.1 Crystallization 
Protein was supplied by Dr. Daniel Altschuler, containing GTPγS as the GTP analogue.  
Hanging drop vapor diffusion crystallizations were set up by Dr. Shoucheng Du.  Crystals were 
obtained from crystallization conditions 0.3 M magnesium chloride, 0.1 M bicine pH 9.0, 25% 
w/v PEG 2000, 15% w/v glycerol and 0.2 M di-potassium phosphate, 20% w/v PEG 3350 for the 
29A and 29D proteins, respectively.  22% ethylene glycerol was added to the mother liquor for 
cryoprotection of the 29D crystals.   
4.2.2 Data Collection and Processing 
Data collection was done at the SER-CAT BM line at the Advanced Photon Source at Argonne 
National Laboratory for the 29A and on a Saturn 944 CCD with a Rigaku FRE Superbright 
generator for the 29D data sets by Dr. Shoucheng Du and Dr. Unmesh Chinte.  Data was 
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processed by Dr. Unmesh Chinte to 2.1 Å and 2.2 Å for the 29A and 29D, respectively, using 
HKL2000 [103].   
 
4.2.3 Model Refinement 
Initial models contained the core of the protein and the mtz data files, which were a product of 
Dr. Unmesh Chinte’s refinement.  The refinement statistics for the received models and final 
models are shown in Table 4.1.  The C-terminus was determined by determining the electron 
density that reappeared after refinement when the terminus position was varied.  All of the 
rotamers were checked against the electron density and standard rotamer conformations.  The 
models were checked using simulated annealing omit maps to determine whether GTP or GDP 
was present in the active site.  Waters and ions were added prior to checking the C-terminal 
placement.  The placement of the C-terminus was modified to better fit the electron density.  
Final rounds of refinement were done in PHENIX [107].  Final model statistics can be found in 
Table 4.1.   
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Table 4.1 Data Refinement Statistics for Rap Ser179D and Rap Ser179A. 
 Rap Ser179Asp 
Before 
Rap Ser179Asp 
After 
Rap Ser179Ala 
Before 
Rap Ser179Ala 
After 
Resolution (Å) 2.2 2.2 2.1 2.1 
Rwork (%) 24.83 17.86 24.72 18.69 
Rfree (%) 29.83 23.36 29.53 23.04 
Bond angle 
RMSD 
2.02 1.08 1.95 1.03 
Bond length 
RMSD 
0.021 0.008 0.021 0.008 
Ramachandran 
statistics 
    
Most favored 89.9 92.8 88.5 96.0 
Allowed 4.0 5.1 4.9 3.0 
Disallowed 6.1 2.1 6.6 1.0 
Clashscore 60.31 17.52 34.41 11.59 
Rotamer outliers 10.7 3.0 8.6 2.3 
Cβ outliers 2 1 0 0 
 
 
4.3 RESULTS 
4.3.1 Overall Structure and Changes in the C-terminus 
Table 4.1 shows the refinement statistics of the two Rap mutants, listed as Ser179Asp 
(Gly12Val-Ser179Asp-Cys181Gly) and Ser179Ala (Gly12Val-Ser179Ala-Cys181Gly).  The 
overall core fold is the same as previous Rap1 and Ras models.  The Gly12Val mutation was to 
keep the Rap1B in an active conformation, and the Cys181Gly mutation removed the 
isoprenylation site.  Both structures contain GDP instead of the GTPγS expected in the 
 147 
nucleotide binding site.  Both Rap models have the same core structure as previous 
cocrystallized Rap models (see Figure 4.1). The C-terminus is away from the core structure, so 
that it is not stabilized by interactions with the core of the protein.  This may allow the core to 
provide a stable site to interact with the effectors and modulating proteins, while allowing the 
terminus to interact with and affect the activity of multiple different proteins.  The structural 
flexibility of the loop would allow it to interact less tightly to a greater variety of proteins rather 
than interact with and affect one or two proteins very strongly.  Considering that Rap must 
activate multiple proteins, the flexibility of the C-terminal loop supports the ability to interact 
with a variety of proteins.   
 
 
Figure 4.1 Superposition of Ser179Ala (magenta) and Ser179D (blue) showing the differences in the 
C-terminal loop position 
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Figure 4.2 C-terminal region showing the Ser179Asp mutant (blue) with the mutation point marked 
with a ball at the Cα and Ser179Ala mutant (magenta).  The C-terminal loop extends in the Ser179 mutant 
and is stabilized by interactions between the negatively-charged Asp179 and the protein core. 
4.3.2 GTP site 
Both Rap1B structures contain GDP and Mg
2+
 in the active site (see Figure 4.2 and Figure 4.3), 
suggesting that this model is in an inactive form.  GTP hydrolysis occurred at some point 
between obtaining the protein and collecting crystal data.  Rap1B is regulated by both the 
presence of GTP vs. GDP, and the phosphorylation at Ser179.  The Ser179Asp mutant contains 
more interactions and more stable interactions in the C-terminal region compared to the 
Ser179Ala mutant.   
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Figure 4.3 GDP binding site in Rap Ser179Ala.  The binding site and interactions are identical in the 
Ser179Ala and Ser179Asp mutants.  Dotted lines show the hydrogen bonding interactions between the 
protein and GDP. 
The GDP is stabilized in position with interactions very similar to the interactions seen in 
the GTP analogue structures.  The guanine base contains hydrogen bonds or charged interactions 
with the backbone nitrogens of residues Lys117, Ala148 and Lys149, and forms a network of 
hydrogen bonds or charged interactions with the sidechains of Asp119, Ser147 and Asn116 (see 
Figure 4.3 and Figure 4.4).  One water molecule is stabilized close to the outer surface of the 
protein.  The ribose sugar uses a much smaller network of hydrogen bonds and charged 
interactions with the backbone of Glu30 and Gly13, and interacts with the NZ atom of Lys117.  
Whether Lys117 stabilizes the sugar, or the significant interactions elsewhere between the GDP 
and Rap1B stabilize the specific conformation of Lys117 is unclear.  The phosphates create a 
significant web, with each oxygen atom interacting with multiple residues in Rap1B.  The 
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backbone atoms of Tyr32, Gly15, Gly13 and Ala18 cradle the α phosphate.  The α phosphate 
also interacts with 4 water atoms.  The β phosphate interacts with the same backbone atoms of 
Gly13 and Gly15, while creating new contacts with the backbone of Val14, Ser11, Lys16 and 
Ser17.  The sidechains of Lys16 and Ser17 also interact with the β phosphate.  The interactions 
stabilize the Mg
2+
 atom that is necessary for GTPase activity, along with four water atoms, two 
of which coordinate with the Mg
2+
 atom.   
 
Figure 4.4 Electron density of the GDP and surrounding residues in Rap1B Ser179A.  The Rap1B 
Ser179D contains the same contacts. 
Attempts to place GTP in the nucleotide binding site support the conclusion that these 
mutants contain GDP.  Positioning GTP in the binding site electron density distorts the geometry 
of the gamma phosphate of GTP.  It would be necessary to replace the Mg
2+
 with the gamma 
phosphate, eliminating the magnesium.  The current magnesium position is supported by other 
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Ras and Rap1 models, all of which have a magnesium ion in a comparable placement to the 
current models.   
4.3.3 Protein changes close to the active site 
One significant alteration in the refined Rap1B structures that has not been seen in previous Rap 
models in the positioning of Thr35.  Previous Rap1 models show Thr35 pointing towards the 
active site of Rap where GTP binds [87-89].  Thr35 points away from the GDP binding site in 
our models.  This area does not interact with symmetry-related Rap monomers, suggesting that 
the alteration is not due to crystal contacts. 
4.3.4 Changes in the Switch II Region 
Although the 29A and 29D models are very similar, with a superimposed Cα RMSD of 1.2 Å, 
there are two main regions that differ.  One region is the C-terminal tail, discussed above.  The 
other region is between Thr61 and Thr65 (see Figure 4.5).  The electron density in this switch II 
region is not as well-defined as the rest of the model, with the exception of the C terminus.  The 
switch II region is further away from the core of the protein in the Ser179A mutant.  The 
Ser179D mutant contains the switch II region closer to the core, in a more stable conformation.  
The electron density for the Ser179D mutant is more visible in this region.  Attempts to refine 
the switch II region of the Ser179A mutant in the conformation that the Ser179D mutant adopts 
do not improve the electron density and increase the Rwork and Rfree values.   
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Figure 4.5 The Cα trace of the Ser179Asp mutant (blue) and Ser179Ala mutant (magenta). 
4.4 DISCUSSION 
We cannot rule out changes that occur due to posttranslational modifications of Rap1B.  
Previous work has shown that the lipid modification of Rap1B is necessary for stimulating C-Raf 
activity through Rap1B [82].  Both mutant models demonstrate active mutants that are the first 
Rap1 models to show the shift in Thr35 that occurs with GDP binding.   
It is possible that in the absence of a “partner protein” Rap1B hydrolyzes GTP at a much 
faster rate than when in complex.  The crystals were obtained 3-5 months after crystallization 
setup (Dr. Shoucheng Du, personal communication).  However, the Gly12Val mutation should 
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have kept Rap1B in its active state and would have stayed complexed with GTP much longer 
than the WT Rap1B.   
4.4.1 Position of Thr35 as a significant modulator 
The conformation of Thr35 significantly changes when in the presence of GDP.  The GTP 
analogues present in other models from the Ras family show that the equivalent of Thr35 
interacts with the gamma phosphate of the GTP analogue.  The Rap1 models in complex with 
other proteins all demonstrate that Thr35 interacts with the Mg
2+
 and gamma phosphate of the 
GTP analogue.  The rotation of Thr35 away from the GTP binding site in the presence of GDP 
suggests that the structural change is necessary for GDP-GTP exchange.  A guanine exchange 
factor (GEF) interacts with the Rap1 in order to complete the conversion from the inactive GDP-
bound state to the active GTP-bound state [165].   
4.4.2 Summary 
These are the first structures to show the changes that occur to Rap1B in the presence of GDP.  
The models also demonstrate that the presence of the negative charge at amino acid position 179 
significantly changes the placement of the C terminus, creating different charged interactions in 
the Rap protein.  The alterations that occur due to the different charges suggest two different 
switches in the interactions between Rap and its activated proteins.  One switch is the 
active/inactive switch previously documented that is triggered by the presence of GTP or GDP.  
The secondary switch is the charged interactions that occur during phosphorylation.  The change 
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in the C terminal position changes the interactions between Rap and other proteins, allowing for 
a level of control that is not present in the GTP/GDP switch.   
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5.0  CONCLUSION 
Multiple systems feed into the cellular respiration pathways, including hemoglobin, glycerol 
metabolism, and G-proteins such as Rap1B.  I have determined structural models of 
Enterococcus casseliflavus glycerol kinase mutants with glycerol or ethylene glycol, 
Pseudomonas aeruginosa glycerol kinase with glycerol or ethylene glycol, octameric human 
hemoglobin mutants, and two Rap1B mutants.  The structures demonstrate that small changes in 
one region of the model can significantly affect the protein activity and adopted conformation of 
other portions of the model.   
The structures of the En. casseliflavus GK mutants allow us to determine how the 
mutations activate the enzyme, and infer how the phosphorylation of His232 activates En. 
casseliflavus GK.  Although the His232Glu mutant was designed to mimic the negative charge 
caused by histidine phosphorylation, the distance between the charge and the Cα is smaller in the 
His232Glu than it would be in the His-PO4.  The shorter distance does not allow Glu232 to 
stabilize the activation loop.  However, the His232Arg mutant contains a longer distance 
between the Cα and the positive charge on Arg232 than the His232Glu mutant.  The His232Arg 
mutant contains contacts between the activation loop and Domain I that stabilize a conformation 
that causes closure of the glycerol binding cleft.  The presence of loop interactions creates a 
domino effect that closes the active cleft and orients the substrates properly for glycerol 
phosphorylation.  The His232Glu mutant is not positioned correctly to make the interactions seen 
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in the His232-PO4 activated form because it is not long enough.  The same loop interactions are 
seen in the ethylene glycol-bound En. casseliflavus GK, which shows the monomer rotation 
necessary to activate GK once glycerol binds.  This suggests that factors that disrupt the 
activation loop would decrease the activity of GK in Gram positive bacteria.  Factors that would 
stabilize the activation loop would therefore increase GK activity.  In contrast to the Gram 
negative structures that are available, the ATP binding site on Domain II does not go through an 
order-disorder transition when ATP binds.  In the absence of ATP, this area is still stable, 
suggesting that directed targeting of the ATP binding site may be another way to differentially 
affect GK activity in Gram positive and Gram negative bacteria. 
Interactions between the En. casseliflavus GK and En. faecalis HPr show that the 
presence of HPr in the crystallization setups affects the activation loop position.  Although the 
phosphorylated histidine is necessary for increased activity in En. casseliflavus GK, the presence 
of HPr stabilizes the activation loop against Domain I.  The stabilization of the activation loop is 
also affected by the stacking interactions that occur between the aromatic residues on the 
activation loop and aromatic residues on Domain I.  Phosphorylation of His232 would create 
interactions between the activation loop and Domain I that would affect the OX dimer interfact 
and increase activity by closing the active cleft.  HPr appears to not only phosphorylate His232 
but also reposition the activation loop so that it is able to create the necessary contacts with 
Domain I.  Unfortunately, the interaction is not visible in the current crystal structures, but 
further experiments using dynamic techniques such as SPR or NMR of the wild type and site-
directed mutants may be able to further identify the regulation and interactions that occur 
between HPr and GK.  Mutations around the activation loop that create different charges would 
be helpful to understand how phosphorylation of His232 modifies the interaction with HPr.  A 
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phosphomimetic mutant of HPr may be necessary to create a stable interaction between HPr and 
GK, as HPr is phosphorylated when it activates GK.  Our initial studies show that 
phosphorylation is not necessary for GK-HPr interaction in SPR experiments, but it may be 
necessary to have a negative charge to stabilize the interaction in crystallization conditions. 
The P. aeruginosa GK adopts similar conformations to the E. coli structure in the 
glycerol-bound form.  The active site residues are very similar between the P. aeruginosa, E. 
coli, and En. casseliflavus GK.  As in the En. casseliflavus structures, the activation cleft closes 
more when bound to glycerol versus ethylene glycol.  However, the ATP binding site on Domain 
II is disordered in both the glycerol-bound and ethylene glycol-bound P. aeruginosa structures.  
A structure of glycerol-bound P. aeruginosa GK with ATP analogues would show whether or not 
the ATP binding site goes through the same disorder-to-order transition that is seen in the E. coli 
GK structures when ATP or ADP is bound.  If Domain II changes during ATP binding, this 
regulation step could be used to differentially inhibit P. aeruginosa GK activity and not affect 
the activity of E. coli GK.  Inhibiting P. aeruginosa GK without affecting E. coli GK would 
allow targeting of the pathogen and preventing biofilm growth without affecting the growth of 
native E. coli strains in the human gut.  Allowing the native E. coli colonies to remain would 
allow the normal balance of the gut to remain and prevent opportunistic pathogens from 
colonizing the gut.  The tetrameric structure of the P. aeruginosa GK created by symmetry-
related monomers is very close to the tetrameric structures of inactive E. coli GK, suggesting that 
these P. aeruginosa GK structures are indicative of inactive GK tetramers.  Further research 
would be necessary to disrupt the OX dimer interface and determine the structures of the active 
P. aeruginosa GK.   
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The octameric structure of the hemoglobin mutants are affected by the presence of ligand 
in the molecule.  When a diatomic ligand is present, there is less motion across the disulfide 
bridges than when no ligand or oxidization is present.  This will affect the ability of the 
octameric hemoglobin to adopt specific conformations.  However, this motion can be altered by 
changing the position of the mutations.  For example, the αAsn78Cys mutant does not show the 
same type of variability in the disulfide bridges, and therefore it does not have as much 
variability in the tetramers as the βGly83Cys mutants.  Restriction of the αAsn78Cys disulfide 
bridges is caused in part by the steric clashes that would result between the two tetramers if the 
disulfide bridges moved.  The restriction on the disulfide bridges also means that the αAsn78Cys 
mutant would have to transition between the unliganded T state and the liganded R state in a 
more coordinated manner than the βGly83Cys mutants.  The structures and crystallographic 
results suggest that the ligand stabilizes the βGly83Cys mutant relative tetramer motion.   
The octameric hemoglobin adopts a tetramer conformation much like the structure 
crystallized in PEG, 1BBB [17], regardless of whether a hydroxyl or cyanide ligand is present in 
the binding pocket.  The ability of the hydroxyl-bound mutants to be in the R state while still 
only partially liganded suggests the transition from the unliganded T state to the liganded R state 
is coordinated between the two linked tetramers, even though the cooperativity is similar to the 
cooperativity seen in adult human hemoglobin (HbA) [34, 128].  The lack of unliganded T state 
models and the presence of the oxidized form of the octameric hemoglobin limits our ability to 
give a broad analysis of the effects of the disulfide bridges on the T state and the transition 
between the unliganded and liganded form.  The propensity of the mutants to form a structure 
with more rotation between the dimers when bound to ligand suggests that part of the higher 
oxygen affinity seen in the βGly83Cys is due in part to the protein being primed to form the R2 
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state by the disulfide bridge.  A concerning point is that all of these structures are oxidized, 
including the liganded form.  Determining the amount of oxidized octameric hemoglobin via 
spectra is necessary to determine the long-term potential of octameric hemoglobin as blood 
substitutes.  Animal models using the octameric hemoglobin as a blood substitute have thus far 
shown no adverse effects and are successful at delivering oxygen (Dr. Chien Ho, personal 
communication), so it is possible that the reducing agents in plasma are sufficient to keep the 
octameric hemoglobin in a reduced state.   
The Rap1B models demonstrate the portions of regulation that are determined by the 
phosphorylation of Ser179 rather than the presence of GTP.  It has been postulated that the 
presence of GTP is the overarching regulator of Rap activity, but the Gly12Val-Ser179Asp-
Cys181Gly and Gly12Val-Ser179Ala-Cys181Gly structures demonstrate a second level of 
regulation caused by the presence of a negative charge on residue 179.  The negatively-charged 
Ser179Asp residue changes the interaction between the C-terminal loop and the core of the 
protein, presenting a binding area on the C-terminal loop that is inaccessible in the Ser179Ala 
mutant.  Changes in the switch II region, which changes when GTP hydrolyzes in other Ras 
superfamilies and regulates protein-protein interactions, also show that the changes in the C-
terminal charge can be transmitted through the protein.  The changes suggest that the regulation 
caused by Ser179 phosphorylation is at least somewhat independent of the GTP-GDP status at 
the active sire.  Further research should examine how the isoprenylation affects the activation of 
Rap1B, and examine the changes that occur with GTP binding, possibly with the use of different 
GTP analogues other than GTPS. 
All of these models demonstrate that the regulation of respiration is multifaceted across 
many biochemical pathways in ways that are just starting to identify.  In many of the structural 
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models examined in this dissertation, the large changes were stabilized by charged interactions or 
hydrogen bonds.  The binding of glycerol in the active site of GK creates hydrogen bonds 
between the glycerol and GK that close the active site and prime the GK for activation.  Further 
interactions stabilize the activation loop that is 30 Å from the active site.  The loop stabilization 
aligns the hydrophobic residues and further closes the active site for activation.  Even in well-
studied human hemoglobin, there are interactions between the heme pocket and the disulfide 
bridges introduced in the octameric hemoglobin that affect the overall ability to bind ligand.   
Each of these components feeds into the respiratory system and affects the other 
components.  Without hemoglobin, aerobic respiration and superoxide production would not 
occur because not enough oxygen would be present.  Rap1B helps to regulate the immunological 
system and creates superoxide from the oxygen delivered by hemoglobin.  The glycerol 
metabolism pathway supplies electrons to the electron transport chain that will end up utilizing 
oxygen to create water.    
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